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Abstract 
 
Programmed protein assembly has vast potential in applications as diverse as 
bioreactors, smart materials and drug delivery. However, to realise this potential, exact 
control of the assembly process is required. Thus, this thesis describes generic 
genetically controlled methods to engineer the self-assembly of geometrically designed 
protein fusions to form user-defined structures. In particular, it shows how designed 
fusion proteins can be reacted to form fibres and encapsulations via split-intein 
mediated native chemical ligation in both one-pot and stepwise syntheses. When 
compatible fusions are mixed, they react quickly via a split-intein mediated native 
chemical ligation (NCL) to produce peptide bonded products in high yields (75 % yield). 
The correctly formed products can be purified to high homogeny and were shown to 
form the intended user-defined structures.  
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1 Introduction 
1.1 Synthetic biology 
There is no stringent definition for synthetic biology. Nonetheless, the simplest and 
arguably the most precise, is defined by the Synthetic Biology Project, ‘Synthetic biology 
is a) the design and construction of new biological parts, devices and systems and b) the 
re-design of existing natural biological systems for useful purposes’ (“What Is Synthetic 
Biology?” 2015). It is also an important method to use in analysing our knowledge of 
biology i.e. do we understand a system to the extent that we can design it according to our 
needs (“What Is Synthetic Biology?” 2015). In March 2003, the MIT Synthetic Biology 
Working Group produced a list of potential applications of synthetic biology. These were 
energy production and storage, new devices and assembly, molecular medical devices, 
bioreactors, programmable devices and control logic, programmed organisms, smart 
materials, sensors, complex assembly and terraforming (Community 2003). This PhD fits 
extremely well into these definitions as it seeks to create a toolkit of designed fusion 
proteins that are engineered to self-assemble into differing nano-structures. These may 
have potential applications in bioreactors, smart materials or drug delivery.  
 
1.2 Self-assembly in nature 
One method to engineer and design novel self-assembly systems is to take inspiration 
from nature, as nature uses self-assembled proteins to produce many diverse structures 
ranging from cages, fibres, network and matrices. Organisms have developed and evolved 
these useful protein structures to perfection over millions of years. Below are examples of 
such protein assemblies found in the nature: 
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 Protein cages 1.2.1
Protein cages are hollow protein nanoparticles that have a number of important roles. 
Perhaps the most well-known cages are the viral capsids, which carry the viral genetic 
material. They have well-defined, symmetrical, capsule-like structures, with a 
monodispersed size (Figure 1.1). They are produced from multiple copies of one or a few 
protein subunits. Due to their function, delivery of their viral genome, these self-
assembled capsids need to be robust and well-regulated. Hence, the size of the viral 
capsid is found to be correlated to the size of the viral genome (Roos et al. 2007; Cadena-
Nava et al. 2012).  
Two mechanisms have been proposed for the assembly of the capsids (nucleation-and-
growth and en masse), both involve the RNA polymers assisting the cage assembly 
(Perlmutter and Hagan 2015). The RNA polymers and cage subunits are produced at the 
same time via the host’s existing organelles. Once the RNA polymers are transcribed and 
the cage subunits are folded, the RNA interacts with the cage subunits, guiding / 
recruiting them to surround it. When the cage subunits are in close proximity, they 
interact with each other to form cages with the RNA polymer in the cavity. The most 
common capsid organisation is icosahedral. An icosahedron has at least 60 identical 
subunits forming at least 20 triangular faces. The triangular number (T = x) refers to the 
number of distinct coat protein subunits present in an icosahedral asymmetric unit. Figure 
1.1A is an illustration of icosahedral assemblies of capsid proteins with different 
triangulation numbers, where the letters denote alternative conformations of the same 
capsid protein. Figure 1.1B is an example of a self-assembly capsid, the cowpea chlorotic 
mottle virus (CCMV) (Perlmutter and Hagan 2015). The capsid is made out of three 
different conformations of protein capsid and assemble to T=3 icosahedral geometry. The 
diameter of the complete CCMV capsids is 28 nm. This highlights that the assembly of 
the viral capsid is highly efficient, where only one gene is needed to encode a protein 
capsid that is able to assemble into a robust protein cage. 
Chapter 1 Introduction 
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Figure 1.1 Structures and self-assembly of spherical viral capsids. (A) Illustration of icosahedral assemblies 
of capsid proteins with different triangulation numbers, where different letters denote different 
conformations of the same capsid protein. (Adapted from Mateu, 2013). (B) Schematic of the assembly 
mechanism for cowpea chlorotic mottle virus (CCMV). Different conformations are distinguished by colour 
(Adapted from Perlmutter and Hagan, 2015). 
 
In contrast to the viral capsid, bacterial microcompartments (BMCs) are a lot larger 
(typically 100-150 nm in diameter) and are assembled from 10 to 20 different proteins. 
BMCs play an important role in metabolic pathways: localising the metabolic enzymes in 
a BMC increases reaction rates, compartmentalising toxic intermediates and enabling 
tight control through regulated access to the cage. This optimises the metabolic pathway 
(Brown, Blackwell, and Hammer 2018). The icosahedral BMCs are assembled from shell 
proteins that come in three main forms, BMC-H, which forms a hexamer, BMC-P, which 
forms a pentamer and BMC-T, which forms a trimer (Kerfeld and Erbilgin 2015; Parsons 
et al. 2010; Chiranjit Chowdhury et al. 2014). The combination of BMC-H and BMC-T 
components tile together to form 20 triangular faces of the icosahedron Figure 1.2. The 
pores in the BMC-H tiles are smaller, allowing molecules of just a few carbon atoms in 
and out of the microcompartment (Kerfeld and Erbilgin 2015). Whereas, the BMC-T 
pores are larger, presumably for movement of bigger molecules, and these can be opened 
or closed (Kerfeld and Erbilgin 2015). BMC-P is the vertex of the icosahedron Figure 1.2. 
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Figure 1.2 Schematic diagram of the icosahedron BMC that assembled from three types of oligomeric 
proteins, i.e. hexamers, trimers and pentamers. Both hexamers and trimers form the faces of the BMC and 
the pentamers form the vertices of the BMC. PduA (PDB ID 3NGK) is an example of the hexameric BMC-
H; PduB (PDB ID 4I61) is an example of the trimeric BMC-T; and CcmL (PDB ID 2QW7) is an example 
of the pentameric BMC-P. 
 
Another interesting example of protein cages are “Anfinsen cage” chaperonins. Various 
types of chaperonins are found in prokaryotic cells, endosymbiotic organelles, archaea 
and eukarya (Spiess et al. 2004). Chaperonins are essential for organismal viability. 
Anfinsen cage chaperonins provide an enclosed environment to enable either unfolded 
proteins to fold or misfolded proteins to be unfolded and then refolded (Motojima 2015; 
Spiess et al. 2004). The most studied chaperonin is the Group I chaperonin, 
GroEL/GroES found in E. coli. Unlike most protein cages, the GroEL/GroES chaperonin 
is not spherical, it is cylindrical with two distinct chambers and ‘lids’ (Figure 1.3A). The 
hollow cylindrical structure with two chambers is assembled from two rings of 
heptameric GroEL and the lids are made up of heptameric GroES. The two chambers 
work in tandem, i.e. when one is “opened” the other is “closed”. In the open GroEL ring 
conformation, ATP is bound to equatorial domains forcing an expanded tube 
conformation.  This exposes an inner hydrophobic surface of the apical domain (Figure 
1.3B) that can bind peptides in an unstructured conformation. Subsequently, GroES 
interacts with the ATP-mobilised apical domains, causing large apical domain 
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movements and capping the chamber to form a cage. These movements lead to the release 
of the unfolded polypeptide into the encapsulated chamber, where re/folding takes place 
(Figure 1.3C). Finally, ATP undergoes hydrolysis, which weakens the affinity for GroES.  
Subsequent binding of ATP in the other GroEL ring sends an allosteric signal that ejects 
GroES, the now folded protein, and the hydrolysed ADP from the chamber (Figure 1.3D-
F). At the same time, the opposite ring is now set up to become the folding-active 
chamber (Figure 1.3E-F). 
 
Figure 1.3 (A) Crystal structure of chaperonin complex GroEL/GroES (PDB ID 1AON); axial view of 
GroES (PDB ID 1HX5); and axial view of GroEL (PDB ID 1IOK). (B-F) A schematic diagram of the 
folding of the non-native polypeptide via the GroEL/GroES chaperonin. T-red circle represents ATP; D-red 
circle represents ADP; blue line represents polypeptide; blue folded line represents folded protein; red curve 
represents GroES; two blue chambers represent two GroELs. (A) The two chambers work in tandem, i.e. 
when one is “opened” the other is “closed”. In the open GroEL ring conformation, ATP is bound to the 
equatorial domains forcing an expanded tube conformation. (B) The unstructured polypeptide binds to the 
inner hydrophobic surface of the apical domain followed by GroES interacting with the ATP-mobilised 
apical domains, causing large apical domain movements and capping the chamber to form a cage. (C) The 
unfolded polypeptide is released into the encapsulated chamber, where re/folding takes place. (D) ATP 
undergoes hydrolysis, which weakens the affinity for GroES.  (E) ATP and polypeptide bind to the other 
GroEL ring. (F) GroEL ejectes GroES, the now folded protein, and the hydrolysed ADP from the chamber 
while the opposite ring is set up to become the folding-active chamber. 
 
A final, simpler, example of intracellular protein cages are Ferritins. Ferritins regulate 
intracellular metal concentrations to prevent any cytotoxic accumulation and aggregation 
of metal particles in the cell (Lawson et al. 1991; J.-L. Lee, Park, and Kim 2007). Ferritin 
is made from 24 monomeric proteins where each subunit consists of a four α-helix bundle 
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with an extra shorter fifth helix at the C-terminus, Figure 1.4A. Each monomer interacts 
with 6 adjacent subunits through 3 different interaction faces (forming a dimer, a trimer 
and a tetramer at different interfaces) to form an octahedral cage with an internal cavity ~ 
80 Å in diameter, Figure 1.4B-D (Zhang and Orner 2011). It is thought that the non-polar 
tetramerisation interfaces acts as an electron transfer channel that can convert insoluble 
Fe(III) to soluble Fe(II). Once converted, the soluble Fe(II) can exit the ferritin cage via 
the hollow channel in the trimerisation interfaces. This channel is created by the polar 
amino acids Asp and Glu (Zhang and Orner 2011).  
 
Figure 1.4 Crystal structure of a human ferritin cage (PDB ID 4Y08). (A) monomeric ferritin subunit. (B-D) 
Human ferritin cages showing 3 different interfaces, i.e. dimer, trimer and tetramer, in rainbow colour.  
 
These examples highlight how nature uses a number of key design features to 
spontaneously assemble complex ordered cage structures:  
(i) Symmetry – In nature, numerous protein domains will form specific dimeric, trimeric 
and higher polymeric species. These form the vertices and/or sides of a cage. Cages can 
be assembled from symmetry related homo-oligomeric proteins or from different 
symmetry related oligomeric proteins.  The symmetry enables docking into the cage 
structure and thus, uses less initial subunits.  
(ii) An ordering driving force - No matter the number of protein monomers required to 
form a cage, they require a specific driving force to dock correctly.  In the case of the 
viral capsids, RNA polymers direct the subunits into position, changing their 
conformation and enabling protein interfaces to form. In the other examples, the docking 
interfaces are already present and are driven to associate via key protein-protein 
interactions.   
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 Fibrous protein assemblies 1.2.2
Unlike protein cages, protein fibres have an elongated shape that can either provide 
structural support and protection for cells/tissues or more negatively, cause disease. 
Fibrous proteins are made up of elongated or globular proteins that assemble into fibrous 
or sheet-like structures. These fibres and sheets are mechanically strong and are water 
insoluble. There are plenty of fibrous proteins around us. An excellent example is keratin.  
Keratins can either curl into helices (α-keratins – Figure 1.5A) or bond side-by-side into 
pleated sheets (β-keratin – Figure 1.5B). The α-keratins are involved in the structure of 
hair, finger nails, the epidermal layer of the skin, quill, hooves and horns (McKittrick et al. 
2012; Bragulla and Homberger 2009; Wang et al. 2016). The β-keratin (also known as 
fibroins and corneous β-proteins) is much tougher than α-keratin, and produces materials 
such as silk, claws, scales, feather, beaks and spider webs (Calvaresi, Eckhart, and 
Alibardi 2016; McKittrick et al. 2012; Bragulla and Homberger 2009; Wang et al. 2016).  
Each α-keratin monomer unit ranges from 40-68 kDa and consists of N-terminal, central 
domain and C-terminal domains (Figure 1.5A). The N and C-termini are responsible for 
interacting with other filaments / the protein matrix, while the central domain forms the 
fibres (Wang et al. 2016; Bragulla and Homberger 2009). The α-keratins are keratins 
folded into right-handed helices that are stabilised by hydrogen bonds. The α-keratins are 
rich in cysteine residues which promote the formation of a left-handed coiled-coils via 
disulphide bonds (45 nm long) (McKittrick et al. 2012; Wang et al. 2016). The long 
coiled-coils stack end-to-end and stagger side-by-side via disulphide bonds to form 
protofilaments. Two protofilaments laterally associate into a protofibril and four 
protofibrils forms the intermediate filament with 7 nm in diameter and can link with 
various matrix proteins. Figure 1.5A summarises the formation of the intermediate 
filaments from α-keratins (Wang et al. 2016).  
For β-keratin, the monomer unit ranges from 10-22 kDa and folds into β-sheets (~2 × 2.3 
nm). These are composed of either parallel or antiparallel chains. The peptide bonds of 
the polypeptide chain force the sheets to arc slightly with respect to each other, termede 
pleated (Wang et al. 2016). The pleated β-sheets stack in an end-to-end manner forming a 
distorted left-handed helical shape. Finally, two pleated sheets superpose in opposite 
directions to form a 3 nm diameter filament. Figure 1.5B summarises the formation of the 
β-keratin filament from the pleated β-sheets (Wang et al. 2016).  
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Figure 1.5 Schematic diagram of the formation of the (A) α-keratin and (B) β-keratin filaments. Image 
adapted from  Wang et al., 2016. (A) The α-keratin folds into a right handed α-helix. Two α-helix chains 
form a dimeric left-handed coiled-coil. The dimers stack end-to-end and side-by-side to form protofilament. 
Two protofilaments form a protofibril and 4 protofibrils form an intermediate filament. (B) β-keratins fold 
into pleated β-sheets that can stack end-to-end to form a distorted left-handed helical shape. Two distorted 
pleated sheets superpose in opposite directions to form a 3 nm diameter β-keratin filament. 
 
Post-translation modifications of keratins, such as the formation of disulphide bonds, 
phosphorylation, glycosylation, inter- and intra-peptide bonds can affect their 
conformation and therefore the structure of the filaments formed (Bragulla and 
Homberger 2009). Interestingly, mechanical forces such as stretching, tension and 
compression can, in certain cases, alter the secondary structure of keratins - from α- to β- 
conformation (Kreplak et al. 2004). 
In contrast to keratin, actin filaments (F-actin) are produced from the globular actin 
domains (G-actin).  The F-actin is a two-stranded helical polymer that is important in 
defining the shape of the cytoskeleton, cell motility, cell division and muscle contraction. 
The 41.8 kDa G-actin monomer’s atomic structure has been solved (Figure 1.6A) and 
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shows a globular ATPase with two major domains each of which has two subdomains. 
The ATP binding side is positioned deep inside a cleft. The ATPase activity of G-actin is 
very low, but the activity is increased by a factor of 40,000 when it polymerises into F-
actin (Kudryashov and Reisler 2013). F-actin assembly starts with a few G-actins forming 
a nucleus and then polymerising in a head-to-tail conformation via ATP driven docking 
(Carlier and Pantaloni 1997). Then the F-actin hydrolyses ATP with a rate constant of 0.3 
s−1. The release of phosphate from the F-actin initiates intra- and intermolecular 
conformational rearrangements in the filament that results in the formation of less stable 
and more flexible ADP-actin filaments (Carlier and Pantaloni 1997). This leads to the 
depolymerisation of F-actin. The growing end of the filament is known as the barbed end 
(minus) and the shrinking end is known as the pointed end (plus).  Subsequently, a steady 
state of F-actin is reached. This is known as treadmilling, where a balance between the 
associations of G-actin to the filament ends is in constant equilibrium with the 
disassociation of G-actin (Figure 1.6B). Treadmilling occurs when the concentration of 
the free actin sub-units reaches a point known as the critical concentration Cc, where Cc 
equals the rate constant for addition of G-actin subunits divided by the rate constant for 
G-actin subunit loss (Carlier and Pantaloni 1997). This process is spontaneous and slow. 
However, in vivo, there are regulatory proteins to speed up the process. For example, the 
protein profilin binds to the ATP-bound G-actin, acting as a cap on the barbed end, 
preventing elongation; the Arp2/3 complex initiates nucleation and introduce branches on 
existing filaments; and the cofilin proteins can severe filaments into short fragments and 
promote the disassociation of subunits (Pollard, Blanchoin, and Mullins 2002; 
Dominguez and Holmes 2011; Carlier and Pantaloni 1997).  
  
Figure 1.6 The polymerisation of the actin filaments. (A) Crystal structure of the G-actin binding an ATP 
molecule (PDB ID 1ATN). (B) A schematic diagram of the treadmilling of an actin filament. Red ovals 
represent ADP-bound G-actins; and the blue ovals represent ATP-bound G-actins. The barbed end is the 
polymerisation of the ATP-bound G-actins polymerases forming F-actin while the pointed end is the 
depolymerisation of the ADP-bound G-actins, shrinking the F-actin. The F-actin hydrolyses ATPs, which 
results in less stable F-actin, hence depolymerisation.  
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These examples highlight how nature uses the same design features found in cage 
assembly to spontaneously assemble fibrous structures:  
(i) Symmetry – In general, fibres use only one or two polymerising units.  However, the 
orientation of these defines how fibres extend. Thus, like cages, the protein subunits are 
symmetry related where the ends of the subunits are orthogonal to ensure head-to-tail 
polymerisation. 
(ii) An ordering driving force – Similar to cage formation, fibre formation requires a 
specific driving force. The key driving force in fibre assembly, in nature, is driven by 
non-covalent bond formation. In the case of keratin, post translational modifications play 
a crucial role in the type of keratin formed, while, the polymerisation of F-actin depends 
on ATP.  Interestingly, many of the driving forces are constitutionally “on” and the 
regulation of the polymerisation is controlled by the availability of subunits.  For example, 
many regulatory proteins inhibit polymerisation through sequestration. 
 
 Protein matrices 1.2.3
Matrix proteins are large molecules tightly bound to form extensive networks via cross-
linking insoluble fibrous protein. Elastin is one interesting example of the structural 
protein that forms an extensive network of elastic fibres, the tropoelastin. It is an 
important component in tissues, such as ligaments, skin, lungs, tendons and major arteries. 
The small soluble tropoelastin (50-70 kDa) has highly extensible yet elastic asymmetric 
coil, with a protruding foot that encompasses the C-terminal cell interaction motif (Figure 
1.7A) (Baldock et al. 2011). Although it has been studied extensively, the exact 
mechanism for assembly has not been completely elucidated. There are, however, several 
models that have been proposed to explain how elastin produces its unique properties, i.e. 
elasticity, resilience and strength (Anwar 1990; Rauscher 2017; Debelle and Alix 2002). 
Importantly, all can agree that elastin undergoes alternative splicing during transcription 
and therefore various tropoelastin isoforms are translated (Green et al. 2014; Debelle and 
Alix 2002). All of these tropoelastin isoforms are rich in alanine, glycine, valine, proline 
and lysine residues (Anwar 1990; Debelle and Alix 2002). The lysine residues react to 
form covalent bonds and thus cross-link tropoelastin monomers together by forming 
desmosine, isodesmosine and other lysine derivatives (Anwar 1990).  It has been found 
that, between the cross-linked regions, there are mixtures of α-helices, β-strands and 
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undefined structures (Debelle and Alix 2002). It is believed that these regions contribute 
to the elasticity. The packing of the tropoelastin is still under investigation because it’s 
hydrated nature is crucial for its elasticity (Rauscher 2017; Debelle and Alix 2002). 
Figure 1.7B shows the crude model of the packing of tropoelastin into elastin fibres and 
the changes in structure when it is being stretched. 
 
Figure 1.7 (A) The structure of tropoelastin solved by SAXS (image adapted from Baldock et al., 2011b). 
(B) A schematic diagram of the packing of elastin fibres in a network and when it undergoes stretching.  
 
Another example of a protein matrix is fibrin, which is important for blood clotting 
(haemostasis). Fibrin forms a net-like structure capturing plasma, red blood cells, white 
blood cells and coagulant enzymes etc. to stop a wound from bleeding. This is achieved 
by a 340 kDa glycoprotein complex protein called fibrinogen. Fibrinogen consists of 
dimers of three proteins, Aα, Bβ and γ. The Aα, Bβ and γ fold into a triple coiled-coil 
arrangement, where A, B and γ form one end of the triple coiled coil and the α, β and γ 
form the other.  The two halves are held together at the N-termini with disulphide bonds 
while the C-termini points in opposite directions (Figure 1.8A). During coagulation, 
thrombin activates fibrin formation by cleaving off small peptides from the N-terminus of 
the Aα, and Bβ proteins – these are termed small fibrinopeptides A and B (FpA and FpB, 
respectively) (Figure 1.8B) (Undas and Ariëns 2011; Kattula, Byrnes, and Wolberg 2017; 
Weisel and Litvinov 2017). This creates “knobs” that insert into “holes” present at the C-
terminal of the β and the γ chains on another fibrin.  The association of these form 
protofibrils. Subsequently, the aggregation of protofibrils forms a network. Finally, with 
the presence of thrombin and calcium ions, transglutaminase factor XIII (FXIII) is 
activated to cross-link the fibre chains. The FXIII cross-links the fibre chains with 
isopeptide covalent bonds between lysine and glutamine residues (Weisel and Litvinov 
2017; Kattula, Byrnes, and Wolberg 2017). The concentration of thrombin present affects 
the rate of cleavage of FpB and hence the thickness and tensile strength of the fibrin 
(Wolberg, Campbell, and Wolberg 2008; Undas and Ariëns 2011). The release of FpB 
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promotes lateral aggregation and hence increases the thickness of the fibrin formed 
(Undas and Ariëns 2011). 
 
Figure 1.8 (A) Crystal structure of fibrinogen without the flexible N-termini of Aα, the FpA and the FpB 
(PDB ID 3GHG). The added schematics represent the flexible N-termini of Aα, the FpA and the FpB. (B) 
Schematic diagram of the formation of a fibrin fibre (adapted from Weisel and Litvinov, 2017). The 
thrombin cleaves off the fibrinopeptides allowing the fibrin monomer to form protofibrils via knob-hole 
interactions. Two protofibrils aggregate  laterally and pack into fibrin fibres. 
 
Protein matrices again show the same design principles as cages and fibres with some 
interesting differences:  
(i) Symmetry – Similar to fibres, the formation of protein matrices tend to involve one or 
two crossing-linking protein subunits. These units have symmetry related orthogonal 
interaction points that order the assembly. 
(ii) An ordering driving force – Although, in line with the discussed cages and fibres, a 
driving force is required for assembly, in these cases both covalent bond formation 
(elastin) and activation via a protease cleavage event (blood clotting) are used. Covalent 
bonds were used when a stronger product was required (elastin). Blood clotting requires 
greater control, thus the subunits are by default inert and “off” until specifically activated.  
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1.3 Protein building blocks for synthetic biology 
Studying the design rules from nature has enabled a number of groups to design and 
engineer self-assembly systems of protein domains into specific nanostructures. These 
include: (i) computational docking of protein domains and the design of protein interfaces 
to produce novel cages and repeat proteins (ii) fusing different oligomeric species 
together to guide self-assembly and (iii) the re-design of existing modular proteins such 
as repeat protein motifs to produce fibres and cages. These will be discussed in more 
detail below. 
 
1.4 Computational docking of protein domains and design of 
protein interfaces to produce specific nanostructures 
A number of recent studies have shown that structures of existing proteins from the 
protein database can be mined for protein domains that can be computationally 
redesigned to self-assemble into a user-specified architecture (King et al. 2014; Voet et al. 
2014; Hsia et al. 2016; Figueroa et al. 2013; Fallas et al. 2017; Bale et al. 2016).  In each 
case, oligomeris structures deposited in the PDB are docked into the desired 
nanostructure using RosettaDock. Then, RosettaDesign is used to modify the protein 
interface regions to increase binding affinity and/or introduce new protein interfaces. The 
RosettaDesign program was coded by the group of David Baker and has been used for 
many re-design and protein engineering purposes (“About RosettaCommons” 2015). 
These include the redesign of individual protein scaffolds into new enzymes and the de 
novo design of individual protein folds (King et al. 2014; Stranges and Kuhlman 2013; 
Voet et al. 2014; Bale et al. 2016; Fallas et al. 2017). 
 
 Nanocages 1.4.1
With regard to novel nanostructure design, one of the most exciting studies was the 
design of novel nanocages by King et. al. (King et al. 2014). Similar to nature, to obtain a 
caged structure they firstly decided on a symmetry related architecture, i.e. tetrahedral, 
cubic, octahedral, etc.  Then, all oligomeric protein structures from the PDB were aligned 
at the vertices of each form. The oligomeric species chosen for each form was such that 
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the proteins symmetrically contacted each other to form the cage.  For example, to create 
tetrahedral or octahedral cages, 271 trimeric proteins were used and docked with 
Rosetta’s tcdock program (King et al. 2014, 2012). From this, 10 (for tetrahedral) or 20 
(for octahedral) trimeric structures had “good” docking (no steric clashing of any two 
non-bonding atoms in the structures) and these were then subjected to RosettaDesign and 
FoldIT. Here, the amino acids at the interfaces were mutated in silico to generate new 
interfaces. The end result were pairs of new amino acid sequences, one for each building 
block. A total of eight tetrahedral and 33 octahedral designs were selected for 
experimental characterisation. Out of seven tetrahedral and 17 octahedral that expressed 
natively, one design of each architecture was crystallographically solved Figure 1.9. 
Recently, these design principles have been taken further and icosahedral cages with 26-
31 nm diameters have been produced using two instead of single protein domain 
components (Bale et al. 2016). 
In addition, Hilvert’s and Sundquist’s groups brought the cages designed by Baker’s 
group a step further by showing its potential in drug delivery. Hilvert and co-workers 
mutated 6 residues on the cavity surface to arginine of 13 nm diameter cages (O3-33), 
creating a positively charged cavity (Figure 1.9C) (Edwardson, Mori, and Hilvert 2018). 
This allowed negatively charged DNA and RNA duplexes to enter the cavity through the 
~3.5 nm pores in vitro. They successfully transported siRNA, via the cages, into GFP-
expressing HeLa cells to knockdown the GFP-expression (Figure 1.9C) (Edwardson, 
Mori, and Hilvert 2018). Moreover, Sundquist and co-workers re-designed Baker’s 60-
subunit nanocage, I3-01, to transport cargo from one cell to another. They engineered a 
fusion protein named EPN-01 by fusing two short peptide sequences to the N and C-
terminus of the I3-01 cage forming protein.  The N-terminal peptide was capable of 
membrane binding and the C-terminal peptide was able to recruit the Endosomal Sorting 
Complexes Required for Transport machinery (ESCRT) (Votteler et al. 2016). The 
ESCRT machinery catalyses the final membrane fission step required for release from the 
cell. The study successfully produced ~100 nm vesicles in human embryonic kidney 
293T cells. These vesicles contain multiple protein nanocages that closely match the 
structure of the I3-01 (Figure 1.9D). The vesicles containing the nanocages was 
successfully released into the cell culture and entered into HeLa cells (Votteler et al. 
2016). They further showed that cargo can be packed in the nanocages and delivered to 
another cell via this system. 
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Figure 1.9 Crystal structure of the designed (A) octahedral and (B) tetrahedral cages (Adapted from King et 
al., 2014). (C) Schematic diagram of modified O3-33 cages designed by Baker and co-workers transporting 
siRNA into HeLa cells, knocking-down gene expression (Adapted from Edwardson, Mori and Hilvert, 
2018). (D) On the left, isosurface model of the 3D cryo-EM reconstruction where the EPN membrane is 
green, individual protein nanocages are gold and the scale bar = 25 nm; in the middle, Western blots 
showing myc-tagged EPN-01 protein harvested from HEK-293T cell culture supernatants (top blot), 
cellular EPN-01 proteins in the Triton-insoluble and Triton-soluble fractions (bottom blots) (both I3-01 and 
EPN were tagged with a myc-tag); on the right, confocal fluorescence images of HeLa cells transfected 
with myc-EPN-01 stained for myc (green), DNA (blue) and actin (red). Note that EPN-01 is localised 
primarily in intracellular compartments and at the plasma membrane (white arrow) (Adapted from Votteler 
et al., 2016). 
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 Repeat protein 1.4.2
Besides nanocages, recent studies have also shown that proteins composed of repeats 
units (see Section 1.6 for description) can also be redesigned with RosettaDesign. In one 
study, Baker’s group screened for repeat proteins that would dock to form new homo-
oligomeric species (C2-C6 symmetries).  Once suitable candidates were selected, protein-
protein interfaces were optimised by RosettaDesign. 96 oligomeric designs were selected 
for protein expression of which 64 were successfully expressed. Of the 64, 26 were 
analysed by SAXS with 15 matching the SAXS profile that was expected. Finally of the 
15 with matching SAXS data, 5 structures (two dimers, two trimers and a tetramer) were 
successfully solved to atomic resolution by X-ray crystallography (Fallas et al. 2017). The 
two dimers and tetramers were built from idealised Ankyrin repeat (ANK) proteins 
(Figure 1.10A,B and E) while the trimers were built from consensus tetratricopeptide 
repeat (TPR) proteins and a de novo designed repeat protein (Figure 1.10C and D) (Fallas 
et al. 2017). 
 
Figure 1.10 Crystal structured of the computationally designed cyclic homo-oligomers based on from (A, B 
and E) Ankyrin repeat proteins, (C) consensus tetratricopeptide repeat proteins and (D) de novo designed 
repeat proteins. 
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Unlike Baker’s high throughput screening approach, Voet et. al. successfully designed 
and created highly soluble, stable six-fold symmetrical β-propeller protein using a 
specific template. A natural six-bladed β-propeller i.e. the sensor domain of a protein 
kinase from Mycobacterium tuberculosis (PDB code 1RWL, Figure 1.11A), was divided 
into individual ‘blades’ for sequence comparison. They used FastML (a webserver for 
probabilistic reconstruction of ancestral sequence) to identify the possible ancestral blade 
sequence. The third blade of 1RWL sequence is most likely to be the ancestor and was 
used as the template to construct a hexameric protein with perfect C6 symmetry using 
RosettaDock (RosettaDesign docking simulation software) (Voet et al. 2014). 1000 
conformations were created and the one with the best scoring was used to build a single 
polypeptide chain carrying six identical repeats using the Molecular Operating 
Environment (MOE). Then, the Rosetta protein modelling suite was used to further 
analyse the energy of all amino acids at each position before final inspection and 
tweaking manually. The final symmetrical β-propeller peptide, Pizza6, consists of 42 
residues. It is highly soluble and folds stably into a six-fold symmetrical β-propeller 
protein Figure 1.11B. Multimeric versions of Pizza6 were also created with two and three 
repeats (Pizza2 and Pizza3), Figure 1.11C and D.  
 
Figure 1.11 Crystal structure of the six bladed β-propeller protein. (A) The non-symmetrical six-bladed 
1RWL template protein. (B) The symmetrical six bladed protein, Pizza6 (PDB ID 3WW9). (C) 
Dimerisation of the three repeats Pizza3 (PDB ID 3WW8). (D) Trimerisation of the two repeats Pizza2 
(PDB ID 3WW7). 
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1.5 Fusing different oligomeric species together to guide self-
assembly 
In nature, numerous protein domains will form specific dimeric, trimeric and higher 
polymeric species. These structures spontaneously assemble and are held together by 
interfaces stabilised by hydrophobic non-covalent interactions, hydrogen bonding and salt 
bridges. The ability of oligomeric domains to self-assemble makes them interesting 
candidates for building nanostructures. For example, if one wished to form a cage, 
specific oligomers can be fused together, causing one oligomer to form the vertices and 
the other oligomer to form the sides.  
 
 Protein fusions of redesigned oligomeric proteins 1.5.1
An excellent example of this type of cage was designed by Lai et. al. (Lai, Cascio, and 
Yeates 2012). They created 16nm cages from the naturally trimeric protein, 
bromoperoxidase (the vertices), and a naturally dimeric protein, M1 virus matrix protein 
(the sides). They fused a subunit of the bromoperoxidase and a subunit of the M1 virus 
matrix protein by an α-helical linker which oriented the symmetry axes of the two 
components to intersect at an angle half the tetrahedral value of 109.5° (Lai, Cascio, and 
Yeates 2012). With this angle, twelve designed subunits self-assembled to form a 
tetrahedral cage as shown in Figure 1.14A. One key point of the design was the 
orientation of each component;  the linker must be rigid enough to keep the components 
at the correct angle but be flexible enough to allow for assembly. 
 
Figure 1.12 Examples of nanostructures formed by oligomers. (A) Schematic diagram of self-assembly 
16nm tetrahedral cage by fusing a homotrimer and a homodimer by an α-helical linker (adapted from Lai, 
Cascio, and Yeates 2012).  
 
Another good example of fusing oligomeric domains and other building blocks to build 
nanostructures is the use of a system called SpyCatcher and SpyTag in conjunction with 
tetrameric avidin subunits (Fairhead et al. 2014). SpyCatcher and SpyTag are peptides 
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engineered to form a spontaneous isopeptide bond with each other. They used the Spy 
system to link chimeric avidin subunits together forming a network. The avidin units used 
were a mixture of dead streptavidin and traptavidin (an ultra-stable designed biotin 
binding avidin). They fused SpyTag or SpyCatcher to the C-terminus of the dead 
streptavidin. The fused dead streptavidin subunits formed a chimeric tetramer with 
traptavidin subunits in various combinations i.e. four dead streptavidin only, three dead 
streptavidin and one traptavidin, two dead streptavidin and two traptavidin, one dead 
streptavidin and three traptavidin or four traptavidin only. Different combinations can be 
separated by ion exchange chromatography. Mixing different chimeric tetramers, desired 
SpyAvidin i.e. octamers or eicosamers can be assembled (Figure 1.13A) (Fairhead et al. 
2014). Different combinations gave rise to different number of traptavidins binding to 
biotin. Besides that, the SpyCatcher/Tag was used to create multimeric enzyme 
nanoclusters (Figure 1.13B). Here, the SpyCatcher peptide and its binding partner SpyTag 
were fused to a dimeric cytochrome P450 monooxygenase mutant (P450BM3m) and a 
tetrameric glucose dehydrogenase (GDH), respectively (Yin et al. 2019). The fusion 
proteins successfully self-assembled into a 2D layer of multimeric enzyme nanoclusters 
that facilitated NADPH regeneration and convert indole into indigo pigment at a much 
faster rate. 
  
Figure 1.13 Nanostructures formed using SpyCatcher/Tag. (A) Schematic diagram of octamer and 
eicosamer construction. The blue strips represent SpyCatchers; the light blue strips represent SpyTags; the 
purple boxes represent dead streptavidin subunits; and the green boxes represent traptavidin subunits that 
bind to biotin (adapted from Fairhead et al., 2014). (B) Schematic diagram of the formation of the 
multimeric enzyme nanoclusters by the protein fusions (adapted from Yin et al., 2019). 
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Artificial created oligomers can be designed to be used as protein building blocks as well. 
Kim et. al. created different oligomers using green fluorescent protein (GFP) (Kim et al. 
2015). They developed a split ‘superfolder’ GFP system where they split the eleven β-
strands of GFP into two i.e. 11th β-strand GFP and truncated 1-10th β-strand GFP. They 
fused the 11th β-strand to the N-terminal of the truncated 1-10th β-strand GFP with an 
addition of a flexible tri-peptide (Gly-Gly-Thr) linker (Figure 1.14). This linker is 
designed to provide maximal polymerisation while avoiding intramolecular GFP 
formation i.e. the 11th β-strand GFP will only polymerise with other truncated 1-10th β-
strand GFP and form a fluorescently matured GFP as shown in Figure 1.14 (Kim et al. 
2015). It can self-assemble to a wide range of oligomers i.e. from dimer to decamer 
(Figure 1.14).  
 
Figure 1.14 Schematic diagrams of the 11th β-strand of GFP fused to the N-terminal of truncated 1-10th β-
strands of GFP using a short peptide linker resulting in oligomerisation and differing GFP oligomers. 
(Adapted from Kim et al., 2015). 
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 Coiled-coils 1.5.2
Besides globular proteins, the elongated coiled-coils have been re-designed to 
oligomerise into novel nanostructures. Coiled-coils contain a heptad repeat pattern of 
hydrophobic and charged amino acid residues, forming an alpha-helical secondary 
structure (Figure 1.15). The heptad repeat pattern is a sequence of seven amino acids in H 
P P H P P P manner, here H represents hydrophobic residues and P represents hydrophilic 
residues. The hydrophobic residues force the helices to gently coil around each other in a 
left-handed direction, forming an amphipathic structure as shown in Figure 1.15 
(Armstrong et al. 2009; Harbury et al. 1998). The amino acids at hydrophobic and 
hydrophilic positions play a role in oligomerisation of coiled-coils. In particular the exact 
amino acids at positions a - d and e - f tend to be the main determinants of the oligomeric 
state.  For example, the dimeric leucine zipper encodes for a leucine at the d position 
(Baxevanis and Vinson 1993; Ciani et al. 2010). 
 
Figure 1.15 Schematic diagram of an heptad repeat coiled-coil. The regular α-helix produces a left-handed 
coiled. H and green circles represent hydrophobic residues, and P represents hydrophilic residues (Adapted 
from Harbury et al., 1998; Armstrong et al., 2009). 
 
With regards to nanostructure design, Fletcher et. al. successfully designed coiled-coils to 
self-assemble into cages with a diameter of 100 nm. The system uses two de novo coiled-
coil building blocks: (i) a homotrimer called CC-Tri3 and (ii) a heterodimer called CC-Di. 
Both the CC-Tri3 and CC-Di possess cysteines on each of their coiled-coils Figure 1.15.  
To create the assembling system the CC-Tri3 is incubated with either half of the CC-Di 
coiled-coil. This creates two complementary trimeric hubs CC-Tri3—CC-Di-A and CC-
Tri3—CC-Di-B via disulphide linkage. When mixed together, these two hubs will self-
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assemble to form hexagonal networks that closes to form cages (Figure 1.16A) (Fletcher 
et al. 2013). Moreover, the homo-trimer coiled-coil can be decorated with peptides or 
proteins via fusion at their termini. For example, recombinantly produced fusion proteins 
of cysteine-free GFP on either terminus of the Cc-Tri3 have successfully formed hubs 
with CC-Di and assembled into cages when mixed (Ross et al. 2017). 
On the other hand, instead of using multimeric assembly, Gradišar et. al. used a single 
polypeptide chain containing 12 coiled-coil segments to fold into a tetrahedral cage 
(Gradišar et al. 2013). This strategy utilises the ability of the coiled-coil segments to form 
defined anti-parallel and parallel dimers. The coiled-coil segments were separated by 
flexible peptide hinges, via a Ser-Gly-Pro-Gly motif. The chain path follows the edges of 
a tetrahedron, passing through each edge exactly twice, so that the polypeptide chain 
interlocks the structure into a stable shape formed by the six coiled-coil dimers (Figure 
1.16B). The protein folds to form a tetrahedral nanocage structure named TET12. 
Recently, the group has developed the system to produce a more soluble tetrahedron, a 
rectangular pyramid (that contains a four-branched vertex), and a triangular prism that 
can self-assemble in vivo and in vitro (Ajasja Ljubetič et al. 2017). 
 
Figure 1.16 (A) Schematic diagram of the self-assembly CC-Tri3—CC-Di-A and CC-Tri3—CC-Di-B.  The 
CC-Di-AB is linked to CC-Tri3 via disulphide bonds producing complimentary trimeric hubs. When mixed 
together, it self-assembles into cages. The green circles represent CC-Tri3, the homotrimer coiled-coil; the 
red circles represent CC-Di-A, the acidic alpha helix of the heterodimer; and the blue circles represent CC-
Di-B, the basic alpha helix of the heterodimer (Adapted from Fletcher et al., 2013). (B) Schematic diagram 
of the self-assembled TET12. A single chain of 12 coiled-coil segments separated by flexible linker folds 
into a tetrahedron by forming specific antiparallel and parallel dimers (Adapted from Ljubetič et al., 2016). 
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 Fusion protein of coiled-coils and oligomeric proteins 1.5.3
Several groups have successfully utilised coiled-coils as the actual driving force to drive 
assembly of structural proteins into differing protein nanostructures (Ross et al. 2019; 
Sciore et al. 2016). For example, octahedral protein cages with ~18 nm diameter have 
been formed by fusing tetrameric four-heptad coiled-coil to the C-terminus of the trimeric 
esterase protein (Figure 1.17A) (Sciore et al. 2016). Here, the esterase proteins act as the 
sides and the coiled-coils are the vertexes. In contrast, nanotubes with a diameter of 
approximately 24 nm and various lengths up to 600 nm were assembled when trimeric 
four-heptad coiled-coil fused to the C-terminus of the pentameric cholera Toxin B (CTB) 
(Figure 1.17B) (Ross et al. 2019). Interestingly, weak interactions of the CTB pentamers 
were observed when the coiled-coil brought them into close proximity. 
 
Figure 1.17 Diagram of the self-assembly of (A) nanocages and (B) microtubes. (A) The fusion of 
homotrimer esterase (PDB 1ZOI), where the C-termini are indicated with red spheres, and homotetramer 
coiled-coil (PDB 3R4A) self-assembled into nanocages. The nanocages formed were analysed by negative 
stained EM. (From right) Representative 2D class-averaged images of the cages and projections generated 
from the 3D electron density map, and the reconstructed electron density viewed along the fourfold and 
threefold axes with one esterase trimer shown modelled into the electron density. The lower images show a 
slice through the electron density (Adapted from Sciore et al., 2016). (B) The fusion of homopentamer CTB 
(PDB 3CHB) and homodimer coiled-coil (to represent homodimer coiled-coil, PDB 1COI was used here) 
self-assembled into microtubules. The microtubules formed were analysed by crystallography and TEM. 
(Top right) A section of the crystal structure looking down the z-axis, showing packing of the tubes and the 
inner lining of the coiled-coils. (Top left) Longitudinal axis of the crystal structure. (Bottom) Incubation of 
58 μM CTB-coiled-coil fusions in 0.5 M ammonium sulphate gave rise to tubular structures under TEM 
with a diameter of approximately 24 nm and various lengths up to 600 nm. 
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1.6 The re-design of existing modular proteins to produce user 
defined nanostructures 
Repeat proteins are a large family of proteins fold that are composed of repeated units of 
20-30 amino acids. These units encode for secondary structural elements that stack 
together and form the final three dimensional fold. Thus, such protein repeats thus 
possess very symmetrical structures, with series of regularly spaced secondary structural 
elements.  Interestingly, the more repeats in a folded domain, the greater the proteins 
stability. Figure 1.18 shows an indicative selection of different repeat proteins: antifreeze 
protein (AFP), ankyrin repeat (ANK), Armadillo repeat (ARM), Huntingtin, elongation 
factor 3, protein phosphatase 2A and the yeast kinase TOR 1 (HEAT) repeat, hexapeptide 
repeat, leucine rich repeat (LRR), tetratricopeptide repeat (TPR) and WD40 repeat (Main, 
Lowe, et al. 2005). 
 
Figure 1.18 Ribbon representations of repeat proteins. (A) The crystal structure of Rhagium inquisitor AFP 
(PDB code 4DT5). (B)  The crystal structure of an improved thermally stabile designed ANK with a 
redesigned C-capping module (PDB code 2XEE). (C) The ARM repeats subunit from murine β-catenin 
(PDB code 3BCT). (D) The HEAT repeats domain from a protein phosphatase 2A holoenzyme with B55 
subunit (PDB code 3DW8). (E) The crystal structure of hexapeptide repeats (1M8N). (F) The LRR region 
from a ribonuclease inhibitor (PDB code 1DFJ). (G) The crystal structure of a TPR (PDB code 1A17). (H) 
The crystal structure of the C-terminal WD40 domain of TUP1 (PDB code 1ERJ). All repeat proteins are 
coloured according to secondary structure where red for α-helices, yellow for β-strands, and green for 
loops. 
 
Chapter 1 Introduction 
41 
 
There has been great success in the design of repeat proteins by creating proteins of 
tandemly arrayed consensus repeats. The consensus residues correspond to the most 
frequent amino acid residue found at each position in the repeated unit. For example, 
Main et. al. used consensus-based design to successfully engineer novel tetratricopeptide 
repeat proteins (TPRs) (Main et al. 2003). They aligned all known TPR sequences and 
selected the most frequent at each position. Currently, the TPR motif can be found in over 
1556 different proteins with differing number of repeats (D’Andrea and Regan 2003; Finn 
et al. 2014). Similarly, Mosavi et. al. and Kohl et. al. designed proteins based on a 
consensus ANK repeat (Mosavi, Minor, and Peng 2002; Kohl et al. 2003). Interestingly, 
these designs produce “bare” scaffolds i.e. while the design process selects for those 
amino acids important for structural integrity, it removes all amino acids important for 
binding functions.  However, binding function can be easily engineered into the structures 
through directed evolution (Schlinkmann and Plückthun 2013; Egloff et al. 2014) or a 
variation of the above consensus approach (Grove et al. 2010, 2012; Speltz, Nathan, and 
Regan 2015).  
Given their designability, repeat proteins have also been successfully used as building 
blocks of various “smart” nanostructures. Examples include: 
(i) Main’s group utilisation of three repeats of CTPR (CTPR3) as a building 
block and intein meditated Native Chemical Ligation (NCL) to form fibrous 
nanostructures. Two different methods were experimented, i.e. (1) 
uncontrolled fibres extension that successfully produced various lengths of 
fibres; and (2) iterative fibres extension where a precise extension of CTPR3 
was produced via stepwise addition. Both methods were successful and the 
details will be discussed further in the next section (Section 1.7). 
 
(ii) The use of an 18 repeat consensus TPR protein (called CTPR18) to form a 
hydrogel by adding multivalent cognate- polyethylene glycol (PEG) cross-
linker (Figure 1.19A) (Grove et al. 2012). Grove et. al. created a gene that 
encoded for 3 repeat TPR units that bound a DESVD peptide (Binders - B) 
with 3 repeat units that were without binding sites (Spacers - S). The order 
was B-S-B-S-B-S (Figure 1.19A). The S acts as a spacer so that the cross-
linking sites are equally spaced and offset by 120° along the helices (Figure 
1.19A). 4-arm star-like PEG-DESVD cross-linkers are created by coupling 
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peptides through an N-terminal cysteine and DESVD peptide is added at the 
C-terminus. The gel was formed when PEG-DESVD was added to CTPR18. 
Interestingly, when 500mM sodium chloride (NaCl) was added, the gel 
dissolved as the DESVD-B interaction is dependent on the ionic strength of 
the solution (Grove et al. 2012).  
 
(iii) The use of the same CTPR18 protein to form a functional film by adding PEG 
as a plasticiser on a Teflon surface. Grove et. al. deposited the same CTPR18 
and PEG 400 (low-molecular-weight grade PEG) on Teflon tape to allow the 
solvent evaporate. After solvent evaporation, solid 100µm thick multi-layered 
films were formed in an ordered manner (Grove, Regan, and Cortajarena 
2013). In this structure, the film could still bind the DESVD peptide 
suggesting that some of the binding sites were “open” to binding. 
 
(iv) A minimised designed β-roll motifs was used to form filaments through the 
reversible polymerisation initiated by the addition of lanthanum (Scotter et al. 
2007). Scotter et. al. designed a 34- and 50-amino acid minimised β-roll motif 
based on the nonapeptide (peptide that contains nine amino acids) consensus 
sequence from alkaline protease. It contained three β-strands and two calcium-
binding sites (34-amino acids) and an elongated version with five β-strands 
and five calcium-binding sites (50-amino acids). Even though both proteins 
are designed with calcium-binding sites, both peptides did not show any 
conformational change upon the addition of calcium. However, both peptides 
did specifically aggregate upon the addition of lanthanum (Figure 1.19B) 
(Scotter et al. 2007). Lanthanum is used to replace calcium because it has an 
additional charge and a similar ionic radius. The aggregations of these 
peptides caused by lanthanum were identified as ordered filaments.  
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(v) A β-strand was designed to form metal-mediated self-assembly β-barrel with a 
hollow centre. The four β-strand residues were fused with loop forming 
residues on the C-terminus and two pyridyl metal binding sites at the C- and 
N-termini (Yamagami, Sawada, and Fujita 2018). The zinc salts coordinate 
two β–strands into dimers, of which three dimers then self-assemble into 
cylindrical antiparallel β-sheets barrel with a hydrophobic pore (Figure 1.19C). 
 
(vi) Zipper-forming protein repeats were designed to create fast self-assembling 
and thermally stable fibrils. Four polypeptide blocks were engineered where 
each block consisted of 16 repeats of a zipper-forming segment from four 
different amyloid morphological classes. These were separated by a flexible 
linker, the glycine-rich sequence from the Nephila clavipes MaSp1 dragline 
spidroin protein (Figure 1.19D) (Dai et al. 2019). All four block polypeptides 
were observed to self-assemble into highly ordered fibrils. 
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Figure 1.19 Examples of nanostructures created by repeat proteins. (A) Schematic diagram of the CTPR18 
from top and the side view, where red blocks are CTPR18 with binding sites (B) and CTPR18 without 
binding sites (S). Formation of a gel with the addition of PEG-peptide cross-linker (adapted from Tijana Z. 
Grove et al., 2012). (B) Schematic diagram of the reversible polymerisation of the minimised designed β-
roll motifs on addition of lanthanum (adapted from Scotter et al., 2007). (C) The formation of a synthetic β-
barrel. The zinc salt (bottom molecule) induced dimer formation of the β-strand-loop fusion peptide (green 
represents the β-strands, blue represents the loop) and three of the dimers formed a hollow β-barrel (adapted 
from Yamagami, Sawada and Fujita, 2018). (D) Schematic diagram of the design of the polypeptide block 
and the atomic force microscopy image of one of the fibrils formed (bottom) (adapted from Dai et al., 
2019).  
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1.7 Native chemical ligation (NCL) driven protein assembly 
Another system of protein assembly that has been employed is the native chemical 
ligation (NCL) mediated protein assembly. Proteins that have intein embedded in its 
polypeptide chain undergo NCL. Upon translation, the intein will excise itself, ligating 
the two flanking protein extein domains via peptide bond (Shah and Muir 2014). The 
formation of a peptide bond between the two exteins is known as protein splicing. During 
protein splicing, an N–S or N–O acyl shift forms a thioester or oxoester bond at the N-
extein/intein junction Figure 1.20A. This reactive intermediate is attacked during 
transthioesterification by the side chain sulfhydryl or hydroxyl group of the first residue 
in the C-extein, which can be Cys, Ser, or Thr, to give a branched intermediate, Figure 
1.20B. Then, cyclisation of the conserved Asn residue at the C-terminus of the intein 
releases the intein. Finally, the thioester bond between the exteins rearranges to a peptide 
bond by a spontaneous S–N or O–N acyl shift, Figure 1.20C. 
 
Figure 1.20 Schematic diagram of NCL driven by inteins. (A) Firstly, an N–S or N–O acyl shift forms a 
thioester or oxoester bond at the N-extein/intein junction. (B) This reactive intermediate is attacked in 
transthioesterification reaction by the side chain sulfhydryl or hydroxyl group of the first residue in the C-
extein, which can be Cys, Ser, or Thr, to give a branched intermediate. (C) The cyclisation of the conserved 
Asn residue at the C-terminus of the intein releases the intein. Finally, the thioester bond between the 
exteins rearranges to a peptide bond by a spontaneous S–N or O–N acyl shift. X can be sulphur or oxygen 
(adapeted from Shah and Muir, 2014). 
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Here are some examples of fibre formation driven by NCL:  
(i) Three repeats of CTPR (CTPR3) were used to form fibrous nanostructures 
by intein initiated NCL. Originally the CTPR3 was designed with an 
additional capping C-terminal helix to prevent oligomerisation (Main et al. 
2003). This had to be removed to introduce a compatible oligomerisation 
interface at the C-terminus (CTPR3S). Phillips et. al. fused a His-tag at 
the N-terminus and a Mxe Gyr A (MxGA) intein to the C-terminus of 
CTPR3S (Jonathan J. Phillips, Millership, and Main 2012). The intein 
was modified to enable cleavage by sodium 2-mercaptoethanesulfonate 
(MESNa), which produced an exposed thioester at the C-terminus.  Factor 
Xa (FXa) was then used to cleave the His-tag at the N-terminus to expose 
a reactive N-terminal cysteine.  The NCL could then take place to produce 
CTPR polymerisation  (Figure 1.21A) (Jonathan J. Phillips, Millership, 
and Main 2012). 
 
(ii) Harvey et. al. demonstrated controlled fabrication of CTPR3S by 
iterative NCL reaction, producing CTPR12S with 12.5 % yield (Harvey, 
Itzhaki, and Main 2018). The fabrication started with the ligation of a cap, 
CTPR3S with an exposed cysteine on the N-terminal (cleaved by TEV 
protease), and linker, CTPR3S sandwiched by a TEV site on the N-
terminus and an exposed thiol group on the C-terminal (MxGA intein 
cleaved by MESNa). The product can be cleaved by TEV protease to 
reveal a C-terminal cysteine and therefore can further ligate with another 
linker (Figure 1.21B). The fibres can then extend to a specific length. 
However, due to the ligation yield, i.e. 75 %, the extension of CTPR3 was 
limited to 4 sequential ligations joining 5 protein modules together 
(Harvey, Itzhaki, and Main 2018). 
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Figure 1.21 Intein-mediated protein assembly. (A) The fusion of CTPR3S, His6 and Intein. CBD is a 
chitin binding protein that is used for protein purification. Factor Xa and MESNa are then used to cleave the 
His6 and intein, which leaves CTPR3S to elongate with other CTPR3S and form fibrous 
nanostructures, as shown in the TEM (adapted from Jonathan J. Phillips, Millership and Main, 2012). (B) 
Schematic diagram of the controlled fabrication of CTPR3S using iterative NCL reaction via MxGA 
intein. 
 
1.8 Thesis aims 
As this introduction shows, many studies have shown that there are a number of ways that 
existing proteins can be used as templates to design novel self-assembly systems – from 
cages to fibres and hydrogels (Woolfson 2014; Flenniken et al. 2009; Fletcher et al. 2013; 
Speltz, Nathan, and Regan 2015; Grove et al. 2012; Jonathan J. Phillips, Millership, and 
Main 2012). Nonetheless, as can be seen, these systems are often very specific or require 
the user to have in depth knowledge of highly intensive computer programming. The 
work reported in this thesis aims to develop a generic self-assembly system that does not 
depend on precise protein domains and specific protein-protein interfaces. The system 
utilises symmetrical protein domains as building blocks and NCL mediated by intein and 
split-intein protein pairs as the main driving force.  These design principles are applied to 
form different complex morphologies such as fibres and cages in a precise manner. 
Importantly, this work presents a novel approach for iterative protein structure assembly 
that is able to incorporate functionalised protein domains onto specific locations of the 
assembled structure.  
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2  Materials and Methods 
2.1 Introduction 
This chapter describes the materials and methods used throughout the thesis.  It includes: 
(i) the methods used to produce recombinant DNA, (ii) expression and purification of 
recombinant proteins, (iii) reaction conditions used for protein ligations, (iv) 
purification of the ligated protein products, (v) the analytical techniques used to analyse 
the ligated products formed and (vi) estimation of yields.  
 
2.2 Molecular biology 
 Vectors used 2.2.1
The vectors used to express the various recombinant proteins were pOPINE, pOPINF 
(OPPF-UK) and pET23b (Novagen) as shown in Figure 2.1. All vectors are high copy 
number plasmids, ampicillin resistance and are a T7 expression system where the 
recombinant protein was inducible with Isopropyl-β-D-1-thiogalactopyranoside (IPTG).  
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Figure 2.1 Map of the vectors used in this thesis. (a) pOPINE vector; (b) pOPINF vector; and (c) pET23b 
(+) vector. The maps show the AmpR is the ampicillin resistance gene (green), the multiple cloning site 
(MCS); the polyhistidine affinity tag (pink arrow); the T7 promoter, the T7 terminator and the KpnI site 
on the pOPINF vector.  
 
 Construction of expression vectors to produce fusion proteins genes 2.2.2
All recombinant fusion protein genes were constructed by cloning combinations of the 
protein domains listed in Table 2.1 into the vectors described in Section 2.2.1. Initially 
the DNA sequence encoding fusion proteins were constructed by inserting genes 
sequentially using the strategy outlined in Figure 2.1. First, the SpeI and BglII 
restriction sites were added into the expression vector along with TEV using the KpnI 
restriction site. Each gene was amplified, by PCR, incorporating a NheI restriction 
enzyme cut site 5’ of the gene and SpeI and BglII restriction enzyme cut sites 3’ to the 
gene. The expression vectors have SpeI and BglII restriction enzyme cut sites; thus to 
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obtain sequential cloning, the expression vector was cut with SpeI and BglII, and the 
amplified gene NheI and BglII restriction enzymes. The NheI and SpeI produce 
compatible overhangs and enable the gene to be ligated into the vector.  On ligation the 
NheI/SpeI sites from the gene and the vector, respectively, are destroyed.  This leaves 
the SpeI and BglII at the 3’ end of the gene ready for the next gene to be ligated into.  
Once the 1st generation of fusion proteins were constructed, 2nd and 3rd generation 
fusions could be created by PCR amplifying sections of the 1st gen fusions and sub-
cloning these with other appropriate restriction enzymes. Table 2.2 summarises all the 
fusion protein plasmids created and used. It lists the protein domains present (from N- 
to C-terminus). All were verified by DNA sequencing (Beckman-Coulter Genomics or 
Source Bioscience) and were constructed either by myself or, where indicated, by Dr. J. 
Wright or K. Richardson. 
Table 2.1 Protein domains used in the Thesis. 
 
Nomenclature (Abbreviation) 
 
DNA size (bp) 
 
Reference 
 
Affinity Tags 
 
Chitin Binding Domain (CBD) 
 
156 Watanabe et al. 1994 
6-Histidine tag (H)  18 Hengen 1995 
Glutathione S-transferase (GST) 218 Frangioni and Neel 1993 
 
Inteins 
 
Mxe Gyr A intein (MxGA) 
 
564 
 
Chong et al. 1997 
Gp4-1 split-intein (GpN/C) 264 and 111 Dassa et al. 2009 
IMPDH-1 split-intein (ImpN/C) 303 and 123 Dassa et al. 2009 
 
Repeat Domains 
 
Monofoil-4P (M4P) 
 
123 
 
Blaber and Lee 2012 
CTPR3S (CTPR3) 306 Phillips, Millership, and Main 2012 
CTPR390S (CTPR390) 306 Cortajarena et al. 2004 
Alpha Helical Linkers  30 Chen, Zaro, and Shen 2013 
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Figure 2.2 Example of the construction of fused sequences via the sequential insertion of domains. The 
first sequence encoding the TEV domain and SpeI/BglII restriction sites were added into the expression 
vector’s KpnI site. Then, the following domains were added sequentially using SpeI/NheI and BglII. SpeI 
and NheII digestions produce compatible overhangs that can be ligated but destroy the SpeI and sites. The 
final product is the plasmid of the fusion protein, H-TEV-GpC-CTPR3-M4P. 
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Table 2.2 Summary of the constructs produced and chapters where they are used. 
Chapter Construct from N- to C-terminus Constructed by 
3 H-M4P-CTPR3-MxGA-CBD JNW 
3 H-TEV-CTPR3-M4P JNW 
3 H-M4P-CTPR3-ImpN JNW 
3 H-GST-ImpC-CTPR3-M4P JNW 
3 H-M4P-CTPR3-GpN JNW 
3 H-GpC-CTPR3-M4P JNW 
3, 5 H-CBD-ImpC-CTPR3-M4P WLW 
3 M4P-CTPR3-ImpN-CBD-H WLW 
3, 5 M4P-CTPR3-GpN-H WLW 
3 H-CTPR3-M4P JNW 
4 H-CBD-ImpC-CTPR3-GpN KR 
4 H-CBD-GpC-CTPR3-ImpN JNW 
4 H-CTPR3-ImpN JNW 
4 H-CTPR3-GpN JNW 
4 H-GpC-CTPR3 JNW 
4 CTPR3-GpN-H WLW 
4 CBD-ImpC-CTPR3-GpN-H WLW 
4,5 H-GpC-CTPR3-ImpN-CBD WLW 
5 H-GpC-CTPR390-ImpN-CBD WLW 
 
Where H is the polyhistidine-tag; CBD is the chitin binding domain; GST is the Glutathione S-transferase; 
TEV is the Tobacco etch virus cleavage site; M4P is the Monofoil-4P; CTPR3 is the three repeats of the 
consensus tetratricopeptide; CTPR390 is the three repeats of the consensus tetratricopeptide with binding 
pocket; MxGA is the Mxe GyrA intein; ImpN is the N-terminal domain of IMPDH-1; ImpC is the C-
terminal domain of IMPDH-1; GpN is the N-terminal domain of Gp41-1; GpC is the C-terminal domain of 
Gp41-1. 
All constructs containing of M4P and CTPR3 / CTPR390 are connected via α-helical linkers. 
 
 
 Standard molecular biology techniques 2.2.3
Below outlined the commonly used molecular biology techniques employed to 
construct the vectors via PCR amplification and restriction digest sub-cloning described 
in Section 2.2.2. 
 
2.2.3.1 Polymerase Chain Reaction (PCR)  
Primer Design. In general, pairs of primers of between 20 and 40 bases long were 
designed with an annealing temperature of 50 – 65 °C.  One primer was complementary 
to the coding strand and the other complementary to the non-coding strand of the gene.  
In addition, the appropriate restriction enzyme sequences were added to each primer so 
that the resultant amplified genes could be inserted into the vector in the appropriate 
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place. The primers were synthesised by Integrated DNA Technologies. The annealing 
temperature (Tm) was determined by SnapGene® software by using nearest neighbour 
(NN) adjusted equations as per Equation 2.1 (SantaLucia and Hicks 2004; Markham 
and Zuker 2008). 
Equation 2.1 
𝑇ெ =
Σ∆𝐻°(1000)
Σ(∆𝑆° + 0.368 ቀ𝑁2ቁ (ln[𝑁𝑎
ା])) + 𝑅(𝐼𝑛 ቀ𝐶்𝜒 ቁ)
− 273.15 
Where H and S values are calculated with regards to the G thermodynamic 
nearest-neighbour parameters in Table 2.3, R is the gas constant (1.9872 cal/K-mol), N 
is the total number phosphates and [Na+] represents the total concentration of 
monovalent cations present (0.05 mM), CT is the molar strand concentration (0.25 uM) 
and c equals 4 for non-self-complementary duplexes and 1 for self-complementary 
duplexes. 
Table 2.3 Nearest neighbour thermodynamic parameter for DNA Watson-Crick 
pairs in 1 M NaCl. 
Propagation sequence H° (kcal/mol) S° (e.u.) G°37 (kcal/mol) 
AA/TT -7.6 -21.3 -1.00 
AT/TA -7.2 -20.4 -0.88 
TA/AT -7.2 -21.3 -0.58 
CA/GT -8.5 -22.7 -1.47 
GT/CA -8.4 -22.4 -1.44 
CT/CA -7.8 -21.0 -1.28 
GA/CT -8.2 -22.2 -1.3 
CG/GC -10.6 -27.2 -2.17 
GC/CG -9.8 -24.4 -2.24 
GG/CC -8.0 -19.9 -1.84 
Initiation +0.2 -5.7 +1.96 
Terminal AT penalty +2.2 +6.9 +0.05 
Symmetry correction 0.0 -1.4 +0.43 
 
PCR Amplification. PCR amplification was carried out in 50 µL reaction volumes 
containing: 10 µL Q5 5x reaction buffer; 1 µL 10 mM dNTPs, 2.5 µL 10 mM Forward 
Primer, 2.5 µL 10 mM Reverse Primer, 1 µL Template (<10 ng), 32.5 µL double 
dionised H2O (ddH2O), 1 µL Q5 DNA Polymerase (NEB). The reaction was initially 
heated to 98 °C for 2 mins to denature the DNA strands. After the initial denaturation 
step, 30 cycles of amplification were performed by using the following: 98 °C 
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denaturation for 30 secs, using the Tm of the primers to anneal for 30 secs and 72 °C 
extension for 30 secs per 1 kbp. The PCR ended with a final extension, 72 °C for 5 mins 
and the PCR product was stored at 4 °C. 
 
2.2.3.2 DNA digestion 
Plasmid and PCR product digestion was carried out with the following components: 1 
µg DNA, 2 µL 10x FastDigest Green buffer, 1 µL of each FastDigest restriction enzyme 
(Thermo Fisher Scientific) and ddH2O to a total volume of 20 µL. The reaction was 
mixed and incubated at 37 °C for 30 mins to 1 hr. 
 
2.2.3.3 DNA gel electrophoresis 
PCR and digested products were analysed and purified (when required) using DNA 
electrophoresis. A 1% agarose gel was made by dissolving 0.5 g of agarose powder 
(Sigma) in 50 mL TAE buffer. Ethidium bromide was added to a final concentration of 
0.04 % and the gel was allowed to set at 25 °C. Samples were loaded into wells after 
being mixed with 6x loading dye or premixed with FastDigest Green buffer (Thermo-
Fisher). A marker, Quickload 2 -log DNA ladder (NEB) was used and the gel was run at 
80 V for 30 mins. Gels were visualised using a UV transilluminator. 
 
2.2.3.4 DNA clean-up and gel extraction 
PCR and digested products were extracted from the gel using Monarch PCR and DNA 
Clean-Up Kit (NEB) following the manufacturer’s instructions. When there were 
multiple PCR products or extracting digested DNA product was required, the wanted 
products were extracted from the DNA Gel after separating DNA fragments via gel-
electrophoresis.  
 
2.2.3.5 DNA ligation 
DNA ligation reactions contained the following components: 2 µL 10 x T4 DNA Ligase 
buffer, 1 µL T4 DNA ligase, digested insert DNA, digested vector DNA (100 ng) and 
ddH2O to a total volume of 20 µL. Ligations were performed with insert to vector ratios 
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of 1:1, 3:1 and 7:1.  100 ng of cut vector was always used with the mass of insert 
calculated as follows: 
Equation 2.2 
Mass Insert (ng) = ൬
𝐼𝑛𝑠𝑒𝑟𝑡𝑅𝑎𝑡𝑖𝑜
𝑉𝑒𝑐𝑡𝑜𝑟𝑅𝑎𝑡𝑖𝑜
൰ × 𝑀𝑎𝑠𝑠 𝑉𝑒𝑐𝑡𝑜𝑟 (𝑛𝑔) × (
𝐼𝑛𝑠𝑒𝑟𝑡𝐿𝑒𝑛𝑔𝑡ℎ(𝑏𝑝)
𝑉𝑒𝑐𝑡𝑜𝑟𝐿𝑒𝑛𝑔𝑡ℎ(𝑏𝑝)
) 
 
In the case of blunt-ended ligations the reaction was supplemented with 2 µl of 50 % 
PEG 4000 to aid efficiency. The reactions were carried out at 22 °C for 60 mins, 
followed by heat inactivation at 75 °C for 5 mins. 
 
2.2.3.6 Bacterial transformation of ligation reactions 
For all molecular biology, the E. coli strain XL-2 Blue (genotype: endA1, supE44, thi-1, 
recA1, gyrA96, relA1, lac, Agilent) was used. 50 µL of cells were thawed on ice before 
mixing with 1 µL of DNA and transferred to a 2 mm electroporation cuvette (Cell 
Projects, UK). The prepared cuvette was transferred to a Bio-Rad Micropulsar and 
pulsed once at 2.5 kV. If the time constant recorded > 3 ms the electroporation was 
considered successful. 500 µL of SOC media (2 % Tryptone, 0.5 % Yeast extract, 10 
mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 20 mM glucose, 10 mM MgSO4) was added to 
the cuvette and mixed with the cell suspension before being transferred to a 7 mL bijou 
container and incubated at 37 °C, 200 rpm, for 1 hr. All the recovered transformation 
was plated onto a LB agar plate supplemented with 100 µg/mL of ampicillin. Plates 
were incubated at 37 °C overnight before being stored at 4 °C. 
 
2.2.3.7 Colony PCR screening 
To obtain XL2 colonies with the desired ligation, PCR screening was carried out. A pre-
made buffer and polymerase mix [OneTaq Quick Load Master Mix (NEB)] with 
primers designed to amplify over the insert region of the vectors were used. Aliquots of 
5 µL of 2x OneTaq Quick Load Master Mix, 0.25 µL of 10 µM Forward primer, 0.25 
µL of 10 µM Reverse primer and 4.5 µL of ddH2O were placed into 96 well plates.  To 
each well a single XL2 colony was mixed and then plated out. The PCR reactions were 
then reacted using the following cycle: initial denaturation 94 °C, 30 secs; 30 cycles of 
94 °C, 15 secs; 48 °C, 15 secs; 68 °C, 1 min per kb; final extension 68 °C, 5 mins. 
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Reactions were then loaded onto a DNA agarose gel (prepared as described above) and 
positive colonies selected for DNA plasmid extraction. 
 
2.2.3.8 DNA plasmid extraction  
Colonies selected for plasmid DNA extraction were prepared by inoculating single 
colonies into separate 10 mL aliquots of LB supplemented with 100 µg/mL ampicillin. 
Cultures were incubated overnight at 37 °C, 200 rpm. 4 mL of each culture was 
harvested in 2 mL Eppendorf tubes (repeated to increase the pellet size). Plasmid DNA 
was extracted from the harvested cells using the GeneJet plasmid miniprep kit 
(ThermoFisher Scientifc). DNA quality was assayed by gel electrophoresis and 
spectrophotometry. 
 
2.2.3.9 Sanger sequencing 
To confirm the sequence of the constructs, DNA plasmids extracted from positive 
colonies were sent for Sanger Sequencing. Sequencing was carried out by 
BeckmanCoulter Genomics or Source Bioscience, using T7 Promoter primer or M13-
Forward primer. Sequencing quality was assessed and aligned to expected sequence 
results using SnapGene Software (GSL Biotech). 
 
2.2.3.10 Preparation of electro-competent cells 
Electro-competent E. coli cell lines C41 (DE3) (Lucigen) and XL2-Blue (Lucigen) were 
used in this thesis. XL2-Blue cells were used for molecular biology as they improve 
insert stability due to the deficiency of the recombination (recA) gene. They prevent the 
cleavage of cloned DNA by the EcoK endonuclease system due to the hsdR mutation. 
XL2-Blue cells also improve the quality of miniprep DNA, as they are endonuclease 
(endA) deficient. E. coli strain C41 (DE3) electro-competent cells were used for 
recombinant protein expression in this thesis. E. coli C41 cells are derived from BL21 
(DE3). It has a mutation to prevent cell death when overexpressing a variety of toxic 
proteins. C41 contain the T7 RNA Polymerase gene needed to produce the T7 promoter 
for vector expression. The T7 RNA Polymerase gene is under the control of the LAC 
promoter; therefore, expression can be controllably induced by addition of IPTG.  
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Both electro-competent cells were produced in our laboratory. The following protocol 
was used for both cells lines. As XL2-Blue cells are resistant to tetracycline, at a 
working concentration of 12.5 μg / mL, tetracycline (Sigma-Aldrich) was added to LB 
agar plates and growth media. LB agar plates and media were not supplemented with an 
antibiotic for C41 (DE3) cells. The desired E. coli strain was streaked from a glycerol 
stock onto LB agar plates and incubated overnight at 37 °C. 10 mL of LB media was 
inoculated from a single colony taken from the streaked plates and incubated overnight 
at 37 °C, at 200 rpm. 500 mL 2xYT cultures were inoculated from the 10 ml starter 
culture and grown until an optical density at 600 nm wavelength (OD600) of 1.0 was 
reached. Cultures were immediately chilled on ice for 30 mins. Cells were harvested by 
centrifugation at 5000 rpm in an Eppendorf table top centrifuge for 10 mins at 4 °C and 
re-suspended in 500 mL of sterile ice cold 10 % glycerol. Cells were pelleted again by 
centrifugation at 5000 rpm for 10 mins at 4 °C and re-suspended in 250 mL of sterile 
ice cold 10 % glycerol. This process was repeated for 100 mL and finally 1 mL of ice 
cold 10 % glycerol. Cells were then resuspended in a minimal amount of 10 % glycerol 
and 50 μL aliquots flash frozen in liquid nitrogen. These were stored at -80 °C until use. 
 
2.3 Recombinant protein expression and purification 
 Transformation of E. coli C41 (DE3) electro-competent cells with 2.3.1
recombinant plasmids 
E. coli C41 (DE3) electro-competent cells were transformed with the recombinant 
plasmids using the same procedure described in Section 2.2.3.6. 50 µL of the 
transformants were plated on a LB agar plate supplemented with 100 µg/mL of 
ampicillin. Plates were incubated at 37 °C overnight before being stored at 4 °C for up 
to 4 weeks. 
 
 Protein expression 2.3.2
A single colony of transformed E. coli C41 electro-competent cells were picked into 
100 mL LB starter culture supplemented with 100 µg/mL ampicillin. This was 
incubated for 16 hr at 37 °C, 200 rpm. 1 L of 2xYT media supplemented with 100 
μg/mL of ampicillin was inoculated with 10 mL of the starter culture and grown at 
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37 °C until an OD600 of ~1.0. Expression was induced by the addition of IPTG to a final 
concentration of 1 mM over a range of temperatures and times that were construct 
dependent. Table 2.4 summarises the protein expression conditions for each construct 
used. 
 
 Protein purification 2.3.3
To purify the proteins, both native and denaturing methods were employed. These used 
both affinity chromatography and size exclusion chromatography (SEC) as required. 
Table 2.4 summarises how each construct was purified with Sections 2.3.3.1 to 2.3.3.3 
describing each type of purification in detail. 
Table 2.4 Summary of the expression conditions, method of purification and yield 
for each protein described here. 
Chapter Construct name Expression condition Method of purification 
Yield 
(mg L-1) Temp. (°C) Duration 
3 H-M4P-CTPR3-MxGA-CBD 37 3 hr Chitin 8.4 
3 H-TEV-CTPR3-M4P 37 Overnight Denat. 50 
3 H-M4P-CTPR3-ImpN 37 3 hr Denat. 19.5 
3 H-GST-ImpC-CTPR3-M4P 37 4 hr Denat. 39.5 
3 H-M4P-CTPR3-GpN 37 Overnight Denat. 12 
3 H-GpC-CTPR3-M4P 37 Overnight Denat. 25 
3, 5 H-CBD-ImpC-CTPR3-M4P 37 4 hr Denat. 15.0 
3 M4P-CTPR3-ImpN-CBD-H 16 Overnight Native 20.5 
3, 5 M4P-CTPR3-GpN-H 16 Overnight Denat. 10 
3 H-CTPR3-M4P 16 Overnight Native 13.6 
4 H-CBD-ImpC-CTPR3-GpN 37 Overnight Denat. 20.75 
4 H-CBD-GpC-CTPR3-ImpN 37 Overnight Native /aDenat. 41.7 
4 H-CTPR3-ImpN 16 Overnight Native 15 
4 H-CTPR3-GpN 16 Overnight Native 15 
4 H-GpC-CTPR3 37 Overnight Denat. 20 
4 CTPR3-GpN-H 16 Overnight Native 40 
4 CBD-ImpC-CTPR3-GpN-H 37 Overnight Denat. 55 
4, 5 H- GpC-CTPR3-ImpN-CBD 16 Overnight Native /aDenat.  50.0 
5 H-GpC-CTPR390-ImpN-CBD 16 Overnight Denat. 53.5 
aIn these cases the denaturing purification yielded higher purity than the native purification. 
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2.3.3.1 Native expression and nickel affinity purification 
Cells were induced and grown 16 °C overnight.  Cells were harvested by centrifugation 
for 10 mins at 10,000 x g, the cell pellet was resuspended in 50 mM Tris pH 8, 300 mM 
NaCl (equilibration/wash buffer) and snap frozen in liquid nitrogen before being stored 
at -80 °C. The resuspended cell pellets were thawed and lysed by sonication on ice for 
10 mins (per 100 mL) with 30 secs pulse using a Vibra-cell sonicator (Sonics).  
Insoluble matter was removed by centrifugation for 30 mins at 39,000 x g at 4 oC.  
The cleared protein lysate was loaded onto a pre-equilibrated Nickel-iminodiacetic acid 
(Ni-IDA) resin. To charge the resin, 10 to 20 mL of iminodiacetic acid (IDA) resin was 
incubated with 2 column volumes (CVs) of 100 mM NiSO4 in a 50 mL gravity flow 
column (Pierce).  It was then washed with 5 CVs of ddH2O and equilibrated with 2 CVs 
of equilibration buffer prior to loading the clear protein lysate. Once the lysate had been 
loaded onto the Ni-IDA resin, it was washed with 10 CVs of equilibration/wash buffer. 
The recombinant protein was eluted from the column with equilibration/wash buffer 
with addition of 250 mM imidazole. Dithiothreitol (DTT) was added to the elution with 
a final concentration of 5 mM. To verify the protein purified and check the purity, 
elution fractions were analysed with sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). If further purification was required, size exclusion 
chromatography (SEC) was performed using a HiLoad 16/60 Superdex 75 or 200 prep 
grade on a fast protein liquid chromatography (FPLC) system (GE Healthcare). 
 
2.3.3.2  Denatured expression and nickel affinity purification 
After induction, the temperature was maintained at 37 oC for between 4 hrs and 
overnight (refer to Table 2.4).  Cells were harvested by centrifugation for 10 mins at 
10,000 x g. The cell pellet was resuspended in 50 mM Tris pH 8, 6 M GuHCl, 300 mM 
NaCl (equilibration and wash buffer 2) and snap frozen in liquid nitrogen before being 
stored at -80oC. The resuspended cell pellets were thawed and lysed by sonication on 
ice for 10 mins (per 100 mL) with 30 sec pulses.  Insoluble matter was removed by 
centrifugation for 30 mins at 39,000 x g at 4oC.  
The cleared protein lysate was then loaded onto a pre-equilibrated Ni-IDA resin and 
washed with equilibrated/wash buffer containing 6 M GuHCl. The resin was charged as 
described in previous section. Proteins were eluted unfolded in 50 mM Tris pH 8, 6 M 
GuHCl, 300 mM NaCl and 250 mM imidazole or refolded via stepping down the 
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denaturant concentration (3 M GuHCl, 1.5 M GuHCl, 0.75 M GuHCl and 1 M urea) in 
the wash buffer 2 whilst bound to the Ni-IDA resin. When eluted denatured, proteins 
were refolded via dialysis with SnakeSkin 3.5K MWCO into 50 mM Tris pH 8, 1 M 
urea, 300 mM NaCl and 5 mM DTT. The refolded protein on the column was eluted 
with 50 mM Tris pH 8, 1 M urea, 300 mM NaCl and 250 mM imidazole. DTT was 
added to the elution with to a final concentration of 5 mM. If further purification was 
required, SEC was performed using a HiLoad 16/60 Superdex 200 prep grade attached 
to a FPLC system. To verify the protein purified and check the purity, elution fractions 
were analysed by SDS-PAGE. 
 
2.3.3.3 Native expression and chitin affinity purification  
Recombinant proteins that contain chitin binding domains attached to full intein 
domains were, when required, purified using chitin resin. An example of this is the 
fusion protein H-M4P-CTPR3-MxGA-CBD. For expression, cells were incubated for 4-
6 hr at 25 °C after induction and then harvested by centrifugation for 10 mins at 10,000 
x g.  The cell pellet was resuspended in 50 mM Tris pH 8, 150 mM NaCl 
(equilibration/wash buffer 3) and snap frozen in liquid nitrogen before being stored at -
80 oC. The resuspended cell pellets were thawed and lysed by sonication on ice for 10 
mins (per 100 mL) with 30 secs pulse.  Insoluble matter was removed by centrifugation 
for 30 mins at 39,000 x g at 4 oC. The clarified lysate was loaded onto 20 mL of Chitin 
Beads (NEB) in a 50 mL gravity flow column after the resin had been prepared with 2 
CVs of equilibration/wash buffer 3. After washing with 3 CVs of equilibration/wash 
buffer 3, the fusion protein was eluted via intein-mediated cleavage with 1 CV of 
cleavage buffer (50 mM Tris, pH 8, 100 mM NaCl, 10 % sodium 2-
mercaptoethanesulfonate (MESNA)). The cleavage buffer was added into the column 
and incubated at 25 °C for 16 hrs. After cleavage, the protein containing a C-terminal 
thioester (H-M4P-CTPR3-thio), was washed from the column. The CBD and intein was 
left bound to the resin.  To verify the protein purified and check the purity, flow-
through fractions were analysed with SDS-PAGE.  
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2.3.3.4 Further purification by Size Exclusion Chromatography (SEC) 
To further purify proteins, SEC was carried out using either a S75 or S200 HiLoad 
FPLC Superdex 16/60 filtration column (dependant on the size of the recombinant 
protein and the nature of contaminant). The Superdex column was attached to an AKTA 
Pure chromatography system (GE Healthcare), utilising a flow-rate controller that kept 
the pre-column pressure to < 0.5 mPa. The column was equilibrated with appropriate 
filter sterilised (0.2 µM) buffer prior to loading. Up to 5 mL of ~ 100 µM protein was 
loaded onto the column via the sample pump (0.5 ml per min flow rate). The column 
was then run using appropriate buffer and 4 mL elution fractions were collected. The 
eluted fractions were analysed with by SDS-PAGE and the elution fractions with 
similar purity were pooled.  
 
 Protein concentration 2.3.4
Pure recombinant proteins were concentrated to 100-200 µM with Amicon Ultra-15 
(Merk-Millipore) 3K MWCO centrifugal filter units. Protein concentrations and yield 
were determined from the absorbance at 280 nm wavelength using the extinction co-
efficient (ε) calculated from the amino acid sequence as per Equation 2.3: 
 
Equation 2.3 
ε(𝑀ିଵ𝑐𝑚ିଵ) = (𝑁𝑜. 𝑜𝑓 𝑇𝑟𝑝 × 5500) + (𝑁𝑜. 𝑜𝑓 𝑇𝑦𝑟 × 1490) + (𝑁𝑜. 𝑜𝑓 𝐶𝑦𝑠 × 125) 
 
The intensity of absorbance was scanned from 200 nm to 400 nm wavelength using a 
WBA Biowave II UV Spectrophotometer in a 1 cm path length Quartz cuvette. The 
concentration of the protein was calculated with Equation 2.4. 
 
Equation 2.4 
𝐶 =
 (𝐴𝑏𝑠ଶ଼଴ × 1000000)
(𝜀 × 𝑙)
 
where C is the concentration in µM, Abs280 is the absorbance at 280 nm, ε is the 
extinction coefficient in M-1cm-1 and l is the path length of the cuvette in cm. 
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 Protein storage 2.3.5
All recombinant proteins purified in this thesis were stored in 1 mL aliquots at -80 °C 
after being flash frozen using liquid nitrogen.  In general, they were stored in 50 mM 
Tris pH8, 300 mM NaCl, 5 mM DTT, 0-1 M urea. 
 
2.4 Native chemical ligation  
 Native chemical ligation via Mxe Gyr A intein. 2.4.1
For NCL to take place via Mxe Gyr A intein, a C-terminal thioester protein and a N-
terminal cysteinyl protein were required. These were achieved by the following: 
 
2.4.1.1 Activation of C-terminal thioesther.  
C-terminal thioester formation of H-M4P-CTPR3-MxGA-CBD was achieved by 
induced cleavage of the C-terminal Mxe GyrA intein using the reducing agent MESNa 
as described in Section 2.3.3.3 
 
2.4.1.2 Activation of N-terminal cysteine  
The H-TEV-CTPR3-M4P N-terminal activation was achieved via Tobacco Etch Virus 
(TEV) protease cleavage of the N-terminal His-tag. The TEV protease cleavage site 
used is the mutated sequence: ENLYFQ↓C, rather than the commonly used site 
ENLYFQ↓G. Thus, when TEV cleaves, it reveals an N-terminal cysteine. Purified H-
TEV-CTPR3-M4P was concentrated to 100 μM and cleaved at 25 °C in 50 mM Tris pH 
8, 150 mM NaCl, 5 % (v/v) glycerol, 5 mM tris(2-carboxyethyl)phosphine (TCEP) for 
16 hrs. Cleaved N-cysteinyl protein was then purified with Ni-IDA from uncleaved 
protein. 
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2.4.1.3 Reaction of the activated components.  
The ligation of the two activated homo-trimers, H-M4P-CTPR3-thioesther and 
cysteinyl-CTPR3-M4P, was performed in 50 mM Tris-HCl pH 8.5, 1 M NaCl, 200 mM 
MESNa, 10 mM TCEP, for 24 hrs at 30 °C with a 1:1 molar ratio of protein and final 
protein concentrations of 50 μM. The reaction was also attempted with the presence of 
denaturant i.e. 4 M GuHCl / urea. The results of ligations were analysed using SDS-
PAGE. 
 
 Native chemical ligation reactions via split-inteins 2.4.2
All ligations, unless otherwise stated, were carried out in mild conditions using a 
reaction buffer (50 mM Tris pH 8, 300 mM NaCl, 5 mM DTT) with different 
concentrations of urea and incubated at room temperature (25 C). The reactions were 
completed either: (1) on affinity column (chitin beads) or (2) in solution. The reactions 
for both methods were left to proceed under mild agitation. The ligated product can be 
purified either with Ni-IDA or chitin beads (IBA Lifesciences) depending on the 
affinity tags present on the reactants and products. Further purification was done with 
SEC. 
 
2.5 Protein analysis 
 Denaturing SDS-PAGE 2.5.1
Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE) was used 
to determine protein purity and to monitor ligation reactions. Protein samples were 
mixed with 2x loading buffer where the final buffer conditions were: 62.5 mM Tris-HCl, 
2 % SDS (w/v), 10 % glycerol (w/v), 100 mM DTT, 0.01 % bromophenol blue (w/v). 2-
20 µL of sample were loaded onto either 14 or 18 % PAGE gels depending on the 
expected protein sizes. The gel was run at 180 V for 50 - 65 mins, in running buffer: 25 
mM Tris-HCl (pH 8.3), 192 mM glycine, 1 % (w/v) SDS. Bands were visualised by 
staining using Coomassie Brilliant Blue R-250 and subsequently destained in 10 % (v/v) 
acetic acid 10 % (v/v) methanol. The resulting gel was digitised using a ChemiDoc 
Touch (Bio-Rad). Images were then annotated using associated Image Lab software 
(Bio-Rad). 
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 Reaction yield from SDS-PAGE gels 2.5.2
Protein bands were visualised using coomassie dye and yields calculated using an 
Odyssey Li-COR in 800 nm imaging channel. Integrated intensity values (I) 
corresponding to each protein band were thereby obtained. 
The equation below was used to obtain the percentage of ligated product formed:  
 
Equation 2.5 
   % Yield = ൥
൬ ಺Pಾೈ೟P
൰
൤൬ ಺Pಾೈ೟P
൰+൬ ಺Rಾೈ೟R
൰൨
൩  x 100 
     
where IP is the integrated intensity of the ligated product, MWtP is the molecular weight 
of the ligated product, IR is the integrated intensity of the most consumed reactant and 
MWtR is the molecular weight of the most consumed reactant. Equation 2.5 assumes 
that the binding of coomassie stain (and, therefore, the intensity) is linearly related to 
the molecular weight of each NCL protein.  
 
 Analytical Size Exclusion Chromatography (SEC).  2.5.3
Analytical SEC was carried out using the SuperdexTM 200 10/30 for the half cage caps, 
cages formed from their ligation and the linkers. For extended cage caps and extended 
cages, a SuperoseTM 6 10/30 column was used. The AKTA Pure or Purifier systems (GE 
Healthcare) were used to operate the columns. The columns were equilibrated into 
running buffer (50 mM Tris pH8, 300 mM NaCl, 5 mM DTT, 0 - 2 M urea (as present 
in protein buffer)). 100 μL of protein sample (50 - 100 μM) was loaded by loop onto the 
column and run at a pressure-controlled flow rate (< 1.4 mPa) with a maximum flow 
rate of 1.5 mL min-1. 1.2 CVs of running buffer were run. In certain cases, fractions 
were collected in 0.4 ml aliquots and analysed by SDS-PAGE to identify peaks and 
purity.  UV absorption peaks were processed using the Unicorn software (v5.0, GE 
Healthcare) and analysed for polydispersity, before being exported and plotted using 
Excel (Microsoft Corporation). UV 280 nm signals were normalised to a maximum of 
50 mAU for clarity. Size was estimated using the Amersham low molecular weight gel 
filtration calibration kit containing the following standards: albumin 67 kDa, ovalbumin 
43 kDa, chymotrypsinogen A 25 kDa. To quantify the relative position of each peak the 
Ve/Vo was calculated and plotted against the log10 of the molecular weight (kDa). A 
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linear trend line was drawn, and the equation used to calculate the molecular weights of 
unknown samples. Where Ve is the elution volume (mL) at the maxima of the UV 
absorption peak appears; and Vo is the void volume (mL) of the mobile phase. 
 
 Western Blot 2.5.4
SDS-PAGE gels was performed as Section 2.5.1 and transferred to the membrane using 
the Bio-Rad Trans-Blot® Turbo™ Transfer System using its preset mixed molecular 
weight program (1.5 A, 25 V for 7 mins). After blocking with 5 % milk in 1x PBS, 0.1 % 
Tween (PBST) for 1 hr, the membrane was washed twice with PBST and incubated in 
PBST with the primary antibodt at 1:1000 (monoclonal anti-His/CBD Tag antibody 
produced in mouse (Sigma)) at room temperature for 1 hr. Membranes were washed 
twice in PBST for 5 mins and incubated with 1:20000 PBST of IRDye® 680LT Goat 
anti-Mouse IgG in PBST for 1 hr in room temperature. Blots were then washed with 
PBST and PBS before being imaged with a Li-COR Odyssey Infrared Imaging System. 
 
 Mass spectrometry 2.5.5
Matrix assisted laser desorption/ionisation - time of flight mass spectrometry (MALDI-
TOF/MS) was carried out to determine accurate masses of recombinant proteins and 
post-splice reaction. To remove/reduce buffer components, samples were prepared 
either by (i) dilution using 50% acetonitrile, 1 % or 0.1 % trifluoroacetic acid in water 
(Sigma) or (ii) using EMD Millipore Zip-Tip® pipette tips according to the 
manufacturer’s instructions. 1 µl of sample from either dilution or Zip-Tip® was mixed 
1:1 with saturated sinapinic acid matrix (dissolved in 50% acetonitrile), spotted onto a 
Bruker MALDI-TOF/MS steel plate and allowed to air dry. The target plate was loaded 
into the Bruker 2000 MALDI-TOF mass spectrometer. Using positive ion mode, the 
gain and laser power was adjusted until the optimal signal/noise ratio was achieved. The 
TOF was operated in the reflectron or linear mode and each spectrum was an average of 
500 laser shots. The spectra were calibrated using Protein standards 1 & 2 (Bruker). The 
data was extracted and visualised using R, Bruker Flex Analysis or Microsoft Excel 
software. 
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 Circular dichroism 2.5.6
Circular dichroism was used to compare the number of α-helices present in the 
precursor proteins and the final product from the NCL reaction. Protein concentrations 
of 2 – 10 µM in 10 mM Tris pH 8, 50 mM NaCl and 2 mM TCEP were analysed in a 
0.5 mm path length cuvette using a Chirascan™ CD Spectrometer (Applied 
Photophysics Ltd, UK). For each sample, a spectrum from 190 – 280 nm was recorded 
with points taken at 1.0 nm intervals and 0.5 secs per point scanning time. The averaged 
spectrum of 3 repeats was taken for each sample. Data was converted to molar 
ellipticity using the equation below, 
 
Equation 2.6 
𝜃௠௢௟௔௥ =
100 × 𝜃௢௕௦
𝑀 × 𝑙
 
     
where θ𝒎𝒐𝒍𝒂𝒓 is the molar ellipticity in deg cm2 dmol-1, θ𝒐𝒃𝒔 is the observed CD signal in 
millidegrees, l is the path length in cm and M is the molar concentration of protein. 
 
 Size exclusion chromatography small angle x-ray scattering (SEC-SAXS) 2.5.7
SAXS cage samples were prepared by ligating 100 mL of 10 μM IMPDH tagged half 
cage caps and purified using the same affinity and size exclusion chromatography steps 
outlined in Section 2.3.3. Purified cages were concentrated to 10 mg/ml and dialysed 
into 10 mM Tris pH8, 50 mM NaCl, 5mM DTT buffer. SAXS experiments were 
recorded on beamline B21 at the Diamond Light Source (DLS), UK, coupled to a 
Shodex KW403-4F size exclusion column.  Data were measured at 20 °C with a 
wavelength of 0.99 Å and a 3 s exposure time per frame on a Pilatus 2 M two-
dimensional detector at 4.014 m distance from the sample, corresponding to a 
momentum transfer range of 0.004 < q < 0.4 Å−1 (q = 4π sin  λ−1, 2 is the scattering 
angle).  
 
2.5.7.1 SEC-SAXS analysis 
Elution peak, buffer selection, and subsequent buffer subtraction, intensity 
normalisation, and data merging were performed in ScÅtter (BIOISIS). Further analysis 
was carried out with a q range of 0.018 < q < 0.35 Å−1. The radius of gyration (Rg) and 
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scattering at zero angle (I(0)) were calculated from the analysis of the Guinier region by 
AUTORG (Petoukhov et al. 2007). AUTORG is a command-line program to estimate 
the radius of gyration (Rg) using the Guinier approximation: 
Equation 2.7 
𝐼(𝑠) = 𝐼(0)exp (
𝑆ଶ𝑅𝑔ଶ
−3
) 
Where I(s) is the scattering intensities, I(0) is the scattering intensities at zero angle, S is 
the scattering vector and Rg is the radius of gyration. 
The value of Rg is estimated from the best possible linear fit of ln[I(s)] versus S2 
(Guinier plot), which is valid for sufficiently small scattering vectors (in the range up to 
sRg ≤ 1.0–1.3). The radius of gyration provides an estimate of the overall size of a 
particle (the root-mean-square distance to centre-of-mass in a particle).  
The distance distribution function (P(r)) was subsequently obtained using GNOM (D. I. 
Svergun 1992), yielding the maximum particle dimension (Dmax). It reads in one-
dimensional scattering curves and evaluates the particle distance distribution function 
p(r). To demonstrate the absence of concentration-dependent aggregation and 
interparticle interference Rg over the elution peaks was inspected and analysis 
performed on frames where Rg was the most stable. The Porod exponent and molecular 
weight were calculated within the ScÅtter (BIOISIS) and ATSAS package (D. Franke 
et al. 2017), respectively. The Porod exponent is to determine the flexibility of the 
protein. 
 
2.5.7.2 Ab initio shape determination from SAXS 
The ab initio modelling was done using either GASBOR or DAMMIF (D. I. Svergun, 
Petoukhov, and Koch 2001; Daniel Franke and Svergun 2009) averaging 100 
simulations. GASBOR reconstructs protein structure by a chain-like ensemble of 
dummy residues corresponding to average residue densities which placed anywhere in 
continuous space with a preferred number of close distance neighbours for each atom. 
The centres of these residues aim to approximate positions of the C-α atoms in the 
protein structure. In addition, the number of residues equal that in the protein. 
DAMMIF is a bead modelling program. In bead modeling, a particle is represented as a 
collection of a large number of densely packed beads inside a search volume. Each bead 
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belongs either to the particle or to the solvent. Starting from an arbitrary initial model 
DAMMIF utilises simulated annealing to construct a compact interconnected model 
yielding a scattering pattern that fits the experimental data. The solutions produced by 
GASBOR/DAMMIF were shortlisted based on biophysical data and averaged using 
DAMAVER (Volkov and Svergun 2003). The averaged model was used as a template 
to generate a DAMMIN model (D. I. Svergun 1999). 
 
2.5.7.3 Comparison of experimental SAXS profile to generated atomic cage 
models 
The SAXS profile was compared to 30 manually generated differing atomic models of 
possible designed cage conformations using the program Crysol (D. Svergun, Barberato, 
and Koch 1995). The models were constructed by first manually positioning the crystal 
structure available in the Protein Data Bank (PDB) using PyMol. COOT was used to 
add connecting sequences between the domains using its Rigid Body Fit Zone 
functionality (Emsley et al. 2010) and three-fold symmetry enforced using PyMol. The 
chains were renumbered (PDBSet, CCP4 suit (Collaborative Computational Project, 
Number 4 1994)) and rigid body refined with REFMAC5 (Vagin et al. 2004) to obtain 
the final lowest energy confirmation. These final lowest energy structures were 
converted to a SAXS profile by Crysol and compared to the experimentally determined 
profile. Crysol evaluates the solution scattering from macromolecules with known 
atomic structure and fits it to experimental scattering curves from SAXS. 
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3 Design of Self-Assembled Cage 
Structure 
3.1 Introduction 
This chapter explores how recombinant protein fusions can be designed to self-
assemble into protein cages/encapsulations. Geometric symmetry design was used to 
specify the desired shapes, with assembly driven by genetically encoded native 
chemical ligation. To validate our method and investigate the limits of the system, 
trimeric half-cage caps were constructed and their assembly characterised.  
 
 System design 3.1.1
Our system is based on recombinantly expressing two fusion proteins, consisting of a 
pair of complementary oligomeric half-cage “caps”.  These use different intein systems 
to drive irreversible assembly. The half-cages are comprised of an oligomerisation 
domain, a rigid functionalisable domain, the intein driving force and affinity tags for 
purification (Figure 3.1).  The oligomerisation domain specifies the geometry of the half 
cage by acting as the primary vertex, with the rigid functionalisable domain acting as 
the cage sides. All fusions are initially inert, and they only react when mixed with a 
compatible construct. When mixed, the intein driving force catalyses the half cage caps 
to fuse via spontaneous native chemical ligation to form the cage (Section 1.7). 
 
Figure 3.1 Schematic diagram of the designed complementary half cage caps with the vertices, β-trefoil 
knot homotrimer M4P (yellow ovals), the alpha-helical linkers that link the vertices and sides (red lines), 
and the side, CTPRs (blue rectangular). Upon mixing, the differing intein assembly systems join them 
together and form a trigonal bipyramidal caged product. 
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 Trimeric half-cage caps 3.1.2
To validate our approach and explore the limits of our systems (structures formed, 
reaction speeds, efficiencies and yields), differing complementary trimeric half-cage 
caps were designed. The half cage caps were composed of: (i) the homotrimer 
Monofoil-4-P (M4P) domain as the primary vertex (Figure 3.2), (ii) consensus-designed 
tetratricopeptide repeat-containing protein (CTPR) as the sides (Figure 3.3), and (iii) 
differing intein assembly systems attached to their termini. An alpha-helical linker, 
(EAAAK)2, connects the M4P and (CTPR) proteins, projecting the CTPR units away 
from each other and thereby reducing the risk of misfolding.  The half-cage caps were 
engineered such that they would react to form a trigonal bipyramidal caged product 
Figure 3.1. 
 
3.1.2.1 Homotrimeric vertex 
The 48 amino-acid homotrimeric Monofoil-4-P (M4P) was selected as the vertex 
(Figure 3.2). Lee et. al designed the M4P by fragmenting the repeating primary 
structure of the fibroblast growth factor protein  (J. Lee et al. 2011). They narrowed the 
domain that folds into a thermostable β-trefoil knot 42 residues domain, with a KD of 
10-50 nM. M4P was chosen due to its stability and the positions of its N and C termini. 
Both termini are exposed on the same plane and are not involved in the formation of the 
β-trefoil knot. Hence, extension via the addition of protein domains at either the N or C 
termini are able to produce complementary fusions without disrupting its homo-trimeric 
behaviour.  
 
Figure 3.2 The designed homotrimer M4P chosen as the vertices for the structures. The side view and the 
top view of the crystal structure of the trimer are shown with each monomer coloured differently 
(magenta, green and turquoise). Each of the N and C termini is exposed on the same plane as labelled. 
The crystal structure of the M4P obtained from PDB 3OL0. 
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3.1.2.2 Rigid, rod-like sides 
The rod-like consensus tetratricopeptide repeat proteins (CTPRn) were chosen to be the 
sides of the tripod half-cage caps due to their rigidity, stability and symmetry (Main et 
al. 2003; J J Phillips et al. 2012). Past studies have shown that these are monomeric, 
helix-turn-helix motif proteins that easily fold into rod-like structures. Most 
importantly, CTPRn can be extended from end to end, forming a superhelix (Main, 
Stott, et al. 2005; Jonathan J. Phillips, Millership, and Main 2012). In addition, they can 
be functionalised through the penta-peptide binding pocket located on the concave 
region of the CTPR (A. L. Cortajarena et al. 2004). For example, several CTPRs have 
been modified to contain binding pockets that bind to differing penta-peptide tags 
(Speltz, Nathan, and Regan 2015; Grove et al. 2012). In our study the CTPRs were 
produced without the C-terminal capping helix.  This enables docking of the structures 
in a head to tail conformation.  Thus, for example, when discussing CTPRs in the 
following chapters CTPR3 corresponds to 3 consensus TPRs only.  
 
Figure 3.3 The sides of each half cage were composed of the repeat protein CTPR3. The crystal structure 
of CTPR3 is shown without its final C-capping solvating helix and with two helices per repeat. The 
crystal structure of the CTPR3 obtained from PDB 1NA0. 
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3.2 Closing mechanism – Previous Work 
Previously in the Main laboratory, Dr. J. Wright successfully produced trimeric half-
cage caps and investigated cage formation via cross linking with  
bis(sulfosuccinimidyl)suberate (BS3) crosslinker reagent and disulphide bond formation 
(Wright 2018). In both cases higher order structures were formed. However, most of the 
product consisted of the half-cage caps reacting intra-molecularly, rather than inter-
molecularly. Thus, the yield of higher order structures was very low.  
 
3.3 1st Generation cage closure system using the Mxe GyrA 
intein 
In order to increase the yield of reaction, differing intein systems were trialled as 
directional driving forces. In nature, inteins are found in the middle of genes. Once 
expressed, they post-translationally modify the proteins they are in by excising 
themselves while ligating the flanking polypeptides regions together (as discussed in 
Section 1.7).  The ligation is irreversible and forms a peptide bond [via native chemical 
ligation (NCL)].  
Our first-generation system was based on the Mxe GyrA (MxGA) intein for the 
directional driving force. This stemmed from work already completed in the Main 
Laboratory that used a modified MxGA intein system for one-pot and step-wise protein-
fibre assembly (Jonathan J. Phillips, Millership, and Main 2012; Harvey, Itzhaki, and 
Main 2018).  This is explained in detail in the introduction (Section 1.7). Briefly - each 
used a number of fusion proteins that contain the protein to be ligated (POI) attached to 
either a C-terminal MxGA intein, a protease activate-able N-terminal cysteine or both. 
The N-terminal cysteine is protected with an affinity tag.  When activation is required, 
the tag is cleaved with TEV protease to reveal a reaction ready cysteine. The MxGA 
intein is activated by adding MESNa reducing agent.  This induces self-cleavage and 
produces an exposed thioester. Upon mixing of the activated components, the C-
terminal thioester spontaneously reacts with the exposed N-terminal cysteine to produce 
a peptide bond.  The reaction proceeds via a transthioesterification reaction, followed by 
an S-N acyl shift which leads to native peptide bond formation (Figure 3.4). Dr. J. 
Harvey demonstrated that natively folded proteins in mild conditions and at 
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concentrations of 50 µM yields 75 % ligation in 24 hrs (Harvey, Itzhaki, and Main 
2018).  
 
Figure 3.4 Schematic diagram of the NCL driven by intein, MxGA. The two half cage caps are activated 
prior to ligation. N-terminal half cage cap, H-M4P-CTPR3-MxGA-CBD is cleaved with MESNA to 
remove MxGA-CBD and expose a thioester group, while the C-terminal half cage cap, H-TEV-CTPR3-
M4P is cleaved with TEV protease at the TEV cleavage site to remove H-TEV and reveal a cysteine. 
Upon mixing, transthioesterification took place leading to a S-N acyl shift and the irreversible formation 
of a native amide peptide bond. 
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 Recombinant protein design 3.3.1
To adapt the system to direct cage formation two protein fusions were constructed as 
follows: 
 (1) H-M4P-CTPR3-MxGA-CBD – the MxGA intein and CBD were fused to the C-
terminal of the half-cage caps and  
(2) H-TEV-Cys-CTPR3-M4P – the cysteine is introduced to the N-terminus of the 
complementary half-cage cap. 
As one would expect, both half-cage caps require activation prior to reaction. H-M4P-
CTPR3-MxGA-CBD is activated by cleaving away the MxGA-CBD with MESNa, 
resulting in a C-terminal thioester (H-M4P-CTPR3-thio). Whereas, the activation of H-
TEV-CTPR3-M4P is achieved by cleaving with TEV protease, exposing an N-terminal 
cysteine (cys-CTPR3-M4P). This enables two homotrimers half-cage caps to fuse 
together to form a single structure via NCL (Figure 3.5). 
 
 
Figure 3.5 A schematic diagram where the two activated homotrimer half-cage caps fuse together to form 
a single structure via NCL. The cleavage of the MxGA-CBD was cleaved by MESNa during chitin 
affinity chromatography. Thus, the H-M4P-CTPR3-thio can be eluted after cleavage. The H-TEV-
CTPR3-M4P is cleaved by TEV protease to reveal a cysteine. The activated half cage caps allow NCL to 
take place when mixed together. Green rectangle represents 6-Histidine tag; orange oval represents M4P; 
red line represents linker; blue rectangle represents CTPR3; pink circle represents MxGA; red rectangle 
represents CBD; and brown square represents TEV cleavage site. 
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 Recombinant expression, purification and trimerisation analysis of H-M4P-3.3.2
CTPR3-thio and H-TEV-CTPR3-M4P 
3.3.2.1 Expression and purification of H-M4P-CTPR3-thio and H-TEV-CTPR3-
M4P 
H-M4P-CTPR3-MxGA-CBD and H-TEV-CTPR3-M4P were successfully produced in 
high yields via recombinant expression and native purification (Section 2.3.3).  Figure 
3.6 shows the successful purification with yields of 8.4 mg/mL and 50 mg/mL, 
respectively. It is noteworthy that (i) H-M4P-CTPR3-MxGA-CBD was purified via 
chitin affinity chromatography (binds the CBD).  Elution of pure reaction ready product 
occured via MESNa induced MxGA cleavage to give H-M4P-CTPR3-thio (i.e. C-
terminal thioester). (ii) The observed sizes on the SDS-PAGE gel appear smaller than 
the expected.  This is due to a gel-shift phenomenon caused by the CTPRs. Previous 
studies have shown that the CTPRs have a more compact structure under standard 
denaturing conditions (Aitziber L Cortajarena, Wang, and Regan 2010). These partially 
unfolded structures may affect the SDS binding and thus exhibit a size difference on the 
gel similar to other helix-turn-helix membrane spanning proteins (Rath et al. 2009). 
 
Figure 3.6 SDS-PAGE analysis of (A) the expression and purification of H-M4P-CTPR3-MxGA-CBD 
and C-terminal thioester production, H-M4P-CTPR3-thio, and (B) the expression and purification of H-
TEV-CTPR3-M4P. (A and B) Lane L, PageRuler Broad Range Unstained Protein Ladder in kDa. (A) 
Lane 1, post-induction cell sample; Lane 2, post-wash chitin resin; Lane 3, 24 hrs cleavage with MESNa 
on chitin resin; Lane 4 and 5, chitin elution (H-M4P-CTPR3-thio); Lane 6, purified H-M4P-CTPR3-thio. 
(B) Lane 1, pre-induction cell sample; Lane 2, post-induction cell sample; Lane 3, native cell lysate; Lane 
4, flow-through fraction; Lanes 5-8, elution fractions; Lane 9, purified H-TEV-CTPR3-M4P. The green 
rectangle represents 6-Histidine tag; orange oval represents M4P; red line represents linker; blue 
rectangle represents CTPR3; pink circle represents MxGA; red rectangle represents CBD; and brown 
square represents TEV cleaving site. 
 
  
Chapter 3 Design of Self-Assembled Cage Structure 
76 
 
3.3.2.2 Trimerisation analysis of H-M4P-CTPR3-thio and H-TEV-CTPR3-M4P 
The trimeric state of the H-M4P-CTPR3-thio and H-TEV-CTPR3-M4P was confirmed 
using SEC analysis in 50 mM Tris pH 8, 100 mM NaCl buffer (Figure 3.7). Fitting of 
the H-M4P-CTPR3-thio and H-TEV-CTPR3-M4P peak maxima to calibration 
standards, gave molecular weights of 73-76 kDa (calculated trimeric molecular weight: 
65.7 kDa) and 63.6 kDa (calculated trimeric molecular weight: 63.6 kDa), respectively 
(Figure 3.7). The differences in expected and observed molecular weights are within 10 % 
error for this technique. SEC also confirms that trimerisation of the half cage caps are 
not concentration dependant in range used in this study. H-M4P-CTPR3-thio elutes as a 
single monodisperse peak at concentrations of 10, 50 and 100 μM (Figure 3.7).  
 
Figure 3.7 Superdex 200 10/30 SEC analysis of trimeric (A) H-M4P-CTPR3-thio and (B) H-TEV-
CTPR3-M4P (A) Trimeric H-M4P-CTPR3-thio at different concentrations, 100 µM (purple), 50 µM 
(blue) and 10 µM (red). (B) Trimeric H-TEV-CTPR3-M4P at 50 µM. (C and D) The half cages Ve/Vo 
(elution volume/column void volume) plotted against their Log10 molecular weights on a standard curve. 
The black squares are protein standards (C) The elution volume used was 14.6 mL. The orange triangle 
represents H-M4P-CTPR3-thio. (D) The orange circle represents H-TEV-CTPR3-M4P. 
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3.3.2.3 Activation of cys-CTPR3-M4P 
H-TEV-CTPR3-M4P was activated to its N-cysteinyl form, cys-CTPR3-M4P, by TEV 
protease cleavage (10 U per mg of H-TEV-CTPR3-M4P substrate) in 50 mM Tris, 150 
mM NaCl, 5 mM TCEP pH 8 for 16 hrs at 25 °C. Cleavage was estimated to reach 
almost 100 % by SDS-PAGE analysis. Post-cleavage cys-CTPR3-M4P was purified by 
nickel affinity chromatography to remove non-cleaved protein and increase purity 
(Figure 3.8).   
  
Figure 3.8 Activation of cys-CTPR3-M4P (18.1 kDa) by cleaving H-TEV-CTPR3-M4P (21.2 kDa) with 
TEV. Lane L, PageRuler Broad Range Unstained Protein Ladder in kDa; Lane 1, pre-cleavage of H-
TEV-CTPR3-M4P; Lane 2, post-cleavage of H-TEV-CTPR3-M4P; Lane 3, flow-through fraction from 
post-cleavage purification; and Lane 4, purified activated cys-CTPR3-M4P. The orange oval represents 
M4P; red line represents linker; and blue rectangle represents CTPR3. 
 
 NCL reaction of H-M4P-CTPR3-thio and cys-CTPR3-M4P 3.3.3
The two activated trimeric H-M4P-CTPR3-thio and cys-CTPR3-M4P were reacted in 
50 mM Tris pH 8.5, 1 M NaCl, 200 mM MESNa, 10 mM TCEP for 24 hrs at 30 °C 
with a final protein concentration of 50 μM in 1:1 molar ratio of protein. These 
conditions have been shown to give high yielding reaction when used for fibre assembly 
(Harvey, Itzhaki, and Main 2018). SDS-PAGE analysis of the reaction is shown in 
Figure 3.9. Unfortunately, there are no significant signs of successful ligation between 
the two trimeric fusion proteins.  
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Figure 3.9 NCL reaction of the activated H-M4P-CTPR3-thio and cys-CTPR3-M4P. Lane L, PageRuler 
Broad Range Unstained Protein Ladder in kDa; Lane 1, activated H-M4P-CTPR3-thio; Lane 2, activated 
cys-CTPR3-M4P; Lane 3, NCL reaction at time 0; Lane 4, NCL reaction at time 24 hrs. Orange oval 
represents M4P; red line represents linker; and blue rectangle represents CTPR3.  
 
 
 Summary 3.3.4
Both SEC and MALDI-TOF analysis confirm that the H-M4P-CTPR3-thio and cys-
CTPR3-M4P are trimeric. However, the NCL reaction of the two half-cage caps failed. 
This work was repeated by Dr. J. Harvey whom obtained the same outcome. The failure 
of the NCL reaction is likely due to steric hindrance. Thus, Dr. J. Harvey also reacted 
the two half-cages in denaturant (4 M GuHCl and 4 M Urea). It was hoped that once 
denatured, the steric hindrance would decrease, enabling the reaction to proceed. 
However, no detectable ligation product was observed (Harvey 2016). Interestingly, it 
has been shown that the trimeric M4P is incredibly stable to both temperature and 
denaturant. For example, the Main laboratory has observed the trimeric half-cages by 
SDS-PAGE after boiling and in the presence of SDS. Thus, the reaction might require 
the half-cages to be left in 8 M GuHCl for 24 hrs prior to the reaction.  Nevertheless, 
such a scheme would be too time consuming and remove many of the benefits of the 
system.  Thus, it was decided to re-engineering the assembly system to use a differing 
driving force: Split-inteins. 
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3.4 2nd Generation cage closure system using the Split-inteins 
Split-inteins are natural variants of intein domains that are divided into two separate 
polypeptide chains (Wu, Hu, and Liu 1998; Martin, Xu, and Evans 2001; Dassa et al. 
2009; Zettler, Schütz, and Mootz 2009; Carvajal-Vallejos et al. 2012). Peptide chains 
with each split-intein half are inert until complementary halves are combined, where 
upon they spontaneously fold together to produce an active intein. The now active intein 
self-catalyses their excision and ligates the two separate peptide chains together (Figure 
3.10).   
 
Figure 3.10 Schematic diagram of NCL driven by split-inteins. Following split-inteins association, an N–
S or N–O acyl shift forms a thioester or oxoester bond at the N-extein/intein junction. This reactive 
intermediate is attacked in transthioesterification by the side chain sulfhydryl or hydroxyl group of the 
first residue in the C-extein, which can be Cys, Ser, or Thr, to give a branched intermediate. The 
cyclisation of the conserved Asn residue at the C-terminus of the intein releases the intein. Finally, the 
thioester bond between the exteins rearranges to a peptide bond by a spontaneous S–N or O–N acyl shift. 
X can be sulphur or oxygen (Carvajal-Vallejos et al. 2012). 
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3.4.1.1 Recombinant proteins design 
In order to obtain a protein system that would enable step-wise assembly the Main 
laboratory (and Dr. J. Wright in particular) selected two natural split-intein pairs which 
were orthogonal but still produced fast and high yielding ligation. These were : Gp41-1 
(Gp), a split-intein from gp41 DNA helicase and IMPDH-1 (Imp), a split-intein from 
inosine-5’-monophosphate dehydrogenase (Dassa et al. 2009). Both of these split-
inteins have been shown to have high reaction rates and yields (90% in 10 mins), and 
have no cross-reactivity at 5 µM concentrations (Carvajal-Vallejos et al. 2012). 
However, the reaction does leave a short insertion of approximately 10 amino acid 
residues. This method has many advantages over the MxGA system. For example, it 
does not require pre-reaction activation and should be substantially faster and higher 
yielding (intra versus inter-molecular reaction). 
Initially 2 sets of constructs were designed:  
(1) H-M4P-CTPR3-GpN and (2) H-GpC-CTPR3-M4P,  
(3) H-M4P-CTPR3-ImpN and (4) H-GST-ImpC-CTPR3-M4P. 
In each case the N-terminus of the split-intein was fused to the C-terminus of the M4P-
CTPR3 and the C-terminus of the split-intein was fused to the N-terminus of the 
CTPR3-M4P (Figure 3.11). Dr. J. Wright investigated the yield of Gp split-inteins while 
I focused on Imp split-inteins.  
 
Figure 3.11 Schematic diagram of the formation of the trigonal bipyramidal cages via split-inteins NCL. 
Here, the N-terminal split-intein ((A) ImpN and (B) GpN) is fused to the C-terminus of the N-terminal 
half-cage caps; and the C-terminal split-intein ((A) ImpC and (B) GpC) is fused to the N-terminus of the 
C-terminal half-cage caps. Upon mixing, the split-inetins fold into an active enzyme that leads to NCL, 
joining the half-cage caps together while excising itself. Green represents the 6-Histidine tag; orange 
represents M4P; red represents the linker; blue represents CTPR3; purple represents Imp split-intein; 
brown represents CBD; and yellow represents Gp split-intein. 
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 Recombinant expression, purification and trimerisation analysis of H-M4P-3.4.2
CTPR3-ImpN and H-GST-ImpC-CTPR3-M4P 
3.4.2.1 Recombination expression and purification of H-M4P-CTPR3-ImpN and 
H-GST-ImpC-CTPR3-M4P 
Initially both H-M4P-CTPR3-ImpN and H-GST-ImpC-CTPR3-M4P were expressed 
recombinantly at differing temperatures and times. Unfortunately, no combination of 
expression conditions produced protein that could be purified natively.  Therefore, a 
denaturing protocol was used (Section 2.3.3) and shown in Figure 3.12. This produced 
good yields (19.5 mg/mL and 39.5 mg/mL respectively) with high purity. However as 
both were eluted from the Ni affinity column in 8 M Urea, they required refolding.  
Both were dialysed overnight into reaction buffer (50 mM Tris pH 8, 300 mM NaCl, 5 
mM DTT) with differing urea concentrations. No visible precipitation was observed 
when H-M4P-CTPR3-ImpN was dialysed into reaction buffer with 1 M urea in it. In 
contrast H-GST-ImpC-CTPR3-M4P showed no precipitation in 2 M and a small amount 
in 1M urea. 
 
Figure 3.12 SDA-PAGE analysis of the purification of (A) H-M4P-CTPR3-ImpN and (B) H-GST-ImpC-
CTPR3-M4P. (A and B) Lane L, PageRuler Broad Range Unstained Protein Ladder in kDa. (A) Lane 1, 
post-induction; Lane 2, native supernatant; Lane 3, native pellet; Lane 4, denatured supernatant; Lane 5, 
denatured pellet; Lane 6, flow-through fraction; Lane 7, wash fraction; Lane 8, elution fraction; and Lane 
9, purified H-M4P-CTPR3-ImpN. (B) Lane 1, post-induction denatured soluble cell lysate; Lane 2, flow-
through fraction; Lane 3-7, elution fractions; and Lane 8, purified H-GST-ImpC-CTPR3-M4P. Green 
represents 6-Histidine tag; orange represents M4P; red represents linker; blue rectangle represents 
CTPR3; purple represents Imp split-intein; and brown represents CBD. 
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3.4.2.2 Analysis of the refolded H-M4P-CTPR3-ImpN and H-GST-ImpC-CTPR3-
M4P 
To determine if the refolding of H-M4P-CTPR3-ImpN and H-GST-ImpC-CTPR3-M4P 
by dialysis was successful, analytical SEC was performed in their reaction buffers 
(Figure 3.13A and B). For H-M4P-CTPR3-ImpN, a single symmetric peak at 13 mL was 
observed.  For H-GST-ImpC-CTPR3-M4P, the 1 M urea refolded sample eluted in the 
void volume. However, the dialysed sample in 2 M urea eluted with a peak at 12.5 mL.  
Comparison of the peak maxima for H-M4P-CTPR3-ImpN obtained 1 M urea and H-
GST-ImpC-CTPR3-M4P obtained in 2 M urea with to calibration standards, gave 
molecular weights of 145 kDa (32 % larger than the calculated trimeric molecular 
weight of 99 kDa) and 160 kDa (1 % larger the calculated mass of 158.1 kDa for a 
homotrimeric species) respectively (Figure 3.13C and D). Thus, the H-M4P-CTPR3-
ImpN half cage caps run slightly larger than the protein standards predict for its trimeric 
molecular weight. This suggests that the H-M4P-CTPR3-ImpN is a less spherical 
structure than H-GST-ImpC-CTPR3-M4P. 
 
Figure 3.13 Superdex 200 10/30 SEC analysis of refolded trimeric (A) H-M4P-CTPR3-ImpN and (B) H-
GST-ImpC-CTPR3-M4P. Trimeric H-GST-ImpC-CTPR3-M4P in 1 M urea (blue) and 2 M urea (orange). 
(C and D) The half cages Ve/Vo (elution volume/column void volume) plotted against their Log10 
molecular weights on a standard curve. The black squares are protein standards. (C) The orange triangle 
represents H-M4P-CTPR3-ImpN. (D) The orange circle represents H-GST-ImpC-CTPR3-M4P. 
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1 The recombinant expression and purification of H-M4P-CTPR3-GpN and H-GpC-CTPR3-M4P were 
performed by Dr. J. Wright. 
 1Recombinant expression, purification and trimerisation analysis of H-M4P-3.4.3
CTPR3-GpN and H-GpC-CTPR3-M4P 
Both H-M4P-CTPR3-GpN and H-GpC-CTPR3-M4P expressed well and were purified 
successfully in denaturing conditions with high yield and purity (12 mg/mL and 25 
mg/mL respectively). The protein was refolded whilst bound to nickel resin to 0 M urea 
(Figure 3.14). Comparison of the peak maxima for H-M4P-CTPR3-GpN and H-GpC-
CTPR3-M4P obtained in 0 M urea with calibration standards, gave molecular weights of 
95.1 kDa (calculated trimeric molecular weight: 106 kDa) and 79.8 kDa (calculated 
trimeric molecular weight: 91 kDa), respectively (Figure 3.15) (Wright 2018). The profile 
shows that the half cage caps run slightly larger than the protein standards predict for 
their trimeric molecular weights. This suggests that they are non-spherical. 
 
Figure 3.14 SDS-PAGE analysis of the purification of (A) H-M4P-CTPR-GpN and (B) H-GpC-CTPR-M4P 
(Data obtained by Dr. J Wright). (A) Lane 1, post-induction; Lane 2, insoluble lysate; Lane 3, soluble 
lysate; Lane 4, flow-through fractions; Lane 5, wash step fractions; Lane 6, elution fraction; and Lane 7, 
purified H-M4P-CTPR-GpN. (B) Lane 1, post-induction; Lane 2, insoluble lysate; Lane 3, soluble lysate; 
Lane 4, flow-through fraction; Lane 5, elution fraction; and Lane 6, purified H-GpC-CTPR-M4P. Green 
represents 6-Histidine tag; orange represents M4P; red represents linker; blue rectangle represents CTPR3; 
and yellow represents Gp split-intein. 
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1 The ligation reactions mediated by Gp split-inteins were performed by Dr. J. Wright. 
 
Figure 3.15 Superdex 200 10/30 SEC analysis of refolded trimeric (A) H-M4P-CTPR3-gpN and (B) H-GpC-
CTPR3-M4P (Data obtained from Dr. J. Wright). (C and D) The half cages Ve/Vo (elution volume/column 
void volume) plotted against their Log10 molecular weights on a standard curve. The black squares 
represent protein standards. (C) The orange triangle represents H-M4P-CTPR3-GpN. (D) The orange circle 
represents H-GpC-CTPR3-M4P. 
 
 NCL reaction of 2nd generation cage closure system1 3.4.4
Ligation reactions of both Imp and Gp cages were initiated by mixing purified cognate 
half-cages in equimolar concentration of 50 µM under mild conditions as described in 
Section 2.4.2. The reaction buffer was supplemented with 1 M urea for the Gp reactions 
(to avoid any aggregation) and 2 M urea for the Imp mediated ligations due to the 
solubility of H-GST-ImpC-CTPR3-M4P. Samples were taken at several time points over a 
24 hr period and analysed by SDS-PAGE (Figure 3.16). Excitingly, both reactions 
successfully produced significant yields of ligated product.  The product H-M4P-CTPR3-
CTPR3-M4P (40.6 kDa) was observed in 5 mins (Imp split-intein mediated ligation) and 
1 min (Gp split-intein mediated ligation) at ~32 kDa on both SDS-PAGE gels. Comparing 
the ligation reactions of both split-inteins, we found that the ligation reaction mediated by 
Imp split-intein took significantly longer to complete and with a much lower yield i.e. 50 % 
yield after 24 hrs as opposed to 85 % yield in 30 mins. This is most likely due to the 
increased urea concentration used in the reaction buffer and the presence of partially 
folded GST tag. 
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Figure 3.16 SDS-PAGE analysis of the reaction between (A) H-M4P-CTPR3-ImpN and H-GST-ImpC-
CTPR3-M4P over 24 hrs, and (B) H-M4P-CTPR3-GpN and H-GpC-CTPR3-M4P over 3 hrs (data collected 
by Dr. J. Wright). (A and B) Lane L, PageRuler Broad Range Unstained Protein Ladder in kDa; (A) Lane 
1, H-GST-ImpC-CTPR3-M4P; Lane 2, H-M4P-CTPR3-ImpN; Lane 3, 0 mins; Lane 4, 5 mins; Lane 5, 10 
mins; Lane 6, 20 mins; Lane 7, 40 mins; Lane 8, 1 hr; Lane 9, 3 hrs; Lane 10, 5 hrs; and Lane 11, 24 hrs. 
An extra band can be observed at time points 3 and 5 hrs (Lanes 9 and 10); this may due to insufficient 
boiling of the samples, causing the product to be in a dimeric/trimeric state. (B) Lane 1, 0 mins; Lane 2, 1 
min; Lane 3, 10 mins; Lane 4, 30 mins; and Lane 5, 180 mins. Green represents 6-Histidine tag; orange 
represents M4P; red represents linker; blue rectangle represents CTPR3; purple represents Imp split-intein; 
brown represents CBD; and yellow represents Gp split-intein. 
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 Purification of ligated products 3.4.5
The characterisation of the ligation product requires the removal of the unligated reactants 
and excised split-inteins. Unfortunately, in the 2nd Gen designs, all reactants and products 
possess similar affinity tags. Thus, affinity chromatography could not be used to separate 
any of the ligation mixture.  Therefore, SEC was trialled for the Gp cage closure reactions 
(Figure 3.17).  It was decided to focus on the Gp closure as ligation, rather than those 
mediated by the Imp split-intein, due to the far greater yields. High yields are extremely 
important in any reaction and particularly so here, given that each trimeric half cage 
requires each of its three sides to react.  For example, if the yield of ligated product is 
lower than 67 % it indicates that, for every trimeric half-cage cap, one “arm” has not 
reacted. 
The preparative SEC of the Gp split-intein ligation mixture gave a broad peak. 
Unfortunately, when the major peak was analysed by SDS-PAGE, it was found that both 
ligated and unligated half-cage caps eluted together (Figure 3.17). Thus, although the 
excised split-inteins can be removed by SEC, the ligated product and unligated reactants 
cannot.  
 
Figure 3.17 Preparative SEC of a 50 μM Gp mediated cage ligation reaction after 24 hrs in 1 M urea with 
the denaturing SDS-PAGE Gel of the major peak. 5 mL of the post ligation reaction mixture was injected 
onto a SuperdexTM S200 16/60 preparative column running standard ligation buffer. Top right corner: Lanes 
of the SDS-PAGE gel correspond to the fractions labelled in the graph. Green represents 6-Histidine tag; 
orange represents M4P; red represents linker; blue rectangle represents CTPR3; and yellow represents Gp 
split-intein. 
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 Summary 3.4.6
All four half cage caps with split-inteins were expressed and successfully refolded into 
their trimeric states in high yields. However, H-GST-ImpC-CTPR3-M4P did require at 
least 2 M urea to refold into its trimeric form. Importantly, all half cage cages could be 
successfully ligated.  The Gp mediated assembly produced a better yield in a shorter time 
compared to Imp mediated assembly (85 % yield in 5 hrs and 50 % yield in 24 hrs, 
respectively). This is most probably due to the higher concentration of denaturant in the 
Imp reaction and the presence of partially refolded GST tag. Significantly, the fusion 
protein design and, more specifically, the placement of the affinity tags within each 
fusion protein, exposed a major limitation - we were unable to separate ligated product 
from unreacted half-cage caps. Therefore, the system was re-designed to enable easier 
purification of the ligated product. 
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3.5 3rd Generation Cage closure system using the Split-inteins 
To separate the fully ligated product from partially ligated and unreacted half-cage caps, 
the fusion constructs were changed to enable affinity purification. The change was 
relative straightforward and involved moving the His-affinity tag on the N-terminus of the 
H-M4P-CTPR3-GpN and H-M4P-CTPR3-ImpN to the C-terminus: M4P-CTPR3-GpN-H 
and M4P-CTPR3-ImpN-H. Thus, upon ligation, all affinity tags will be excised along with 
the split-inteins. As a result, there is no affinity tag on the ligated product. When 
subjected to affinity chromatography, the ligated product will not bind, enabling easy 
purification. In addition, the H-GST-ImpC-CTPR3-M4P construct was further modified to 
remove the GST-tag to aid refolding.  In its place a CBD tag was added to aid solubility. 
This is because the ImpC split-intein is known to require an additional domain close by to 
aid production (Personal Communication, J. Wright).  The final construct was: H-CBD-
ImpC-CTPR3-M4P. Finally, a CBD tag was also added to the M4P-CTPR3-ImpN-H 
construct: M4P-CTPR3-ImpN-CBD-H. This was to ensure that, when ligated, the cage 
product would not overlap with the reactants on SDS-PAGE. Figure 3.18 shows the 
improved constructs reaction scheme for both split-intein systems.  
 
Figure 3.18 Schematic diagram of the formation of the trigonal bipyramidal cages via 2nd generation split-
inteins NCL system. Here, all affinity tags are fused to split-inteins. Upon mixing, the split-inetins fold into 
an active enzyme which leads to NCL, joining the half-cage caps together while excising itself along with 
the affinity tags. The completely ligated product does not contain any affinity tag and therefore can be 
purified via affinity chromatography. Green represents 6-Histidine tag; orange represents M4P; red 
represents linker; blue rectangle represents CTPR3; purple represents Imp split-intein; red represents CBD; 
and yellow represents Gp split- intein. 
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 Recombinant expression, purification and trimerisation analysis of M4P-3.5.1
CTPR3-ImpN-CBD-H and H-CBD-ImpC-CTPR3-M4P 
3.5.1.1 Recombination expression and purification of M4P-CTPR3-ImpN-CBD-H 
and H-CBD-ImpC-CTPR3-M4P 
M4P-CTPR3-ImpN-CBD-H and H-CBD-ImpC-CTPR3-M4P were successfully expressed 
and purified as per Section 2.3.3with high yields and purity (20.5 mg/mL and 15.0 
mg/mL respectively) (Figure 3.19). M4P-CTPR3-ImpN-CBD-H was purified natively. In 
contrast, the H-CBD-ImpC-CTPR3-M4P could only be purified via a denaturing 
purification.  H-CBD-ImpC-CTPR3-M4P was easily refolded either by dialysis or whilst 
being purified via affinity chromatography into reaction buffer supplemented with 1 M 
urea. 
 
Figure 3.19 SDA-PAGE analysis of the purification of (A) M4P-CTPR3-ImpN-CBD-H and (B) H-CBD-
ImpC-CTPR3-M4P. (A and B) Lane L, PageRuler Broad Range Unstained Protein Ladder in kDa; Lane 1, 
pre-induction; Lane 2, post-induction; Lane 3, native supernatant. (A) Lane 4, native pellet; Lane 5, 
denatured supernatant; Lane 6, denatured pellet; Lane 7, flow-through fraction; Lane 8-10, elution fractions; 
and Lane 11, purified M4P-CTPR3-ImpN-CBD-H. (B) Lane 4, denatured supernatant; Lane 5, denatured 
pellet; Lane 6, flow-through fraction; Lane 7-14 elution fractions; and Lane 15, purified H-CBD-ImpC-
CTPR3-M4P. Green represents 6-Histidine tag; orange represents M4P; red represents linker; blue 
rectangle represents CTPR3; purple represents Imp split-intein; and red represents CBD. 
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3.5.1.2 Trimerisation analysis of M4P-CTPR3-ImpN-CBD-H and H-CBD-ImpC-
CTPR3-M4P 
The trimeric states of the M4P-CTPR3-ImpN-CBD-H and H-CBD-ImpC-CTPR3-M4P 
were confirmed using SEC analysis in reaction buffer with 1 M urea (Figure 3.20). Fitting 
of the M4P-CTPR3-ImpN-CBD-H and H-CBD-ImpC-CTPR3-M4P peak maxima to 
calibration standards, gave 139 kDa (calculated trimeric weight of 111 kDa) and 97.8 kDa 
(calculated trimeric weight of 98.1 kDa), respectively (Figure 3.20). This suggests that the 
M4P-CTPR3-ImpN-CBD-H is a more elongated shape than H-CBD-ImpC-CTPR3-M4P. 
 
Figure 3.20 Superdex 200 10/30 SEC analysis of refolded trimeric (A) M4P-CTPR3-ImpN-CBD-H and (B) 
H-CBD-ImpC-CTPR3-M4P in reaction buffer with 1 M urea. (C and D) The half cages Ve/Vo (elution 
volume/column void volume) plotted against their Log10 molecular weights on a standard curve. The black 
squares are protein standards. (C) The orange triangle represents M4P-CTPR3-ImpN-CBD-H. (D) The 
orange circle represents H-CBD-ImpC-CTPR3-M4P. 
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1 All ligation reactions mediated by Gp split-inteins were performed by Dr. J. Wright. 
 1Recombinant expression, purification and trimerisation analysis of M4P-3.5.2
CTPR3-GpN- H 
M4P-CTPR3-GpN-H was successfully expressed and purified under denaturing conditions 
(10 mg/L - Figure 3.21). The recombinant protein was dialysed into reaction buffer 
containing 1 M urea with little precipitation. SEC confirmed that the recombinant protein 
was successfully refolded into its trimeric state (Figure 3.22). Fitting of the peak maxima 
for M4P-CTPR3-GpN-H to calibration standards, gave 129.4 kDa [calculated trimeric 
molecular weight (94.1 kDa)].  
 
Figure 3.21 SDS-PAGE gels analysis of the purification of M4P-CTPR-GpN-H. Lane 1, pre-induction 
culture; Lane 2, post-induction culture; Lane 3, denatured insoluble lysate; Lane 4, denatured soluble lysate; 
Lane 5, flow-through fraction; Lane 6-7, elution fractions and Lane 8, purified M4P-CTPR-GpN-H (Data 
obtained by Dr. J Wright). Green represents 6-Histidine tag; orange represents M4P; red represents linker; 
blue rectangle represents CTPR3; and yellow represents Gp split-intein. 
 
 
Figure 3.22 (A) Superdex 200 10/30 SEC analysis of refolded trimeric M4P-CTPR3-GpN-H (Data obtained 
by Dr. J. Wright). (B) The half cages Ve/Vo (elution volume/column void volume) plotted against their 
Log10 molecular weights on a standard curve. The black squares represent protein standards; and orange 
triangle represents M4P-CTPR3-GpN-H.  
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1 All ligation reactions mediated by Gp split-inteins were performed by Dr. J. Wright. 
 NCL reaction of 3rd generation cage closure system1 3.5.3
Ligation reactions were initiated by mixing purified cognate half-cages in equimolar 
concentrations from 1 µM to 200 µM under mild conditions (reaction buffer with 1 M 
Urea – Section 2.4.2). Samples were taken at several time points over a 24 hr period and 
analysed by SDS-PAGE (Figure 3.23). As with the 2nd generation cages, both Gp and Imp 
mediated ligation reactions produced successful ligations at all concentrations.  Figure 
3.23 shows a typical reaction conducted at the 100 µM, for both Gp and Imp mediated 
ligations.  Importantly, both Imp and Gp produced rapid, high yielding ligations. 
Interestingly, even though Gp mediated reactions have a higher reaction rate than Imp, 
they gave lower overall yields (Figure 3.24). Both split-intein-mediated ligations 
produced ≥ 65 % yield within 10 mins, and the Imp reactions reaching ≥ 80 % and Gp ≥ 
70 % within 3 hrs. After 3 hrs, all the reactions were close to completion with only small 
additional increases in yield when the reactions were left for 24 hrs. Moreover, there was 
very little difference in the final yields across the protein concentration range of 1-100 
μM for either Imp or Gp ligations. At the higher concentration of 200 μM, the reactions 
produced some protein precipitation leading to a small reduction in yields. Interestingly, 
although the yields were very high, we did not achieve the ~95 % values of the previous 
study (Carvajal-Vallejos et al. 2012). This is consistent with the theory that the structure 
of the tripod half-cage caps creates steric hindrance that reduces the efficiency. In the 
case of NCL by MxGA intein (Section 3.3), the trimeric structures stopped any reaction; 
whereas here, the steric hindrance reduced the splicing efficiency by 10 to 30 % 
(depending on the split-intein and reaction conditions used). 
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Figure 3.23 Example of the SDS-PAGE of NCL 3rd generation split-intein reaction in 100 µM final 
concentration. (A) Reaction of Imp split-inteins: M4P-CTPR3-ImpN-CBD-H and H-CBD-ImpC-CTPR3-
M4P; (B) reaction of Gp split-inteins: M4P-CTPR3-GpN-H and H-GpC-CTPR3-M4P. Data collected by 
Dr. J. Wright. (A and B) Lane L, PageRuler Broad Range Unstained Protein Ladder in kDa; Lane 1, 0 
sec; and Lanes 2-9, various time points. Green represents 6-Histidine tag; orange represents M4P; red 
represents linker; blue rectangle represents CTPR3; purple represents Imp split-intein; red represents 
CBD; and yellow represents Gp split-intein. 
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Figure 3.24 (A and B) Graphs of the initial rates of percentage production formation obtained from SDS-
PAGE fitted with a single exponential plus linear drift [(A*(1 -exp(k*t))) + (m*t)] (A) 2nd generation Imp 
split-inteins mediated NCL and (B) 2nd generation Gp split-inteins mediated NCL. (C and D) Graphs of 
the percentage production formation up to 24 hrs after the reaction was initiated. Error bars equate to 
standard deviation of multiple repeat experiments (at least three in all cases). (C) 2nd generation Imp split-
inteins mediated NCL and (D) 2nd generation Gp split-inteins mediated NCL; and (E) Comparison of rate 
constants of ligation production formation for Imp and Gp mediated NCL at differing protein 
concentrations.  Error bars equate to standard error of fit to initial rates. 
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 Purification of completely ligated products 3.5.4
To separate the fully ligated assemblies from unreacted and excised split-inteins, nickel 
affinity chromatography was performed. After the first affinity chromatography step, all 
ligation reactions contained > 95 % purity of fully ligated assemblies as assayed by 
SDS-PAGE and anti-His affinity tag Western blot (Figure 3.25).  
 
Figure 3.25 SDS-PAGE gel analysis of reaction purification at a range of concentrations. (A) Imp split-
intein system. (B) Gp split-intein system (Data collected by Dr. J. Wright). (A and B) Odd number lanes 
are flow-through and wash fractions, even numbers are elution fractions: Lanes 1 and 2, 1 µM reaction 
concentration; Lanes 3 and 4, 10 µM reaction concentration; Lanes 5 and 6, 50 µM reaction 
concentration; Lanes 7 and 8, 100 µM reaction concentration; Lanes 9 and 10, 200 µM reaction 
concentration. (C, D) Calculated percentage of the complete ligation and partial ligation for the Imp and 
Gp split-intein systems respectively, at a range of concentrations Error bars equate to standard deviation 
of multiple repeat experiments (at least three in all cases). (E) SDS-PAGE and anti-His Western blot of 
Imp split-inteins system in 1 µM reaction, aligned on border, Lanes 1 and 2, SDS-PAGE; Lanes 3 and 4, 
Western blot: Lanes 1 and 3, flow-through and wash fractions; Lanes 2 and 4, elution fractions. (A, B 
and E) Lane L, PageRuler Broad Range Unstained Protein Ladder in kDa. Green represents 6-Histidine 
tag; orange represents M4P; red represents linker; blue rectangle represents CTPR3; purple represents 
Imp split-intein; red represents CBD; and yellow represents Gp split-intein. 
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Interestingly, SDS-PAGE showed that there is “ligated product” bound to the Ni 
affinity column during the purification step. This stems from partially ligated trimeric 
structures. i.e. where at least one ‘arm’ of the trimeric half-cage cap has been ligated, 
but where the others were not. It is interesting to speculate that the partially ligated 
products may stem from the irreversibility of the reaction.  For example, when A-B-C 
subunits from one cap react with a-b-c from another, they can link in a correct manner 
giving a discrete cage (A-a, B-b and C-c). However, they can also react to produce 
partially ligated faulty “dead-end” structures (A-a, B-c).  
The relative intensities of the bands in the flow-through and elution samples were used 
to estimate the percentage of partially and completely ligated products. Importantly, the 
amount of completely ligated product increased as the concentration of reactants is 
lowered. From the analysis, it is clear that the Gp mediated ligations lead to more partial 
ligation and less cage closure than the Imp mediated ligations. For example, Imp 
mediated ligations at lower protein concentrations (1 μM to 50 μM) all produced > 75 % 
fully ligated product. In contrast, Gp mediated ligations at lower protein concentrations 
(1 μM and 10 μM) produced only ~ 50 % fully ligated product.  Thus, the faster ligation 
speed of the Gp split-inteins hinders discrete cage formation and leads to the production 
of higher proportions of partially ligated structures and networks. 
 
 Analysis of ligated product and purification of discrete cages 3.5.5
The purified ligation reactions were analysed using size-exclusion chromatography 
(SEC) (Figure 3.26). This analysis showed that all ligations generated, to a greater or 
lesser extent, heterogeneous mixture of differently sized proteins.  That is, in addition to 
the expected fully ligated discrete cages, the ligation reactions also produced networks 
of “cross-ligated” proteins.  In both the Imp and Gp split-inteins mediated NCL, higher 
ligation concentrations exhibited both a larger void volume peak and broader major 
peak. Excitingly, and in contrast, lower protein concentrations, i.e. < 50 µM, gave a 
better separated monodisperse peak at 12 mL elution volume. Overall, the ligation 
mediated by Imp split-inteins produce a more monodisperse peak compared to Gp. This 
elution peak when fitting to calibration standards gave an estimated mass of 122 kDa, 
consistent with the calculated mass of a homotrimeric cage product (113 kDa) (Figure 
3.26C).  
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Thus, to obtain high quantities of purified discrete caged product the Imp mediated 
ligation reactions were conducted at 10 µM overnight in reaction buffer supplemented 
with 1 M urea.  They were purified using the two-stage process outlined above (Ni 
affinity chromatography followed by SEC).  This produced a high purity, homogeneous 
sample for further structural analysis. 
 
Figure 3.26 Analytical SEC profiles of the purified completely ligated products (A) Imp split-intein 
mediated NCL and (B) Gp split-intein mediated NCL (Data collected by Dr. J Wright), at a range of 200 
– 1 µM reaction concentrations. 100 μL of concentrated flow-through was injected onto a Superdex 200 
10/30 analytical column using standard ligation buffer. (B) The product purified from 200 µM and 100 
µM ligation reactions were analysed before a filter change on the Superdex 200 10/30. Note: the peak 
difference of 1 mL of the products purified from 200 µM and 100 µM ligation reactions mediated by Gp 
split-intein is because the samples were analysed before a filter change on the Superdex 200 10/30. (C) 
The cages Ve/Vo (orange triangle) plotted against their Log10 molecular weights on a standard curve. 
Black squares represent protein standards.  
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 Structure analysis of purified cage products 3.5.6
The purified fully ligated cage structures were characterised by matrix-assisted laser 
desorption/ionization - time-of-flight (MALDI-TOF) mass spectrometry (MS), circular 
dichroism (CD) and SEC-small angle x-ray scattering (SEC-SAXS).  
 
3.5.6.1 MALDI-TOF MS 
MALDI-TOF MS was performed to confirm the size of the cage product (Section 2.5.5). 
A strong signal was obtained for the monomeric M4P-CTPR6-M4P product at a mass 
of 39 kDa (calculated mass of 38 kDa) (Figure 3.27). A peak corresponding to a dimeric 
(M4P-CTPR6-M4P)2 product was also seen at a mass of 78 kDa (calculated mass of 76 
kDa). Unfortunately, the complete trimeric cage (M4P-CTPR6-M4P)3 product was not 
observed.  This may be due a combination of the limitations of the detector and the 
inherent method of laser power required for ion formation via MALDI. 
 
Figure 3.27 MALDI-TOF analysis of cage product. Monomer expected size 38 kDa, observed 39 kDa, 
percentage difference 3 %. Dimer expected size 76 kDa, observed 78 kDa, percentage difference 2 %. 
Trimer expected size 113.37 kDa, no further peak was observed. 
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3.5.6.2 Circular dichroism 
Far-UV CD spectroscopy analysis was performed to observe the secondary structure in 
solution of the purified cage product (Section 0). The purified cage product was 
compared to a half-cage cap that contains no split-inteins. The resulting CD spectra was 
calculated and plotted as shown in Figure 3.28. The far-UV CD spectra of the ligated 
cages show that: (i) they are highly alpha-helical, and, importantly, (ii) have exactly 
twice the molar ellipticity at 222 nm as that of the half cage caps that do not contain 
split-intein domains (Figure 3.28A). Figure 3.28B shows the molar ellipticity per 
residue. The differences in the intensity at 222 nm between the half cage and cage 
because the number of residues of the cage is not two times of the number of residues of 
the half cage; the half cage contains a 6-Histidine tag and a FXa cleaving sites, while 
cage contain the 10 amino acids essential for NCL. The molar ellipticity per CTPR 
(Figure 3.28C) shows that the extra amino acids present in both half cage and cage did 
not form more helices. Moreover, the ligation reaction has had no effect on the 
secondary structure of the CTPR (had not caused any local unfolding). 
 
Figure 3.28 Far UV-CD spectra of cage product (red) in comparison to a half-cage cap without split-
intein (black) with (A) molar ellipticity in deg cm2 dmol-1; (B) molar ellipticity in deg cm2 dmol-1 residue-
1; and (C) molar ellipticity in deg cm2 dmol-1 CTPR-1. 
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3.5.6.3 SEC-SAXS 
SAXS was carried out to identify the 3D shape of the cage structure.  The collected 
SAXS data was processed and analysed as described in Section 2.5.7.1. Guinier and 
Kratky plot analysis of the SAXS data confirmed that the purified cages were 
monodisperse and highly rigid. Moreover, the analysis shows that the cages are non-
spherical and elongated with a radius of gyration (Rg) of 3.85 nm and a maximum 
linear particle diameter (Dmax) of 12.6 nm (Figure 3.29). This is in contrast with the 
SAXS data of the non-ligated half cage caps, where Kratky plot analysis shows that 
their structures are highly dynamic. Additionally, the molecular weight of the cages 
obtained from the SAXS data is in close agreement with that calculated from its amino 
acid sequence (110.5 kDa versus 113.4 kDa, respectively). Table 3.1 summarises the 
SAXS parameters of cage products obtained from the analysis. 
 
Figure 3.29 Analysis of SAXS of ligated cage and Kratky analysis of half-cage cap. (A) Guiner analysis, 
(B) distance distribution functions P(r) and (C) Kratky analysis of the SAXS for the ligated cages. (D) 
Kratky analysis for the half-cage cap. 
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Table 3.1 SAXS parameters obtained from analysis of the purified cage products 
SAXS parameters SAXS cage products 
q range (Å-1) 0.004 to 0.350 
I(0) (Å) 0.134 +/-0.00011 
Rg (nm) (from Guinier) 3.85 +/-0.023 
Rg (nm) (from P(r)) 3.82 +/-0.014 
Dmax (nm) (from P(r)) 12.6 
Porod Exponent 3.7 
MWSAXS (Da) 110,568 
MWsequence (Da) of ligated cage 113,058 
MWMass Spec (Da) of ligated cage 39,235 (monomeric) 
 
As the SAXS profile of the cage has a number of prominent features it allowed for the 
determination of its shape to a higher resolution via two different approaches: (i) a 
SAXS ab initio model re-constructed using the program GASBOR (D. I. Svergun, 
Petoukhov, and Koch 2001) and (ii) a comparison of the experimental SAXS profile to 
30 models generated from different possible atomic models of the cage using the 
program Crysol (D. Svergun, Barberato, and Koch 1995) as described in Section 2.5.7.2. 
 
3.5.6.4 (i) ab initio GASBOR modelling 
GASBOR reconstructs protein structure by a chain-like ensemble of dummy residues. 
The ab initio GASBOR modelling gave five models that are supported by our 
biophysical data. Twenty-seven solutions were discarded when, for example, the 
CTPR/M4P domains would be required to fit protein density envelopes by either 
adopting non-native conformations or by ligating in a nonsensical formation (discarded 
examples are shown in Figure 3.30 C-F).  The five biophysically relevant solutions 
were averaged with DAMAVER (Volkov and Svergun 2003) to produce a final model 
with excellent fit to the data (χ2 = 1.06) (Figure 3.30 A-B). Excitingly, this final ab 
initio model shows that the ligated cages form our intended structure with protein 
density that closely resembles the designed trigonal bipyramidal structure and, 
importantly, a central hollow cavity (M4P oligomer at the “primary” vertices and the 
CTPRs forming the three cage sides).   
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Figure 3.30 ab initio model generated by GASBOR. (A) Experimental SAXS profile (black dots) of 
ligated cages overlaid with ab initio GASBOR generated model SAXS profile (red line). (B) Two 
orientations of the ab initio GASBOR generated model. (C–F) Discarded ab initio models obtained from 
experimental SAXS of ligated cage using Gasbor. Solutions were discarded when, for example, the 
CTPR/M4P domains would be required to either adopt non-native conformations or be ligated in an 
impossible manner to fit the calculated protein density envelopes. 
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3.5.6.5 (ii) Comparison of the experimental SAXS profile to models 
30 atomic models were generated with slightly different orientation and sizes compared 
to the SAXS profile using Crysol. Interestingly, all of the generated atomic models that 
had the same arrangement of protein domains and the central hollow cavity were found 
to recapitulate the experimental SAXS profile (Table 3.2). Those that have expanded 
cages or that did not contain a central hollow core gave profiles that were very different 
from the experimental data.  The model that produced the closest fit between 
experimental and generated SAXS profiles used a continuous CTPR6 as the cage sides 
(Figure 3.31 A). Here, the CTPR3 modules from the half cages dock upon ligation to 
form a single CTPR6 superhelix, rather than simply two linked CTPR3 domains like 
beads on a string. This would account for the increased rigidity of the cage in contrast to 
the dynamic half cage caps. The final χ2 value between the model and experimental 
SAXS profiles was 1.66, with only a small discrepancy at the highest resolution SAXS 
data (suggesting an ambiguity between the modelled and exact rotation of the CTPR 
sides and their packing relative to their M4P vertices) (Figure 3.31 B). This model also 
fits extremely well into the ab initio GASBOR model envelope (Figure 3.31 C). 
 
Figure 3.31 Comparison of the ‘best-fit’ model to the ab inito model and the experimental SAXS profile. 
(A) Experimental SAXS profile (black dots) of cage products overlaid with “best-fit” cage atomic model 
SAXS profile (red line). (B) Two orientations of the “best” ligated cage atomic model. (C) Two 
orientations of the “best” ligated cage atomic model superimposed into the ab initio GASBOR generated 
model. 
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Table 3.2 Comparison of experimental cage SAXS profile and calculated SAXS 
profile from atomic models of cages. 
Model χ2 Comparison of Experimental Ligated Cage SAXS 
profile (black circles) and model SAXS profile (red line) 
Cages with a central cavity but CTPR domain sides not docked 
 
5.6 
 
 
5.4 
 
 
8.8 
 
 
7.9 
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Model χ2 Comparison of Experimental Ligated Cage SAXS profile 
(black circles) and model SAXS profile (red line) 
Cages with a central cavity and CTPR domain sides not docked contd. 
 
5.6 
 
 
3.5 
 
Asymmetry Cages, with central cavity but CTPR domains sides not docked  
 
3.6 
 
 
3.8 
 
 
4.4 
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Model χ2 Comparison of Experimental Ligated Cage SAXS profile 
(black circles) and model SAXS profile (red line) 
Asymmetry Cages, with central cavity but CTPR domain sides not docked contd. 
 
4.7 
 
 
4.6 
 
 
4.7 
 
 
3.9 
 
 
5.0 
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Model χ2 Comparison of Experimental Ligated Cage SAXS 
profile (black circles) and model SAXS profile (red line) 
Cage with “crossed” CTPR domain sides and no cavity 
 
9.9 
 
Cage with docked CTPR domain sides and no cavity 
 
8.6 
 
Expanded cages 
 
8.1 
 
 
18.5 
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Model χ2 Comparison of Experimental Ligated Cage SAXS 
profile (black circles) and model SAXS profile (red line) 
Expanded cages, contd. 
 
13.9 
 
 
6.4 
 
 
5.0 
 
 
4.1 
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Model χ2 Comparison of Experimental Ligated Cage SAXS 
profile (black circles) and model SAXS profile (red line) 
Cages where the CTPR sides are docked together into a CTPR6 structure 
 
4.3 
 
 
6.7 
 
 
1.8 
 
 
3.2 
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 Summary 3.5.7
Excitingly, the 3rd generation recombinant proteins of the Imp and Gp split-inteins 
successfully ligated the half-cage caps in 1 M urea buffer condition with high reaction 
rates and yields. The various ligated products and excised split-inteins can be easily 
separated in a two-step process to give homogeneous ligated discrete cages. The yield 
of discrete cages can be influenced by the concentration of the reactants and the split-
intein, which mediates the assembly. For example, it is obvious that lowering the 
concentrations of reactants and using the Imp-mediated ligation produce more 
completely ligated discrete cages.  
Importantly, when the discrete cages were characterised by MS, CD and SAXS it 
showed that our design produced the expected trigonal bipyramidal cages with a central 
hollow cavity. Interestingly, the closest fit model shows that the docking interface 
between the CTPR3 domains is able to form a continuous superhelix (similarly to 
CTPR6) despite the 10 amino acids linker between them. Table 3.3 summarises the 
SAXS profile of the ab initio model and ‘best’ atomic model to the experimental data. 
Both experimental data and atomic modelling concluded that the ligated cages form an 
open shell, with a central hollow cavity, that closely resembles the intended designed 
trigonal bipyramidal structure. Both models showed a closed cage with apertures of  
35 Å between each side at the widest point and encloses a central cavity of  70 Å by 
55-60 Å.   
Table 3.3 Comparison of models to experimental SAXS profile 
 
 
 
  
Comparison of Model to Experimental Determined SAXS 
Profile 
ab initio Gasbor model χ2 fit 1.06 
ab initio Gasbor model NSD 1.02 
“Best” Atomic model χ2 fit 1.66 
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3.6  Conclusion 
In this chapter it has been shown that genetically programmed NCL can be successfully 
utilised to assemble modular proteins designed with simple geometric symmetry into 
user-defined protein cages. Through an iterative design process a high yielding system 
was developed that used split-intein domains, coupled with a two-step purification 
strategy, to produce homogenous samples of discrete protein cages. To investigate the 
limits of the system, Imp and Gp split-inteins were trialled separately to drive two-
component assembly of the half-cage modules (trefoil vertex and CTPR sides).  
Significantly, this process generated the expected 113 kDa square bipyramidal structure.  
The combined properties of the split-inteins fusion and reaction/purifications yields 
show that the Imp mediated two-component system could be easily expanded to co-
expression and assembly in vivo. The use of extendable CTPR sides additionally 
provides a method for loading cargo into the central hollow cavity of the nanostructures 
by using a binding module as the linker (Chapter 5). In conclusion, this assembly 
system provides a more general route to producing protein cages that avoids many time-
consuming and system-specific processes (for example, those requiring computational 
design). No bioconjugation, chemical modification or post-ligation refolding steps were 
required, and only a short sequence was inserted at the point of the NCL.  
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4 Design of Controlled Fibre Assembly 
4.1 Introduction 
This chapter investigates the use of orthogonal split-inteins (Chapter 3) as a driving 
force to create a stepwise protein fibre extension system. Two different methodologies 
were employed: (i) tethered linker synthesis - whereby the growing product is eluted 
from immobilised fusion proteins via affinity tags and (ii) in solution synthesis - 
whereby protein fusions are reacted in solution and the product of each step is affinity 
purified. Finally, the limits of both syntheses were delineated (i.e. the number of 
extensions possible).  
 
  System design 4.1.1
As with Chapter 3, the system is based on recombinantly expressing a number of fusion 
proteins. These were termed “caps” and “linkers”. Caps contain the protein to be 
assembled (POI) expressed as a fusion with a single split-intein half either at its N or C 
terminus. In contrast the linkers contained the POI sandwiched between two orthogonal 
split-intein halves (Figure 4.1A). Cloning, expressing and purifying different proteins in 
these constructs produced initially inert fusions. Mixing with a compatible fusion 
produced irreversible stepwise assembly, driven by NCL, and enabled directional 
construction of poly-proteins with specific compositions and spatial arrangements.  The 
fabrication process began with a cap fusion reacting with a linker and allowed the build-
up of the protein nanostructures either from the N or C-terminus. Figure 4.1B, showed 
an exemplar construction from the N-terminus. 
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Figure 4.1 (A) The recombinant fusions required for stepwise extension: Caps and Linkers, where INT 
can be either Imp or Gp split-intein. (B) Schematic diagram of fibre extension.  As an example, sequential 
linker extension from CTPR3-ImpN is shown. However, extension could be produced with any cap. 
 
4.2 Previous work and motivation 
 Mxe Gyr A intein mediated stepwise extension 4.2.1
The Main laboratory has shown that a similar system, using the Mxe GyrA (MxGA) 
intein as an assembly driver, produces head-to-tail orientated fibres in both one-pot and 
sequential stepwise fabrications (Jonathan J. Phillips, Millership, and Main 2012; 
Harvey, Itzhaki, and Main 2018). The stepwise assembly process allowed the controlled 
extension of protein modules with individual reactions producing a yield of 80 % after 
16 hrs. However, fibre extension can only be initiated from the N to C-termini and the 
purification of the ligated product of each step caused a loss of up to 50 %. Therefore, 
the combined yield after each stepwise addition is ~50 %, suggesting that 3 to 4 
sequential ligations joining 4 to 5 protein modules together is the realistic limit of the 
system. 
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 Split-inteins mediated stepwise extension 4.2.2
Given the limitations of the MxGA intein system, Dr. J. Wright from the Main 
laboratory redesigned the system as described in Section 4.1.1 to use the orthogonal 
split-inteins described in Chapter 3 i.e. Imp and Gp. These react faster, are completely 
orthogonal and do not require activation via protease / reducing agent mediated 
cleavage. He used the Main laboratories model protein of choice, CTPR3 (a protein 
consisting of 3 consensus tetratricopeptide repeats), as the protein to be assembled and 
constructed a minimal system of one cap and two linkers. He then explored both 
product / linkers tethered stepwise extension and stepwise solution extension. 
 
4.2.2.1 Product tethered stepwise extension:  
To enable product tethering, the initial cap fusion was modified to include a Twin-
StrepII tag (TStr) at the N-terminus. When mixed with Strep-tactin resin, the affinity tag 
binds, thus immobilising it. Then, compatible linkers can be added sequentially and left 
to react with the bound cap to produce bound products (Figure 4.2A). Figure 4.2B 
shows a SDS-PAGE of the products after each round of a three-step extension. 
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Figure 4.2 (A) Schematic of iterative Twin-StrepII tag tethered product reactions. (B) Following three 
rounds of alternate linker additions, H-CBD-ImpC-CTPR3-GpN and H-GpC-CTPR-ImpN-CBD to the 
anchoring domain TStr-CTPR3-ImpN. All samples are resin samples from Strep-tactin resin. Lane 1, Post 
loading TStr-CTPR3-ImpN; Lanes 2 and 3, first round linker addition; Lane 4, second round linker 
addition; Lane 5, third round linker addition. Black arrows represent each round's reaction product '*' 
represents unreacted linker components. Single green rectangle represents 6-Histidine tag; double green 
rectangle represents twin-strep tags; green circle represents strep resins; blue rectangle represents CTPR3; 
purple represents Imp split-intein; red represents CBD; and yellow represents Gp split-intein. (Data 
obtained by Dr. J. Wright) 
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From analysis of the SDS-PAGE, it is clear that the stepwise extensions were successful. 
However, heterogeneity of the product increased after each round of extension. This is 
because the reaction yields were not 100 % and thus, the unreacted cap/product can 
later be extended when further compatible linkers were added (i.e. unreacted cap from 
the first round was extended in the third round). 
 
4.2.2.2 Linker tethered stepwise extension:  
Next, linker tethered synthesis was trialled. Here, instead of a cap fusion being 
immobilised, the linkers were (Figure 4.3). The linkers were immobilised via their 
chitin binding domains (CBD) bound to chitin resin (H-CBD-ImpC-CTPR3-GpN and H-
CBD-GpC-CTPR3-ImpN). In each case, when a stepwise reaction takes place the 
excised split-inteins remained bound to the resin and the product is eluted. By switching 
between resin loaded with linker fusions containing different split-inteins, the fibre can 
be extended multiple times (Figure 4.3A & Figure 4.3B). 
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Figure 4.3 (A) Schematic diagram of the tethered linker product extension. (B) Composite of two gels for 
clarity, aligned at the border. Lane 1, resin sample of loaded H-CBD-GpC-CTPR3-ImpN; Lane 2, cap 
CTPR3-GpN; Lane 3, resin sample of first linker and cap - 30 mins timepoint; Lane 4, elution from first 
linker resin 1 hr post reaction; Lane 5, wash from chitin resin; Lane 6, resin sample of loaded H-CBD-
ImpC-CTPR3-GpN; Lane 7, pooled first reaction wash and elution product; Lane 8, resin sample of 
second linker and first product reactants - 1 hr timepoint; Lane 9, elution from second reactant resin 2 hr 
post reaction; Lane 10, second reactant resin sample post elution and wash. Black arrows represent the 
product generated after each round. Green represents 6-Histidine tag; blue represents CTPR3; purple 
represents Imp split-intein; red represents CBD; orange represents chitin resins; and yellow represents Gp 
split-intein.  (Data obtained by Dr. J. Wright). 
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Although the stepwise extension was successful, the reaction yield mediated via the Imp 
split-intein was much lower than via Gp split-intein (60 % and 90 % in 2 hrs, 
respectively). Moreover, after the second extension, product was observed in the 
washed resin samples. This suggests that either the Imp split-intein mediated reaction or 
ligations that react larger reactants may cause precipitation.  
 
4.2.2.3 Stepwise solution extension: 
With regards to the stepwise extension in solution, Dr. J. Wright trialled SEC as a 
method of separation between products and reactants. He performed two rounds of 
extension without purification (Figure 4.4A & B). Then, SEC was trialled to separate 
product from the mixture. Moreover, to determine if the ligated product could be 
functionalised, the CTPR3 in one linker was replaced with a modified CTPR3, the 
CTPR390 (H-CBD-ImpC-CTPR390-GpN) - Figure 4.4A. CTPR390 is a three-repeat 
CTPR that contains a binding pocket which can then bind to a specific pentapeptide 
sequence. The first step used excess cap (2:1) and the second equimolar linker.  The 
reactions were left to react for 3 hrs. Figure 4.4B is the SDS-PAGE of the reaction. The 
extension was successful, however the attempt of purifying the final product by SEC 
was less successful (Figure 1.4C). This was likely due to the elongated nature of the 
CTPR proteins, causing differences in molecular weight to not be equally reflected in 
resolution. The low quality of separation by SEC caused ~50 % loss of the product. 
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Figure 4.4 (A) Schematic diagram representing the three-step solution extension. (B) Lane 1, H-CBD-
ImpC-CTPR390-GpN; Lane 2, CTPR3-ImpN; Lane 3, 30 min timepoint sample of the reaction of H-CBD-
ImpC-CTPR390-GpN and CTPR3-ImpN (first reaction step); Lanes 4 & 5, 1 and 3 hr timepoint samples of 
the first reaction step, respectively; Lane 6, timepoint 0 after the addition of the second linker (H-GpC-
CTPR-ImpN-CBD); Lane 7, timepoint 30 secs of the 2nd reaction step; Lane 8, timepoint 1 min of the 2nd 
reaction step. Black arrows indicate the generation of the 1st and 2nd reaction products. (C) SEC and 
SDS-PAGE gel of the SEC of the H-CTPR3-CTPR390-CTPR3-ImpN reaction mixture. SDS-PAGE gel: 
Lane 1, sample of concentrated pre-loaded reaction mixture; Lanes 2-10, SEC fractions corresponding to 
the graph. (B and C - Data obtained by Dr. J. Wright). Green represents 6-Histidine tag; blue rectangle 
represents CTPR3; pink represents CTPR390; purple represents Imp split-intein; red represents CBD; and 
yellow represents Gp split-intein. 
Chapter 4 Design of Controlled Fibre Assembly 
120 
 
4.3 Optimisation of stepwise fibre formation in both linker-
tethered and solution synthesis 
As can be seen from Dr. Wright’s work, optimisation of the stepwise fibre formation via 
either the linker-tethered or solution synthesis should enable larger assemblies to be 
constructed. This is because the product after each round of synthesis can be purified to 
homogeneity. In contrast, product-tethered was investigated, however, optimisation could 
not increase the yield sufficiently to counteract the increase heterogeneity with each 
stepwise addition (data not shown). Therefore, linker-tethered and solution synthesis 
reactions were optimised as follows: 
(i) Linker-tethered Synthesis: Firstly, the length of time required for Imp split-intein 
mediated ligation was increased to 16 hrs. Secondly, instead of initiating the extension 
with Gp mediated ligation (Gp cap fusion and linker), the extension was initiated with 
Imp (Imp cap and linker).  
(ii) Solution Synthesis: Here, optimum conditions were initially determined by only 
extending with “Spacer” CTPR domains. The “Binder” CTPR domain that Dr. Wright 
used required higher denaturant concentration to remain soluble. However, this reduced 
the overall yield. The system was optimised to enable convergent extension from two 
caps (Figure 4.5). Finally, the convergent extension was redesigned to enable easier 
purification of each stepwise extension product. 
 
Figure 4.5 Schematic diagram of the making of CTPR18. Two rounds of extension from both the N and C-
terminal caps to obtain CTPR9. Then, the two CTPR9s with compatible split-inteins were reacted to obtain 
CTPR18. Green represents 6-Histidine tag; blue represents CTPR3; purple represents Imp split-intein; red 
represents CBD; and yellow represents Gp split-intein. 
Chapter 4 Design of Controlled Fibre Assembly 
121 
1 The recombinant expression and purification of H-CTPR3-ImpN, H-CTPR3-GpN, H-GpC-CTPR3 were 
performed by Dr. J. Wright. 
4.4 Recombinant expression and purification of protein 
fusions 
To enable the experiments outlined above, the following cap and linker protein fusions 
were produced and purified as follows:  
 Recombinant expression and purification of caps: 1H-CTPR3-ImpN, 1H-4.4.1
CTPR3-GpN, 1H-GpC-CTPR3 and CTPR3-GpN-H 
All caps except H-GpC-CTPR3 were successfully expressed and purified natively as 
described in Section2.3.3.1, with 15 - 40 mg/mL yield and high purity. Whereas, the 
purification of H-GpC-CTPR3 required the denatured protocol (Section 2.3.3.2). The 
denatured recombinant protein was refolded on the column. The protein was eluted in 
buffer 1 M urea, 50 mM Tris pH 8, 300 mM NaCl and 250 mM imidazole. 5 mM DTT 
was added into the elution to prevent disulphide formation.  
 
Figure 4.6 SDS-PAGE of the purification of (A) 1H-CTPR3-ImpN, (B) 1H-CTPR3-GpN, (C) 1H-GpC-
CTPR3 and (D) CTPR3-GpN-H. (A-D) Lane L, PageRuler Broad Range Unstained Protein Ladder in kDa. 
(A-C) Lane 1, post-induction culture sample; Lane 2, native insoluble cell lysate; Lane 3, native soluble cell 
lysate; (A-B) Lane 4, flow-through fraction; Lane 5, elution fraction; and Lane 6, purified H-CTPR3-ImpN 
and H-CTPR3-GpN respectively; (C) Lane 4, elution fraction; Lane 5, purified H-GpC-CTPR3. (D) Lane 1, 
pre-induction culture sample; Lane 2, post-induction culture sample; Lane 3, native/denatured insoluble cell 
lysate; Lane 4, native/denatured soluble cell lysate; Lane 5, flow-through fraction; Lane 6-10, elution 
fractions; Lane 11, purified CTPR3-GpN-H. (1 data obtained by Dr. J Wright). Green represents 6-Histidine 
tag; blue represents CTPR3; purple represents Imp split-intein; red represents CBD; and yellow represents 
Gp split-intein. 
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1 The recombinant expression and purification of H-CTPR3-ImpN, H-CTPR3-GpN, H-GpC-CTPR3 were 
performed by L. Synchyshyn 
 Recombinant expression and purification of linkers: H-CBD-ImpC-CTPR3-4.4.2
GpN, H-CBD-GpC-CTPR3-ImpN, CBD-ImpC-CTPR3-GpN-H1 and H-GpC-
CTPR3-ImpN-CBD 
All linkers were successfully purified under denaturing conditions and refolded as 
described in Section 2.3.3.2. The proteins were eluted in buffer 1 M urea, 50 mM Tris pH 
8, 300 mM NaCl, and 250 mM imidazole. 5 mM DTT were added into the elution to 
prevent disulphide formation. The purification of all proteins yielded 20–55 mg/mL 
respectively.  
 
Figure 4.7 SDS-PAGE of the purification of (A) H-CBD-ImpC-CTPR3-GpN, (B) H-CBD-GpC-CTPR3-
ImpN, (C) CBD-ImpC-CTPR3-GpN-H and (D) H-GpC-CTPR3-ImpN-CBD. (A-C) Lane L, PageRuler Broad 
Range Unstained Protein Ladder in kDa. (A) Lane 1, pre-induction cell sample; Lane 2, post-induction cell 
sample; Lane 3, flow-through fraction; Lanes 4-9, elution fractions; and Lane 10, purified H-CBD-ImpC-
CTPR3-GpN. (B) Lane 1, denatured flow-through; Lanes 2 and 3, elution fractions; and Lane 4, purified H-
CBD-GpC-CTPR3-ImpN. (C) Lane 1, pre-induction culture sample; Lane 2, post-induction culture sample; 
Lane 3, denatured insoluble lysate; Lane 4, denatured soluble lysate; Lane 5, flow-through fraction; Lanes 
6-7, elution fractions; and Lane 8, purified CBD-ImpC-CTPR3-GpN-H. (D) Lane 1, pre-induction culture; 
Lane 2, post-induction culture; Lane 3, native soluble lysate; Lane 4, native insoluble lysate; Lane 5, 
affinity column flow-through; Lane 6, affinity column wash; Lane 7, affinity column elution fraction; Lane 
8, denatured soluble lysate, Lane 9, denatured insoluble lysate; Lane 10, affinity column flow-through; 
Lane 11, affinity column elution fraction; and Lane 12, purified H-GpC-CTPR3-ImpN-CBD. Green 
represents 6-Histidine tag; blue represents CTPR3; purple represents Imp split-intein; red represents CBD; 
and yellow represents Gp split-intein. 
Chapter 4 Design of Controlled Fibre Assembly  
123 
 
4.5 Linker tethered extension optimisation 
 Reaction Conditions 4.5.1
7 mL of chitin resin was charged with an excess of the required linker fusion. These 
were thoroughly equilibrated in reaction buffer supplemented with 1 M urea which 
removed any excess or loosely bound linker (Figure 4.8).  
 
Figure 4.8 The SDS-PAGE of (A) H-CBD-GpC-CTPR3-ImpN and (B) H-CBD-ImpC-CTPR3-GpN bound 
to a chitin resin column. (A and B) Lane L, PageRuler Broad Range Unstained Protein Ladder in kDa; 
Lane 1, purified linker; Lane 2, flow through of the linker from the column; Lane 3, wash fraction; and 
Lane 4, resin of the bound protein. Green represents 6-Histidine tag; blue represents CTPR3; purple 
represents Imp split-intein; red represents CBD; and yellow represents Gp split-intein. 
 
To initiate the reaction, 5 mL of 50 µM of cap was added to resin charged with a 
compatible linker. The reaction was incubated with gentle agitation at 25 °C. Once the 
reaction had reached completion, the flow through of the column was collected and 
concentrated to 5 mL. This could then be added to resin charged with the next 
compatible linker to initiate the next stepwise extension. The process could then be 
repeated to produce iteratively larger assemblies (Figure 4.3A).  
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 Varying Imp split-intein mediated reaction time 4.5.2
For the first round of extension, Dr. J. Wright’s protocol was repeated. Here, step one 
reacted the cap, H-CTPR3-GpN, with immobilised H-CBD-GpC-CTPR3-ImpN linker. 
The reaction was mediated by a Gp split-intein and was left to proceed for 2 hrs at 
25 °C. Figure 4.9A shows the SDS-PAGE of the reaction. The reaction yield was 
calculated using the band intensities of the product and unreacted protein found in the 
elution (Figure 4.9A-Lane 3) – Section 2.5.2. The reaction yield mediated by Gp split-
intein was consistent with Dr. J. Wright’s findings, which was 90 % yield.   
In order to increase the reaction yield in the second round of extension, the reaction 
time of the concentrated H-CTPR6-ImpN and immobilised H-CBD-ImpC-CTPR3-GpN 
(mediated by Imp split-intein) was extended to 16 hrs. The reaction yield obtained was 
same as the result obtained by Dr. J. Wright, i.e. 60 %. 
 
Figure 4.9 SDS-PAGE of the linker tethered extensions. (A) First extension, ligation of H-CTPR3-GpN 
and immobilised H-CBD-GpC-CTPR3-ImpN. Lane 1, resin sample of bound H-CBD-GpC-CTPR3-ImpN, 
Lane 2, H-CTPR3-GpN; Lane 3, elution fraction after 1 hr reaction time (expected product, H-CTPR6-
ImpN, 38.6 kDa) (B) Second extension, ligation of H-CTPR6-ImpN and immobilised H-CBD-ImpC-
CTPR3-GpN. Lane 1, resin sample of bound H-CBD-ImpC-CTPR3-GpN; Lane 2, elution fraction after 16 
hrs reaction time (expected product, H-CTPR9-GpN, 50.2 kDa). (A and B) Lane L, PageRuler Broad 
Range Unstained Protein Ladder in kDa. Green represents 6-Histidine tag; blue represents CTPR3; purple 
represents Imp split-intein; red represents CBD; and yellow represents Gp split-intein. 
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 Stepwise extension initiated by Imp split-intein 4.5.3
Increasing the reaction time of the second step (Imp mediated ligation) failed to 
increase the reaction yields. This suggests that the Imp split-intein might have lost some 
reactivity before step 2.  Therefore, it was decided to change the sequence of the split-
inteins used. Instead of initiating with a Gp-mediated ligation, an Imp split-intein cap 
(H-CTPR3-ImpN) was reacted with a compatible linker (H-CBD-ImpC-CTPR3-GpN). In 
solution this reaction proceeded to 85 % yield within 3 hrs (data not shown). Excitingly 
when the reaction was performed with the linker tethered to the resin, a similarly high 
yield of 80 % was obtained (Figure 4.10A).  The product was isolated successfully and 
the 2nd stepwise addition was trialled.  This was mediated by Gp split-inteins with resin 
bound H-CBD-GpC-CTPR3-ImpN linker (incubated for 2 hrs) (Figure 4.10B). This was 
also successful, with a yield of 80 %.  Finally, a third extension was performed with the 
2nd reaction product (H-CTPR9-ImpN) reacted with the initial H-CBD-ImpC-CTPR3-
GpN charged resin (Figure 4.10C). A reaction yield of 65 % was obtained but 50 % of 
the product was lost during purification and concentrating steps. Figure 4.11 shows the 
product from each stepwise addition.  
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Figure 4.10 The SDS-PAGE of the stepwise extension of the fibres. (A) The reaction of H-CTPR3-ImpN 
and H-CBD-ImpC-CTPR3-GpN, producing H-CTPR3-CTPR3-GpN (30 kDa) in 3 hrs. (B) The reaction of 
H-CTPR3-CTPR3-GpN and H-CBD-GpC-CTPR3-ImpN, producing H-CTPR3-CTPR3-CTPR3-ImpN (39 
kDa) in 2 hrs. (C) The reaction of H-CTPR3-CTPR3-CTPR3-ImpN and H-CBD-ImpC-CTPR3-GpN, 
producing H-CTPR3-CTPR3-CTPR3-CTPR3-GpN (54.8 kDa). (A-C) Lane L, PageRuler Broad Range 
Unstained Protein Ladder in kDa; Lane 1, reactant added to the column bound with the linker; Lane 2, 
resin sample of the bound linker; Lane 3, resin sample after the reaction; Lanes 4-6, the flow-through and 
wash fraction after the reaction; Lane 7, resin sample of bound protein after wash; and Lane 8, 
concentrated sample of the flow-through and wash fractions after the reaction. Green represents 6-
Histidine tag; blue represents CTPR3; purple represents Imp split-intein; red represents CBD; and yellow 
represents Gp split-intein. 
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Figure 4.11 The SDS-PAGE of the stepwise extension of CTPR3. Lane L, PageRuler Broad Range 
Unstained Protein Ladder in kDa; Lane 1, bound H-CBD-ImpC-CTPR3-GpN; Lane 2, bound H-CBD-
GpC-CTPR3-ImpN; Lane 3, H-CTPR3-ImpN; Lane 4, 1st round of extended product, H-CTPR3-CTPR3- 
GpN (30 kDa); Lane 5, 2nd round of extended product, H-CTPR3-CTPR3-CTPR3-ImpN (39 kDa); and 
Lane 6, 3rd round of extended product, H-CTPR3-CTPR3-CTPR3-CTPR3-GpN (54.8 kDa). Green 
represents 6-Histidine tag; blue represents CTPR3; purple represents Imp split-intein; red represents 
CBD; and yellow represents Gp split-intein. 
 
 Summary – Linker tethered stepwise extensions 4.5.4
Dr. Wright had successfully shown that linker tethered ligations could be successfully 
used in a 2-reaction sequence to link three proteins together.  The first Gp-mediated 
reaction step produced high yields.  However, the 2nd Imp-mediated step only produced 
60 % yield. As Imp requires longer than Gp to react, increasing the time for the Imp 
reaction step was trialled. However, this did not increase the yield higher than the 
original 60 %. The low yield may be due to Imp split-intein losing its reactivity or 
aggregating during the first ligation reaction. Hence, the system was redesigned to start 
the extension with the Imp split-intein. Excitingly, this significantly increased the yield 
for the Imp step to ~80 %.  A second round of extension via Gp split-intein was then 
successfully achieved with an ~80 % yield. However, when a further Imp mediated 
round of extension was trialled the yield dropped to 65 %. The reduced in yield, in the 
third round, occured with the Imp mediated split-intein again. One reason for the 
decrease in yield could be that the size of the protein becomes either sterically hindered 
or more likely to aggregate on the resin or losing its reactivity. No matter the exact 
cause of the reduced in reaction yield in the 3rd step, and the loss of product during the 
concentrating step, it can be concluded that the tethered linker synthesis is limited to 
two rounds of extension. 
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4.6 Stepwise solution extension  
From Dr. Wright’s work and the previous sections it is obvious that 3 to 4 ligations are 
the limit of Gp / Imp split-intein mediated assembly.  However, we can assemble from 
both the N and C-termini. Therefore, the effective size of product can be increased by 
extending from both termini and using the final ligation step to ligate both together. For 
example, three rounds of extension of CTPR3 from either N or C termini produces a 
CTPR12 protein.  Whereas extending from both N / C termini and then ligating both in 
the 3rd round could produce a CTPR18 protein (Figure 4.5).  Moreover, the increased 
size differential should enable easy SEC separation of the final product.  
 
 1st Generation 4.6.1
Our first convergent solution assembly, Figure 4.5, uses Gp-mediated ligation in step 1, 
followed by Imp-mediated ligation in step 2. Both products are then combined in step 3 
and ligated together via a final Gp-mediated ligation. Steps 1 and 2 were performed 
using a ratio of 2 : 1 : 2 (cap : 1st linker : 2nd linker), where the concentration of the cap 
protein was 100 µM. An excess of cap in step 1 and linker in step 2 were used to drive 
the generation of the greatest possible. All reactions were performed under standard 
reaction conditions (Section 2.4.2) with a reaction buffer supplemented with 1 M urea. 
The reaction time for Gp and Imp mediated ligation were 1.5 hrs and 3 hrs, respectively. 
Figure 4.12 shows the results from the 3 rounds of extension.  
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Figure 4.12 SDS-PAGE of the extension of fibres in solution. (A) Extension from both N and C-terminal 
caps. Lane 1, H-CBD-GpC-CTPR3-ImpN, Lane 2, H-CBD-ImpC-CTPR3-GpN; Lane 3, H-CTPR3-GpN; 
Lane 4, H-CTPR6-ImpN (41.7 kDa); Lane 5, H-CTPR9-GpN (53.4 kDa); Lane 6, H-GpC-CTPR3, Lane 7, 
H-CBD- ImpC-CTPR6 (40.6 kDa); and Lane 8, H-CBD-GpC-CTPR9 (54.2 kDa). (B) Ligation of 
extended caps. Lane 1, H-CTPR9-GpN; Lane 2, H-CBD-GpC-CTPR9; Lane 3, the reacted mixture after 
1.5 hrs. (A and B) Lane L, PageRuler Broad Range Unstained Protein Ladder in kDa. Green represents 6-
Histidine tag; blue represents CTPR3; purple represents Imp split-intein; red represents CBD; and yellow 
represents Gp split-intein. 
 
4.6.1.1 Summary 
The performance of Gp and Imp split-inteins were consistent. A high yield was gained 
from Gp-mediated ligation, whereas Imp-mediated ligation gave a slightly lower yield. 
The final ligation produced very little CTRP18. This was due to the unwanted ligation 
of extra reactants. To solve this problem, the purification of the product was required 
after each round of ligation. Hence, the system was redesigned as per the next section. 
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 2nd Generation 4.6.2
To enable easier purification of each step and to reduce unwanted “side reactions”, the 
linkers and caps were redesigned. The position of the affinity tags were changed in 
three constructs:  
(i) H-CTPR3-GpN to CTPR3-GpN-H 
(ii) H-CBD-ImpC-CTPR3-GpN to CBD-ImpC-CTPR3-GpN-H 
(iii) H-CBD-GpC-CTPR3-ImpN to H-GpC-CTPR3-ImpN-CBD 
Thus, the reaction scheme should proceed as per Figure 4.13. 
 
Figure 4.13 Flow chart of the process of making CTPR18. After each round of ligation reaction, the 
desired products were purified via affinity chromatography. Green represents 6-Histidine tag; blue 
represents CTPR3; purple represents Imp split-intein; red represents CBD; and yellow represents Gp 
split-intein. 
 
With these changes, after each round of ligation, the product was purified by using 
either nickel or chitin affinity chromatography. Moreover, no concentration steps were 
performed until after the final round of ligation.  This increased yields after each stage 
and did not reduce reaction efficiency.   
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4.6.2.1 First round of ligation and purification 
The first round of extension for both caps was mediated by Gp split-inteins under the 
same reaction conditions as the first generation designs (50 µM concentrations, 50 mM 
Tris pH 8, 300 mM NaCl, 1 M Urea, 2 mM DTT) in a 1 to 1 ratio (Figure 4.14). Ni 
affinity chromatography was performed after the reaction to obtain the purified 
extended caps. From analysing the band intensity on the SDS-PAGE, the yield of each 
reaction achieved >85 % yield and the purification of the extended caps, CTPR6-ImpN 
and CBD-ImpC-CTPR6 were successful with only ~10 % loss of product. 
 
Figure 4.14 SDS-PAGE of the first round of reaction and purification. (A and B) Lane L, PageRuler 
Broad Range Unstained Protein Ladder in kDa; Lane 1, time 0; Lane 2, after 1.5 hrs of reaction; Lane 3, 
purified products (A) CTPR6-ImpN-CBD (44.2 kDa) and (B) CBD-ImpC-CTPR6 (37.5 kDa) via Nickel 
affinity chromatography. Green represents 6-Histidine tag; blue represents CTPR3; purple represents Imp 
split-intein; red represents CBD; and yellow represents Gp split-intein. 
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4.6.2.2 Second round of ligation and purification 
The second round of extension was mediated by Imp split-inteins (Figure 4.15). The 
conditions were identical to step 1 except a reaction concentration of 20 µM was used 
(as, the purified step 1 product was reacted without concentrating to reduce losses). The 
yield of the C-terminal reaction achieved ~85 %. Unfortunately, the reaction yield of 
the N-terminal reaction cannot be quantified because the product, CTPR9-GpN-H, and 
the linker, CBD-ImpC-CTPR3-GpN-H, migrate at the same size on the denaturing gel. 
The purifications of the CTPR9-GpN-H and the H-CBD-CTPR9 via chitin affinity 
chromatography were successful with ~10 % loss of the product. 
 
Figure 4.15 SDS-PAGE of the second round of reaction and purification. (A and B) Lane L, PageRuler 
Broad Range Unstained Protein Ladder in kDa; Lane 1, time=0; Lane 2, 3 hrs after the reaction; Lane 3, 
purified products (A) CTPR9-GpN-His (52.9 kDa) and (B) His-GpC-CTPR9 (47.7 kDa) via Ni affinity 
chromatography. Green represents 6-Histidine tag; blue represents CTPR3; purple represents Imp split-
intein; red represents CBD; and yellow represents Gp split-intein. 
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4.6.2.3 Final ligation and purification 
Finally, the purified CTPR9-GpN-H and H-CBD-CTPR9 were reacted in 1 to 1 ratio for 
2 hrs in the same conditions, except the concentration was 6 µM (again to avoid losses 
during concentration). The reaction time was increased to ensure complete ligation. 
Nickel affinity chromatography was performed to remove the unreacted proteins 
(Figure 4.16). The yield of the ligation attained > 75 % with the purification step again 
only reducing the yield by 10 %. Figure 4.17 shows the stepwise assembly of the 
CTPR18.  
 
Figure 4.16 SDS-PAGE of the final round of reaction and purification. Lane L, PageRuler Broad Range 
Unstained Protein Ladder in kDa; Lane 1, time=0; Lane 2, 2 hrs after the reaction of CTPR9-GpC-H and 
H-CBD-GpC-CTPR9; Lane 3, purified product CTPR18 (81.5 kDa) via Nickel purification. Green 
represents 6-Histidine tag; blue represents CTPR3; and yellow represents Gp split-intein. 
 
 
 
Figure 4.17 SDS-PAGE of the stepwise assembly of CTPR18. Lane L, PageRuler Broad Range 
Unstained Protein Ladder in kDa; Lane 1, CTPR3-GpN-H; Lane 2, CTPR6-ImpN-CBD; Lane 3, CTPR9-
GpN-H; Lane 4, CTPR18; Lane 5, H-GpC-CTPR9; Lane 6, CBD-ImpC-CTPR6; Lane 7, H-GpC-CTPR3. 
Green represents 6-Histidine tag; blue represents CTPR3; purple represents Imp split-intein; red 
represents CBD; and yellow represents Gp split-intein. 
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4.6.2.4 Secondary structure analysis of the assembled CTPR18 
Far-UV CD spectroscopy analysis was performed to observe the secondary structure of 
the purified CTPR18 in solution, as described in Section 0. The purified CTPR18 fibril 
product was compared to a CTPR3 without the solvating helix (purified by Dr. C. 
Millership) that contains no split-inteins or affinity tags. The resulting CD spectra was 
calculated and plotted as shown in Figure 4.18. The far-UV CD spectra of the CTPR18 
show that: (i) they are highly alpha-helical, and, importantly, (ii) have exactly six times 
the molar ellipticity in deg cm2 dmol-1 at 222 nm as that of the CTPR3 (Figure 4.18A). 
Figure 4.18B shows the molar ellipticity in deg cm2 dmol-1 residue-1. The slight 
differences in the intensity at 208-235 nm are due to the extra amino acids (required for 
NCL and cloning) present in the CTPR18, which results in the number of residues of 
CTPR18 being 6.7 times more than the number of residues of CTPR3. The molar 
ellipticity deg cm2 dmol-1 CTPR-1 (Figure 4.18C) shows that the extra amino acids 
present in CTPR18 did not affect the secondary structure of the CTPR18. Moreover, the 
ligation reaction had not caused any local unfolding on the secondary structure of the 
CTPR proteins. 
 
Figure 4.18 Far UV-CD spectra of CTPR18 (red) in comparison to a CTPR3 without split-inteins (black) 
with (A) molar ellipticity in deg cm2 dmol-1; (B) molar ellipticity in deg cm2 dmol-1 residue-1; and (C) 
molar ellipticity in deg cm2 dmol-1 CTPR-1. 
 
4.6.2.5 Summary 
The 2nd generation stepwise solution extension system successfully produced pure 
CTPR18. Moreover, the change of position of the affinity tags made the purification of 
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product after each round of reaction easier. Purification after each reaction eliminated 
any unwanted reactants and hence increased reaction yield. All of the reaction yields 
were in excess of 75 % and in certain cases as high as 90 %. Moreover, designing the 
system so that the product did not bind to the affinity resin and removing the need for 
concentrating after each round of purification, reduced losses to only 10 %. Thus, after 
each reaction and purification yields were on average 78 % yield with the final ligation 
and purification slightly lower at 68 %. Thus, the convergent 3-steps produced a final 
yield of the product CTPR18 of approximately 55 %. 
4.7 Conclusion 
In this chapter, it has been shown that the stepwise fibre extension mediated by this 
split-intein system is a much faster and higher yielding alternative to the MxGA intein 
system. Moreover, the split-intein system requires no activation steps. Both linker-
tethered and solution syntheses were trialled and optimised. These showed: 
Linker tethered synthesis:  Immobilisation of the reactant proteins on chitin resin did 
not affect the initial Gp or Imp-mediated ligations.  However, after two rounds of 
ligation, a significantly lower reaction yield was obtained for Imp-mediated ligation. 
This is likely due to either aggregation or steric hindrance. To improve reaction yields, 
spacer proteins could be introduced increasing the distance between the resin and the 
reactive split-inteins and reducing aggregation/steric hindrance during ligation. The 
reduction in reaction yield and loss of product during concentrating steps limited the 
tethered linker synthesis to two rounds of extension. 
Solution synthesis: The solution synthesis was modified to enable purification of 
product after each stepwise extension. Importantly, by removing any concentrating 
steps, 90 % of the product was recovered from each of these.  Thus, the overall yield of 
each step dictated that 3 rounds of extension produced a total yield of 55 % (each 
individual step produced > 75 %). Significantly, as the system can be convergently 
extended from both the N and C termini, larger structures can be produced than 
extension from only one terminus, with the same high yield. In conclusion, for the same 
number of extensions as the Mxe GyrA intein system, the split-intein mediated 
convergent synthesis enables the generation of larger products (joining 6 modules 
versus 4 modules) with a significantly greater yield (55 % versus 13 %) in a third of the 
time. 
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5 Assembly of Larger Cages 
5.1 Introduction 
This chapter explores the stepwise assembly of larger cages via iterative NCL addition 
mediated by the split-inteins described in Chapter 3 and 4. To show proof of principle 
non-functionalisable larger cages were produced by reacting half cage caps with CTPR3 
“Spacer” linker constructs. Once this was established, cages were functionalised by 
replacing the CTPR3 in the linker with CTPR390. The CTPR390 has a motif that binds 
to specific pentapeptide tag (Cortajarena et al. 2004; Grove et al. 2012). Therefore, 
cargo that is tagged with the pentapeptide tag can be loaded onto the functional cages.  
 
  System design 5.1.1
The stepwise assembly requires three components: 2 half cages and a linker construct. 
In a similar manner to the fibre assembly, the larger cage assembly used a step-wise 
extension system. Here, one half cage cap was first reacted with a linker construct to 
create an extended half cage.  Then the cage was completed by reacting the extended 
half cage with a complimentary half cage cap (Figure 5.1). After each reaction, affinity 
chromatography was performed to purify the product. Functional cages were assembled 
using the same method, except the linker contained a CTPR390 binding module as 
opposed to a “spacer” CTPR3 (H-GpC-CTPR390-ImpN-CBD).  
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Figure 5.1 Schematic diagram of the process to assemble larger cages. First, the extended half cage cap 
was assembled by reacting M4P-CTPR3-GpN-H and H-GpC-CTPR3-ImpN-CBD. The product was 
collected in the flow-through and wash fractions during purification. The extended half cage cap was 
ligated with H-CBD-ImpC-CTPR3-M4P to make larger cages. The final product was purified via 2-step 
purification: affinity chromatography and SEC. Green represents 6-Histidine tag; orange represents M4P; 
red represents linker; blue represents CTPR3; purple represents Imp split-intein; red represents CBD; and 
yellow represents Gp split-intein.  
 
 Recombinant expression and purification of the required protein fusions 5.1.2
As seen in Figure 5.1, the three components required are M4P-CTPR3-GpN-H, H-GpC-
CTPR-ImpN-CBD and H-CBD-ImpC-CTPR3-M4P. The expression and purification of 
the M4P-CTPR3-GpN-H and the H-CBD-ImpC-CTPR3-M4P was described in Section 
3.4.2, and the H-GpC-CTPR3-ImpN-CBD was described in Section 4.4.2. 
H-GpC-CTPR390-ImpN-CBD was expressed and purified denatured (Section 2.3.3.2). It 
was refolded via step-down denaturant dialysis to determine its solubility condition. The 
final buffer condition was 50 mM Tris pH 7, 2 M urea, 300 mM NaCl, 5 mM DTT. The 
protein fusions were successfully refolded with 53.5 mg/L yield and high purity. 
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Samples were taken during the purification process and analysed by SDS-PAGE 
(Figure 5.2). As seen from the Figure 5.2, CTPR390 does not exhibit gel shift on SDS-
PAGE as CTPR3 does. 
 
Figure 5.2 SDS-PAGE of the expression and purification of H-GpC-CTPR390-ImpN-CBD. Lane L, 
PageRuler Broad Range Unstained Protein Ladder in kDa; Lane 1, pre-induction culture; Lane 2, post-
induction culture; Lane 3, denatured soluble lysate; Lane 4, denatured insoluble lysate; Lane 5, flow-
through fraction; Lane 6-8, elution fractions; and Lane 9, purified dialysed H–GpC-CTPR390-ImpN-CBD. 
Green represents 6-Histidine tag; pink represents CTPR390; purple represents Imp split-intein; red 
represents CBD; and yellow represents Gp split-intein. 
 
 
5.2 Stepwise Assembly of larger cages  
 1st Step - NCL of half cage caps and linker 5.2.1
It is extremely important to obtain the highest yield possible for each reaction step in 
any multi-step reaction. It is particularly so here, given that each trimeric half cage 
requires each of its three sides to react.  Therefore, both half-cage caps, with their 
differing split-inteins, were trialled in the first-step ligation to the linker fusion. This 
enabled the relative yields of a Gp and Imp mediated ligation to be assayed. In addition, 
differing excesses of linker fusion were also used to determine if this can increase the 
yield of extended half-cage product.  100 µL reaction volumes were used, with the half 
cage cap concentration always kept at 33 µM. The ratio of cap to linker was trialled at 
1:3, 1:6 and 1:9, respectively, in standard reaction conditions, for 3 hrs, where the ratio 
is trimeric cage to monomeric linker. Figure 5.3 shows the results. The product yields 
were calculated against the amount of half cage caps left after the reaction.  
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Figure 5.3. (A and B) SDS-PAGE of each reaction after 3 hrs. (A) Ligation reaction of H-CBD-ImpC-
CTPR3-M4P and H-GpC-CTPR-ImpN-CBD in different ratios (product, H-GpC-CTPR6-M4P, 40 kDa). 
(B) Ligation reaction of M4P-CTPR3-GpN-H and H-CBD-ImpC-CTPR3-M4P and H-GpC-CTPR3-ImpN-
CBD in different ratios (product, M4P-CTPR6-ImpN-CBD, 50 kDa). (A and B) Lane L, PageRuler Broad 
Range Unstained Protein Ladder in kDa; Lane 1, 1 to 3 ratio; Lane 2, 1 to 6 ratio; and Lane 3, 1 to 9 ratio. 
(C) Calculated percentage yield of ligation mediated by the Imp and Gp split-inteins respectively, at 
different ratios. Error bars equate to standard deviation of multiple repeat experiments (at least twice in 
all cases). Green represents 6-Histidine tag; orange represents M4P; red represents linker; blue represents 
CTPR3; purple represents Imp split-intein; red represents CBD; and yellow represents Gp split-intein. 
 
The reaction yield mediated by the Gp split-intein appears to be independent of the 
reaction ratio. An average yield of 60 % was obtained for all three ratios. In contrast, 
the reaction yield mediated by the Imp split-intein increased substantially from 42 % 
when reacted in a 1:3 ratio to 90 % when an excess of linker was used (1:6 and 1:9). To 
determine the optimal time for the Imp split-intein extended cage reaction a time course 
of 3 hrs was recorded (Figure 5.4).  As can be seen, the reaction was complete after 1 hr 
with ~90 % yield. Hence, to gain maximum yield of extended half cage product, the 
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Imp split-intein mediated reaction of half cage to linker was chosen.  The reaction was 
carried out for 2 hrs and in a ratio of 1:6 (half cage cap trimer to monomeric linker). 
Separation of Fully Ligated Product: Once reacted, the extended product was purified 
via chitin affinity chromatography (Figure 5.4A – Lane 9). Any unreacted half cage / 
linker fusions, partially spliced half cage caps and reacted split-inteins bound to the 
chitin resin, whereas the fully reacted extended half cages did not. The purified product 
was concentrated before proceeding with the next reaction. The yield of fully ligated 
extended half-cage after purification and concentration was approximately 50 %.  
Complete ligation and purity were confirmed by anti-CBD affinity tag Western blot 
(Figure 5.4B).   
 
Figure 5.4 Ligation reaction of H-CBD-ImpC-CTPR3-M4P and H-GpC-CTPR-ImpN-CBD. (A) SDS-
PAGE of the reaction in 1 to 6 ratio (H-CBD-ImpC-CTPR3-M4P to H-GpC-CTPR3-ImpN-CBD). Lane L, 
PageRuler Broad Range Unstained Protein Ladder in kDa; Lane 1, time=0; Lane 2, 30 secs; Lane 3, 60 
secs; Lane 4, 5 mins; Lane 5, 10 mins; Lane 6, 30 mins; Lane 7, 1 hr; Lane 8, 3 hrs; Lane 9, purified 
extended half cage (40 kDa). (B) Anti-CBD Western blot. Lane L, PageRuler Plus Prestained Protein 
Ladder in kDa; Lane 1, H-GpC-CTPR-ImpN-CBD; Lane 2, H-CBD-ImpC-CTPR3-M4P; Lane 3, H-GpC-
CTPR6-M4P. (C) The initial rates of percentage ligated obtained from SDS-PAGE analysis fitted with a 
single exponential plus linear drift [(A*(1 -exp(-k*t))]. Green represents 6-Histidine tag; orange 
represents M4P; red represents linker; blue represents CTPR3; purple represents Imp split-intein; and red 
represents CBD.   
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 2nd Step - Cage Closure 5.2.2
The next stepwise ligation reacted the extended half cage with a compatible Gp-half 
cage cap to form the closed cage. To favour the formation of discrete cages rather than 
networks, the cage closure was carried out with equimolar concentrations of reactants at 
1 μM (as per Chapter 3 Gp-mediated cage synthesis). Excitingly, within 3 hrs, the 
percentage yield reached 70 %. This is consistent with the percentage yield of the 
smaller cage formation mediated by the Gp split-intein (Figure 5.5).  
Separation of Fully Ligated Product: The fully ligated product was purified, as 
previously, by nickel chromatography and complete ligation confirmed by anti-His 
Western blot (Figure 5.5A-Lane 13 and B). Again, the percentage of complete ligation 
versus partial ligation was ~ 66 % (Figure 5.5D), which was consistent with the Gp-
mediated cage formation. 
  
Figure 5.5 Ligation reaction of M4P-CTPR3-GpN-H and H-GpC-CTPR6-M4P. (A) SDS-PAGE of the 
reaction. Lane L, PageRuler Broad Range Unstained Protein Ladder in kDa; Lane 1, 30 secs; Lane 2, 60 
secs; Lane 3, 10 mins; Lane 4, 30 mins; Lane 5, 1 hr; Lane 6, 3 hrs; Lane 7, 18 hrs; and Lane 8, The 
purified product, M4P-CTPR9-M4P (51 kDa). (B) Anti-His Western blot. Lane L, PageRuler Plus 
Prestained Protein Ladder in kDa; Lane 1, H-GpC-CTPR-ImpN-CBD; Lane 2, H-CBD-ImpC-CTPR3-
M4P; Lane 3, H-GpC-CTPR6-M4P; Lane 4, M4P-CTPR3-GpN-H; Lane 5, purified M4P-CTPR9-M4P; 
and Lane 6, elution fractions from the purification of M4P-CTPR9-M4P. (C) The initial rates of 
percentage ligated obtained from SDS PAGE gels analysis fitted with a single exponential plus linear 
drift [(A*(1 -exp(-k*t))]. (D)  Calculated percentage of complete and incomplete ligation. Error bars 
equate to standard deviation of multiple repeat experiments (at least three in all cases). Green represents 
6-Histidine tag; orange represents M4P; red represents linker; blue represents CTPR3; and yellow 
represents Gp split-intein.   
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Separation of discrete cages from networks: As for the one-pot cages (Chapter 3), 
discrete cage structures were separated from extended networks via SEC. Figure 5.6A 
shows the results when a Superdex 200 10/30 column was used in standard reaction 
buffer. A monodispersed peak can be observed with an elution volume of 11.4 mL. 
Thus, the cage closure was successful, with a substantial proportion of the fully ligated 
product forming discrete assemblies rather than extended networks. When the elution 
volume of the extended cage was compared to that obtained for the two component 
cages, a difference of 0.5 mL was observed (extended cages eluted at 11.4 mL, and the 
two-component cage eluted at 11.9 mL). Fitting of the peak maxima of the larger cage 
to calibration standards, gave a molecular weight of 127 kDa (a difference of 20 % to 
the calculated trimeric molecular weight of 153 kDa) (Figure 5.6B). Thus, as expected, 
the extended cages form a slightly larger structure than the two-component cage, but not 
so large as to indicate a dramatic change in conformation. 
 
Figure 5.6 Trimeric analysis of the larger cages. (A) Superdex 200 10/30 SEC analysis. (B) The extended 
cages Ve/Vo (orange triangle) (elution volume/column void volume) of the extended cage plotted against 
their Log10 molecular weight on a standard curve. Black squares represent protein standards. 
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 Structural analysis by SEC-SAXS 5.2.3
In a similar manner to Chapter 3, the extended cages were analysed by SEC-SAXS to 
obtain more information on their 3D shape.  The collected SAXS data was processed 
and analysed as described in Section 2.5.7.1. Interestingly, initial inspection of the 
SAXS profile (Figure 5.7) showed differing features to the smaller one-pot cages 
described in Chapter 3.  In particular, the region from 0.1 to 0.2 1/Å did not exhibit as 
prominent a concave feature. Thus, the addition of an extra 3 CTPR repeats has changed 
some features of the cage. This was to be expected, as the shape of the CTPR superhelix 
would be, at the very least, in a differing register with the addition of the extra CTPR 
motifs.  Importantly, the curve still possesses several features that enable shape 
determination to a higher resolution. 
 
Figure 5.7 The SAXS profile of (A) larger cage product and (B) smaller cage product. 
 
Initial analysis: Guinier and Kratky plot analysis of the SAXS data confirmed that the 
purified cages were monodisperse, rigid and multi-domained proteins. However, the 
Kratky plot analysis showed they are not as rigid as the smaller cages. The analysis 
showed that the extended cages are non-spherical and elongated with a radius of 
gyration (Rg) of 5 nm and a maximum linear particle diameter (Dmax) of 17.1 nm 
(Figure 5.8). Thus, the extended cages also have an elongated shape similar to the 
smaller cages, yet are slightly larger in both dimensions. The molecular weight of the 
extended cages obtained from the SAXS data is in agreement with that calculated from 
its amino acid sequence (157 kDa versus 155 kDa, respectively). Table 5.1 summarises 
the SAXS parameters of cage products obtained from the analysis and compares them 
to the smaller cages. 
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Figure 5.8 Analysis of SAXS of ligated cage and Kratky analysis of half-cage cap. (A) Guiner analysis, 
(B) distance distribution functions P(r) and (C) Kratky analysis of the SAXS for the ligated larger cages. 
 
Table 5.1 SAXS parameters obtained from analysis of the purified extended cage 
and cage products 
SAXS parameters SAXS extended cage products SAXS cage products 
q range (Å-1) 0.010 to 0.350 0.004 to 0.350 
I(0) (Å) 0.160 +/-0.0002 0.134 +/-0.00011 
Rg (nm) (from Guinier)  5.00 +/-0.033 3.85 +/-0.023 
Rg (nm) (from P(r)) 4.98 +/-0.006 3.82 +/-0.014 
Dmax (nm) (from P(r)) 17.1 12.6 
Porod Exponent 3.4 3.7 
MWSAXS (Da) 157,050 110,568 
MWsequence (Da) 154,533 113,369 
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Particle Reconstruction: Currently full particle reconstruction is still in progress.  As 
with the smaller cages both ab initio and manual modelling construction techniques are 
being used. Below the results to date are summarised: 
Ab initio – In a similar manner to the smaller cages, ab initio modelling was used with 
the program DAMMIF and P32-symmetry restraints. GASBOR was trialled, but failed, 
to generate sensible models. 60 models were generated and those that supported the 
biophysical data (5 models) were selected for averaging using DAMMAVER. An ab 
initio model (Figure 5.9A) was generated via DAMMIN using the averaged model as a 
template (as descript in Section 2.5.7.2). It generated an excellent fit to the SAXS curve 
with a χ2 of 1.1 (Figure 5.9B).  As can be seen, the model possesses a cage like structure, 
which is elongated by the addition of the TPR domains to the CTPR cage sides. It 
possesses an enclosed bipyramidal shape.  However, the side domains do not seem as 
well defined as with the smaller cages. 
 
Figure 5.9 (A) Two orientations of the ab initio DAMMIN generated model. (B) Experimental SAXS 
profile (black circles) of ligated extended cages overlaid the ab initio DAMMIN generated model SAXS 
profile (red line). 
 
Manually generated atomic model – Models were generated as described in 
Section2.5.7.3. To date, we have generated several models. We have trialled: (1) a 
trigonal pyramidal model that uses a docked CTPR9 superhelix, (2) a trigonal 
pyramidal model with a docked CTPR6 superhelix attached to an undocked CTPR3 and 
(3) a trigonal pyramidal model with all CTPR3 sides undocked. Models (1) and (3) gave 
a χ2 of >50. This is in agreement with the Kratky plot analysis, where the extended cage 
is only slightly more flexible than smaller cages. Whereas, model (2) gave a χ2 of 2.85 
(Figure 5.10). It is expected that the CTPR6 formed in the first step will maintain the 
CTPR6 superhelix structure but the third CTPR3 from the second ligation does not dock 
into a superhelix. Presently, more differing models are being generated to better fit the 
SAXS profile. 
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Figure 5.10 (A) Two orientations of the best atomic model generated. (B) Experimental SAXS profile 
(black circles) of ligated extended cages overlaid the generated model SAXS profile (red line). 
 
 Summary 5.2.4
We have shown that the stepwise assembly system successfully yielded ~23 % of 
highly pure extended cages, with a substantial proportion of the fully ligated product 
forming discrete assemblies rather than extended networks. Hence, this three-
component system permits a realistic scalable extension limit of two reactions.  
However, if a convergent ligation strategy as described chapter 4 was used, this could 
enable the connection of 4 models together. Both SEC and SEC-SAXS, as expected, 
show that the extended cages form a slightly larger structure than the two-component 
cages, but not so large as to indicate a dramatic change in conformation. Model 
reconstruction of the larger cage is on-going. 
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5.3 Assembly of functional cages 
As the stepwise assembly successfully produced larger cages, the next phase was to 
form functional cages. There are two ways of functionalising the cages: (1) Replace the 
CTPR3 in the half cage cap constructs with a binding module and perform a two-
component synthesis; or (2) use a three-component two-step synthesis and use a linker 
with a binding module. Here, the second approach was explored.  
For the binding module, we used CTPR390.  This is a CTPR3 variant whose 
pentapeptide binding pocket has been designed to recognise the -DESVD sequence 
(Speltz, Nathan, and Regan 2015). Thus, in future, molecules of interest can be tagged 
with the pentapeptide sequence and then ‘loaded’ onto the nanostructure.  
 
 NCL of half cages and functional linker 5.3.1
Given the success of the Imp-mediated half-cage extension ligation, it was decided to 
form an extended half cage by reacting the ImpC tagged half cage cap with a CTPR390 
containing linker construct.  The reaction was conducted as previously, i.e. in the ratio 
of 1 to 6 (half cage cap to linker). Figure 5.11 shows the reaction of H-CBD-ImpC-
CTPR3-M4P and H–GpC-CTPR390-ImpN-CBD after an 1 hr incubation. The ligation 
reaction was in 50 mM Tris pH 7, 2 M urea, 300 mM Tris, 5 mM DTT. 2 M urea was 
used as the linker was not soluble in 1 M Urea. During the 1 hr reaction, a large quantity 
of precipitation was observed. Fortunately, the precipitant could be denatured in 6 M 
GuHCl and refolded into reaction buffer supplemented with 3 M urea. A SDS-PAGE of 
the reaction, the precipitant, refolded precipitant and soluble reaction product is shown 
in Figure 5.11. Unfortunately, the CTPR390 linker and extended half cage product 
migrated at the same size on the denaturing gel. Both the refolded and soluble reaction 
product was subjected to chitin affinity chromatography.  As per the previous extended 
half cage reaction, every protein will bind to the resin except the fully ligated extended 
half cage product.  The purified, fully ligated, product is shown in Figure 5.11A-Lane 5. 
Optimisation of the purification steps (using new chitin resin and slower flow rates) 
increased the overall yield from 20 % to 50 %. 
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Figure 5.11 SDS-PAGE of the Imp-mediated ligation to form an extended half cage. Lane L, PageRuler 
Broad Range Unstained Protein Ladder in kDa; Lane 1, time=0; Lane 2, 1 hr of reaction; Lane 3, 
insoluble fraction of the reaction; Lane 4, refolded reaction mixture; and Lane 5, purified product via 
chitin chromatography. Green represents 6-Histidine tag; orange represents M4P; red represents linker; 
blue represents CTPR3; pink represents CTPR390; purple represents Imp split-intein; red represents 
CBD; and yellow represents Gp split-intein. 
 
 Functional Cage Closure 5.3.2
The cage was closed with Gp mediated ligation of M4P-CTPR3-GpN-H cap and the 
extended functional half cage cap. Similar to section 5.2.2, H-GpC-CTPR390-CTPR3-
M4P and M4P-CTPR3-GpN-H were reacted in 1 µM to favour the formation of discrete 
cages. The reaction was left for 5 hrs in reaction buffer supplemented with 3 M urea. 
Figure 5.12A shows the reaction at different time points over 5 hrs. The reaction was 
completed within 3 hrs with 60 % yield.  This is in line with both the smaller and 
extended Gp-mediated cage reactions (Figure 5.12B).  
Separation of Fully Ligated Product: The ligation products, unreacted starting material 
and split-inteins were then separated via Ni affinity chromatography. As with the 
smaller cages, unreacted and partially reacted proteins will bind to the Ni, whereas fully 
ligated proteins will not.  Figure 5.11C compares those proteins bound to the resin with 
those that were not.  This allowed the yield of complete to incomplete ligation products 
to be delineated. As can be seen, the percentage of complete ligation is much lower 
(37 %) compared to both the smaller and extended Gp-mediated cage reactions (66 %). 
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Figure 5.12 Gp-mediated ligation to produce extended cages. (A) SDS-PAGE of the reaction. Lane L, 
PageRuler Broad Range Unstained Protein Ladder in kDa; Lane 1, time=0; Lane 2, 30 secs; Lane 3, 60 
secs; Lane 4, 5 mins; Lane 5, 10 mins; Lane 6, 30 mins; Lane 7, 60 mins; Lane 8, 3 hrs; Lane 9, 5 hrs; 
and Lane 10 purified of the product via Ni affinity chromatography (product formed, M4P-CTPR3-
CTPR390-CTPR3-M4P, 51 kDa). (B) The initial rates of the percentage ligated obtained from SDS 
PAGE gels analysis fitted with a single exponential plus linear drift [(A*(1 -exp(-k*t))]. (C) Calculated 
percentage of complete ligation and incomplete ligation. Green represents 6-Histidine tag; orange 
represents M4P; red represents linker; blue represents CTPR3; pink represents CTPR390; purple 
represents Imp split-intein; red represents CBD; and yellow represents Gp split-intein. 
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Separation of discrete cages from networks: To separate discrete functional cages from 
networks and other impurities, SEC was performed (Figure 5.13). A Superose 6 10/300 
column was run in 50 mM Tris pH 8, 3 M urea, 300 mM NaCl, 5 mM DTT buffer. A 
peak was observed at a similar size to the previously extended cage (15 mL in 50 mM 
Tris pH 8, 1 M urea, 300 mM NaCl, 5 mM DTT buffer – orange dotted line). The 
difference in elution volumes (1 mL) was likely due to the concentration of denaturant 
used in the buffer. 
 
Figure 5.13 Purification of discrete functional cages via SEC (blue line). Superose 6 10/300 column was 
run in 3 M urea, 300 mM NaCl, 50 mM Tris pH 7, 5 mM DTT buffer. The possible discrete cages (red 
box) fractions were pooled and concentrated. Orange dotted line – larger cage in 50 mM Tris pH 8, 1 M 
urea, 300 mM NaCl, 5 mM DTT buffer. Green represents 6-Histidine tag; orange represents M4P; red 
represents linker; blue represents CTPR3; and pink represents CTPR390. 
 
 Summary 5.3.3
Functional product has been successfully assembled with final yield of 10 % using a 2-
step assembly system. The product was effectively purified through affinity 
chromatography and SEC. Further characteristics of the functional product i.e. SEC-
SAXS are required to confirm the structure formed. 
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5.4 Conclusion 
In this chapter it has been shown that the designed protein fusions i.e. half cage caps 
and linkers, can be successfully utilised to assemble larger cages in a stepwise manner 
and can incorporate modules that have binding capacity. In particular, a two-step 
extension system was shown to form discrete cages and incorporate sides with either 
non-binding or binding modules.  These could be purified to homogeneity with a 
combination of affinity and size exclusion chromatography.  
Significantly, when the extended non-binding cages were analysed with SEC and SAXS, 
they were shown to produce elongated cage structures that were larger than the one-pot 
cages (Chapter 3), but not so large as to suggest a change in the expected trigonal 
bipyramidal structure. Moreover, the expected molecular weight agreed with that 
calculated from the amino acid sequence (157 kDa). Importantly, from the initial 
analysis, it can be concluded that the structure is a cage with P3-symmetry and an 
enclosed cavity. Further structure reconstruction is still in progress.  
When the CTPR binding module was used in the linker construct, the yield of final 
cages was decreased.  This might be due to the higher concentration of denaturant used 
or a more inherent property of the binding module (more aggregation prone). Once the 
cage closure reaction was concluded, the discrete cages could be purified to 
homogeneity and were found to be stable (non-aggregation prone) in 1 M urea. This is 
in contrast with non-functionalised cages that are stable in non-denaturing aqueous 
buffer.  The increased aggregation potential is likely due to the instability of the binder 
module used. However, this may be overcome by using other, less aggregation-prone 
CTPR binding modules (Speltz, Nathan, and Regan 2015). Nonetheless, this chapter 
demonstrates functional cages can be produced with relative ease and thus provides a 
general route to enable the loading of cargo.  
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6 Conclusions 
6.1 Discussion and further work 
This thesis explored the use of genetically encoded NCL to control the assembly of 
designed and recombinantly produced protein fusions into specific user-defined 
nanostructures and biomaterials. Firstly, in Chapter 3, fusion proteins were designed 
that are capable of self-assembling into protein nanocages with a central hollow cavity. 
In Chapter 4, the limits of the NCL system were examined by determining the most 
NCL reactions that can be performed to form a linear structure. Finally, in Chapter 5, 
we further explored cage forming fusion proteins by designing in functionality. 
 
 Design and assembly of symmetric protein cages 6.1.1
In Chapter 3 and 5, we have proof that genetically programmed split-intein mediated 
NCL can be successfully employed to assemble modular proteins designed with simple 
geometric symmetry into user-defined protein cages. Two pairs of split-inteins, Imp and 
Gp split-inteins were used (i) separately to drive two-component assembly, assembling 
two half-cage modules (M4P vertex and CTPR3 sides) to form a cage; and (ii) together 
to drive three-component assembly, assembling two half cages and a linker to form 
larger cages. Under mild conditions, mixing compatible oligomeric protein fusions 
resulted in rapid and irreversible ligations with high yield of ligated products (via 
peptide bond formation). The fusion proteins were designed to enable discrete, fully 
ligated, cages to be easily and efficiently separated to homogeneity from each reaction 
in a 2-step purification. Significantly, this process generated the expected square 
bipyramidal structures ranging from 113 kDa (for the two-component, one reaction) to 
157 kDa (three-component, two-step reactions). Furthermore, the cage produced from 
the two-component system was shown to contain a central hollow cavity that could 
accommodate cargo up to 70 × 55–60 Å. As for the larger cages, from the initial 
analysis of SEC-SAXS, it can be concluded that the structure is a cage with P3-
symmetry, slightly flexible and has an enclosed cavity. Further structural reconstruction 
is still in progress. Interestingly, although both split-inteins gave high ligation yields, a 
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greater yield of fully ligated discrete cages was obtained when lower reactant 
concentrations and the slower reacting Imp split-intein were used.  
The use of extendable CTPR sides additionally provided a method for loading cargo 
into the central hollow cavity of the nanostructures by using a binding module as the 
linker. However, when the CTPR binding module, CTPR390, was used in the linker 
construct, the yield of final cages was decreased. This was due to a combination of the 
higher concentration of denaturant used and the more aggregation prone nature of the 
binding module. Once the cage closure reaction was concluded, the discrete cages could 
be purified to homogeneity and were found to be stable in non-denaturing buffer for the 
non-functional cage and 1 M urea for the functional cage. The increased aggregation 
potential of the functional cage was due to the instability of the binder module used. 
Fortunately, this may be overcome by using other, less aggregation-prone CTPR 
binding modules (Speltz, Nathan, and Regan 2015). Moreover, each CTPR binding-
modules recognises specific pentapeptide tag sequences (Speltz, Nathan, and Regan 
2015). Thus, molecules of interest could be tagged with a pentapeptide sequence and 
then ‘‘loaded’’ onto the nanostructure via the binding module, creating a generic 
loadable system. The use of proteins such as TPRs, which are natural binding proteins, 
is an advantage of our assembly systems compared with others: for example, those 
based on coiled-coils that do not possess such intrinsic binding capabilities. 
In conclusion, our protein assembly system provides a more general route to producing 
protein cages that avoids many time-consuming and system-specific processes (for 
example, those requiring computational design). No bioconjugation, chemical 
modification, or postligation refolding steps were required, and only a short sequence 
was inserted at the point of the NCL.  
 
 Limitation of the systems 6.1.2
In Chapter 4, we explored the maximum number of NCL that can be achieved via 
iterative fibre formation. A total of four fusion proteins were required: two linker fusion 
proteins, with flanking orthogonal intein pairs and two capping fusion proteins, each 
with a single complementary intein domain either on the N or C-terminus. Two methods 
of stepwise extension were investigated: (i) tethered linker system - whereby the 
growing product is eluted from immobilised fusion proteins via affinity tags and (ii) in 
solution synthesis - whereby protein fusions are reacted in solution and the product of 
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each step affinity purified. Finally, the limits of both syntheses were delineated (i.e. the 
number of extensions possible). Both syntheses concluded that 3 NCL reactions can be 
achieved in a short time with ~55 % final yield. Excitingly, as the system can be 
convergently extended from both the N and C termini, larger structures can be produced 
compared to extension via intein mediated NCL where it can only extended from the C-
terminus (Harvey, Itzhaki, and Main 2018). In addition, linkers with binding modules, 
i.e. CTPR390, can be utilised to assemble functionalisable fibres. 
 
6.2 Further directions 
 Creating new geometries 6.2.1
Nature has a vast range of protein domains that engineer different geometric shapes and 
coupled with these high-yielding split-inteins to drive the reaction, there are many 
opportunities for exploiting our self-assembling protein system. Alternative protein 
structures could be formed with differing vertices geometry. For example, replacing the 
trimeric M4P used for cage assembly with a hexameric PduA protein. In nature, PduA 
is a 37.4 kDa homohexamer that is used in the formation of bacterial 
microcompartments. Its selective permeable pore regulates the influx of substrate and 
efflux of toxic intermediate (C Chowdhury et al. 2015). Similar to M4P domain, both 
the N and C-termini of PduA are located on the same protein face (Figure 6.1A) (Pang 
et al. 2014). Using PduA as the vertices, linear repeat proteins as the sides and a split-
intein driving force to close both ends, a hexameric rod could be assembled (Figure 
6.1B). Furthermore, hexameric PduA packs to form flat sheet in the crystal or can self-
assemble to from synthetic protein nanotubes in low salt concentration solution (Pang et 
al. 2014; Uddin et al. 2018). Hence, a bilayer sheet can be assembled with the 
hexameric rod in low salt concentration solution (Figure 6.1C), a biomaterial that could 
be loaded with biomolecules for biopharmaceutical approaches or used to filter 
heterogeneous particle solutions.  
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Figure 6.1 Assmbly of hexameric rod. (A) Crystal structure of PduA (PDB ID 3NGK). (B) Schematic 
diagram of the assembly of hexameric rod via split-intein mediated NCL. (C) Schematic diagram of the 
assembly of bilayer sheets. Orange represents PduA; and blue represents CTPR3. 
 
 Creating multifunctional nanocages 6.2.2
The one-pot cage and two-step cage assembly described in this thesis has potential 
biotechnological and biomedical applications, using specific modules to bind target load. 
For example, Speltz et. al. designed three TPR binding modules (TRAPs) that binds to 
its cognate peptide and exhibits low cross-reactivity with the peptides bound by the 
other TRAPs (Speltz, Nathan, and Regan 2015). Hence, the CTPR3 used in this thesis 
can be replaced with any of these TRAPs to assemble two or more-components 
nanocages (Figure 6.2A). Then, different cargos and/or site recognition peptides could 
be tagged with its cognate peptide and loaded onto the cages (Figure 6.2B). These 
multifunctional nanocages have potential use in targeted drug delivery where it allows 
medicine to be transported to an exact location in the body, e.g. a cancerous tumour, 
while minimising the damage to tissues surrounding the treatment site and degradation. 
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Figure 6.2 (A) Schematic diagram of the differing nanocages that could be assembled. (B) The domains 
used in assembling the nanocages and potential load that each TRAP can carry. Orange represents M4P; 
red represents linker; blue represents CTPR3; purple represents TRAP1; and green represents TRAP2. 
Chapter 7 References 
157 
 
7 References 
“About RosettaCommons.” 2015. https://www.rosettacommons.org/about. 
Anwar, Rashid A. 1990. “Elastin: A Brief Review.” Biochemical Education 18 (4): 
162–66. https://doi.org/10.1016/0307-4412(90)90121-4. 
Armstrong, C T, A L Boyle, E H Bromley, Z N Mahmoud, L Smith, A R Thomson, and 
D N Woolfson. 2009. “Rational Design of Peptide-Based Building Blocks for 
Nanoscience and Synthetic Biology.” Faraday Discuss 143: 305–72. 
http://www.ncbi.nlm.nih.gov/pubmed/20334109. 
Baldock, Clair, Andres F. Oberhauser, Liang Ma, Donna Lammie, Veronique Siegler, 
Suzanne M. Mithieux, Yidong Tu, et al. 2011. “Shape of Tropoelastin, the Highly 
Extensible Protein That Controls Human Tissue Elasticity.” Proceedings of the 
National Academy of Sciences of the United States of America 108 (11): 4322. 
https://doi.org/10.1073/PNAS.1014280108. 
Bale, J. B., S. Gonen, Y. Liu, W. Sheffler, D. Ellis, C. Thomas, D. Cascio, et al. 2016. 
“Accurate Design of Megadalton-Scale Two-Component Icosahedral Protein 
Complexes.” Science 353 (6297): 389–94. https://doi.org/10.1126/science.aaf8818. 
Baxevanis, A D, and C R Vinson. 1993. “Interactions of Coiled Coils in Transcription 
Factors: Where Is the Specificity?” Curr Opin Genet Dev 3 (2): 278–85. 
http://www.ncbi.nlm.nih.gov/pubmed/8504253. 
Blaber, Michael, and Jihun Lee. 2012. “Designing Proteins from Simple Motifs: 
Opportunities in Top-Down Symmetric Deconstruction.” Current Opinion in 
Structural Biology 22 (4): 442–50. https://doi.org/10.1016/j.sbi.2012.05.008. 
Bragulla, Hermann H, and Dominique G Homberger. 2009. “Structure and Functions of 
Keratin Proteins in Simple, Stratified, Keratinized and Cornified Epithelia.” J. 
Anat 214: 516–59. https://doi.org/10.1111/j.1469-7580.2009.01066.x. 
Brown, Sam P, Helen E Blackwell, and Brian K Hammer. 2018. “GA.s 6th Conference 
on Cell-Cell Communication in Bacteria.” Jb.Asm.Org 1 Journal of Bacteriology 
200: 291–309. https://doi.org/10.1128/JB. 
  
Chapter 7 References 
158 
 
Cadena-Nava, Ruben D, Mauricio Comas-Garcia, Rees F Garmann, A L N Rao, 
Charles M Knobler, and William M Gelbart. 2012. “Self-Assembly of Viral Capsid 
Protein and RNA Molecules of Different Sizes: Requirement for a Specific High 
Protein/RNA Mass Ratio.” Journal of Virology 86 (6): 3318–26. 
https://doi.org/10.1128/JVI.06566-11. 
Calvaresi, Matteo, Leopold Eckhart, and Lorenzo Alibardi. 2016. “The Molecular 
Organization of the Beta-Sheet Region in Corneous Beta-Proteins (Beta-Keratins) 
of Sauropsids Explains Its Stability and Polymerization into Filaments.” Journal of 
Structural Biology 194 (3): 282–91. https://doi.org/10.1016/j.jsb.2016.03.004. 
Carlier, Marie France, and Dominique Pantaloni. 1997. “Control of Actin Dynamics in 
Cell Motility.” Journal of Molecular Biology. 
https://doi.org/10.1006/jmbi.1997.1062. 
Carvajal-Vallejos, P, R Pallissé, H D Mootz, and S R Schmidt. 2012. “Unprecedented 
Rates and Efficiencies Revealed for New Natural Split Inteins from Metagenomic 
Sources.” J Biol Chem 287 (34): 28686–96. 
https://doi.org/10.1074/jbc.M112.372680. 
Chen, Xiaoying, Jennica L. Zaro, and Wei-Chiang Shen. 2013. “Fusion Protein Linkers: 
Property, Design and Functionality.” Advanced Drug Delivery Reviews 65 (10): 
1357–69. https://doi.org/10.1016/j.addr.2012.09.039. 
Chong, S, F B Mersha, D G Comb, M E Scott, D Landry, L M Vence, F B Perler, et al. 
1997. “Single-Column Purification of Free Recombinant Proteins Using a Self-
Cleavable Affinity Tag Derived from a Protein Splicing Element.” Gene 192 (2): 
271–81. http://www.ncbi.nlm.nih.gov/pubmed/9224900. 
Chowdhury, C, S Chun, A Pang, M R Sawaya, S Sinha, T O Yeates, and T A Bobik. 
2015. “Selective Molecular Transport through the Protein Shell of a Bacterial 
Microcompartment Organelle.” Proc Natl Acad Sci U S A 112 (10): 2990–95. 
https://doi.org/10.1073/pnas.1423672112. 
Chowdhury, Chiranjit, Sharmistha Sinha, Sunny Chun, Todd O Yeates, and Thomas A 
Bobik. 2014. “Diverse Bacterial Microcompartment Organelles.” Microbiology 
and Molecular Biology Reviews 78 (3): 438–68. 
https://doi.org/10.1128/MMBR.00009-14. 
  
Chapter 7 References 
159 
 
Ciani, B, S Bjelic, S Honnappa, H Jawhari, R Jaussi, A Payapilly, T Jowitt, M O 
Steinmetz, and R A Kammerer. 2010. “Molecular Basis of Coiled-Coil 
Oligomerization-State Specificity.” Proc Natl Acad Sci U S A 107 (46): 19850–55. 
https://doi.org/10.1073/pnas.1008502107. 
Collaborative Computational Project, Number 4. 1994. “The CCP4 Suite: Programs for 
Protein Crystallography.” Acta Crystallographica Section D Biological 
Crystallography 50 (5): 760–63. https://doi.org/10.1107/S0907444994003112. 
Community, Synthetic Biology. 2003. “Synthetic Biology: Applications and 
Dimensions.” Synthetic Biology Project. 
http://syntheticbiology.org/Applications.html. 
Cortajarena, A. L., T. Kajander, W. Pan, M. J. Cocco, and L. Regan. 2004. “Protein 
Design to Understand Peptide Ligand Recognition by Tetratricopeptide Repeat 
Proteins.” Protein Engineering Design and Selection 17 (4): 399–409. 
https://doi.org/10.1093/protein/gzh047. 
Cortajarena, Aitziber L, Jimin Wang, and Lynne Regan. 2010. “Crystal Structure of a 
Designed Tetratricopeptide Repeat Module in Complex with Its Peptide Ligand.” 
FEBS Journal 277 (4): 1058–66. https://doi.org/10.1111/j.1742-
4658.2009.07549.x. 
D’Andrea, L D, and L Regan. 2003. “TPR Proteins: The Versatile Helix.” Trends 
Biochem Sci 28 (12): 655–62. https://doi.org/10.1016/j.tibs.2003.10.007. 
Dai, Bin, Cameron J Sargent, Xinrui Gui, Cong Liu, and Fuzhong Zhang. 2019. “Fibril 
Self-Assembly of Amyloid–Spider Silk Block Polypeptides.” Biomacromolecules, 
acs.biomac.9b00218. https://doi.org/10.1021/acs.biomac.9b00218. 
Dassa, Bareket, Nir London, Barry L Stoddard, Ora Schueler-Furman, and Shmuel 
Pietrokovski. 2009. “Fractured Genes: A Novel Genomic Arrangement Involving 
New Split Inteins and a New Homing Endonuclease Family.” Nucleic Acids Res 37 
(8): 2560–73. https://doi.org/10.1093/nar/gkp095. 
  
Chapter 7 References 
160 
 
Debelle, Laurent, and Alain J.P. Alix. 2002. “The Structures of Elastins and Their 
Function.” Biochimie 81 (10): 981–94. 
https://pdf.sciencedirectassets.com/272115/1-s2.0-S0300908400X00363/1-s2.0-
S0300908499002217/main.pdf?x-amz-security-
token=AgoJb3JpZ2luX2VjEML%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwE
aCXVzLWVhc3QtMSJHMEUCIQD6FKBHXaKGMP2QE9qebiLsos9xceGRLut
%2FZhR9PpIgNgIgVmyqg2K9Mn. 
Dominguez, Roberto, and Kenneth C Holmes. 2011. “Actin Structure and Function.” 
Annual Review of Biophysics 40: 169–86. https://doi.org/10.1146/annurev-
biophys-042910-155359. 
Edwardson, Thomas G. W., Takahiro Mori, and Donald Hilvert. 2018. “Rational 
Engineering of a Designed Protein Cage for SiRNA Delivery.” Journal of the 
American Chemical Society 140 (33): 10439–42. 
https://doi.org/10.1021/jacs.8b06442. 
Egloff, P, M Hillenbrand, C Klenk, A Batyuk, P Heine, S Balada, K M Schlinkmann, D 
J Scott, M Schütz, and A Plückthun. 2014. “Structure of Signaling-Competent 
Neurotensin Receptor 1 Obtained by Directed Evolution in Escherichia Coli.” Proc 
Natl Acad Sci U S A 111 (6): E655-62. https://doi.org/10.1073/pnas.1317903111. 
Emsley, P., B. Lohkamp, W. G. Scott, and K. Cowtan. 2010. “Features and 
Development of Coot.” Acta Crystallographica Section D Biological 
Crystallography 66 (4): 486–501. https://doi.org/10.1107/S0907444910007493. 
Fairhead, M, G Veggiani, M Lever, J Yan, D Mesner, C V Robinson, O Dushek, P A 
van der Merwe, and M Howarth. 2014. “SpyAvidin Hubs Enable Precise and 
Ultrastable Orthogonal Nanoassembly.” J Am Chem Soc 136 (35): 12355–63. 
https://doi.org/10.1021/ja505584f. 
Fallas, Jorge A., George Ueda, William Sheffler, Vanessa Nguyen, Dan E. McNamara, 
Banumathi Sankaran, Jose Henrique Pereira, et al. 2017. “Computational Design of 
Self-Assembling Cyclic Protein Homo-Oligomers.” Nature Chemistry 9 (4): 353–
60. https://doi.org/10.1038/nchem.2673. 
  
Chapter 7 References 
161 
 
Figueroa, M, N Oliveira, A Lejeune, K W Kaufmann, B M Dorr, A Matagne, J A 
Martial, J Meiler, and C Van de Weerdt. 2013. “Octarellin VI: Using Rosetta to 
Design a Putative Artificial (β/α)8 Protein.” PLoS One 8 (8): e71858. 
https://doi.org/10.1371/journal.pone.0071858. 
Finn, R D, A Bateman, J Clements, P Coggill, R Y Eberhardt, S R Eddy, A Heger, et al. 
2014. “Pfam: The Protein Families Database.” Nucleic Acids Res 42 (Database 
issue): D222-30. https://doi.org/10.1093/nar/gkt1223. 
Flenniken, M L, M Uchida, L O Liepold, S Kang, M J Young, and T Douglas. 2009. “A 
Library of Protein Cage Architectures as Nanomaterials.” Curr Top Microbiol 
Immunol 327: 71–93. http://www.ncbi.nlm.nih.gov/pubmed/19198571. 
Fletcher, J M, R L Harniman, F R Barnes, A L Boyle, A Collins, J Mantell, T H Sharp, 
et al. 2013. “Self-Assembling Cages from Coiled-Coil Peptide Modules.” Science 
340 (6132): 595–99. https://doi.org/10.1126/science.1233936. 
Frangioni, J.V., and B.G. Neel. 1993. “Solubilization and Purification of Enzymatically 
Active Glutathione S-Transferase (PGEX) Fusion Proteins.” Analytical 
Biochemistry 210 (1): 179–87. https://doi.org/10.1006/abio.1993.1170. 
Franke, D., M. V. Petoukhov, P. V. Konarev, A. Panjkovich, A. Tuukkanen, H. D. T. 
Mertens, A. G. Kikhney, et al. 2017. “ATSAS 2.8 : A Comprehensive Data 
Analysis Suite for Small-Angle Scattering from Macromolecular Solutions.” 
Journal of Applied Crystallography 50 (4): 1212–25. 
https://doi.org/10.1107/S1600576717007786. 
Franke, Daniel, and Dmitri I Svergun. 2009. “DAMMIF, a Program for Rapid Ab-Initio 
Shape Determination in Small-Angle Scattering.” Journal of Applied 
Crystallography 42 (Pt 2): 342–46. https://doi.org/10.1107/S0021889809000338. 
Gradišar, Helena, Sabina Božič, Tibor Doles, Damjan Vengust, Iva Hafner-Bratkovič, 
Alenka Mertelj, Ben Webb, Andrej Šali, Sandi Klavžar, and Roman Jerala. 2013. 
“Design of a Single-Chain Polypeptide Tetrahedron Assembled from Coiled-Coil 
Segments.” Nature Chemical Biology 9 (6): 362–66. 
https://doi.org/10.1038/nchembio.1248. 
Green, E M, J C Mansfield, J S Bell, and C P Winlove. 2014. “The Structure and 
Micromechanics of Elastic Tissue.” Interface Focus 4. 
https://doi.org/10.1098/rsfs.2013.0058. 
Chapter 7 References 
162 
 
Grove, Tijana Z., Jason Forster, Genaro Pimienta, Eric Dufresne, and Lynne Regan. 
2012. “A Modular Approach to the Design of Protein-Based Smart Gels.” 
Biopolymers 97 (7): 508–17. https://doi.org/10.1002/bip.22033. 
Grove, Tijana Z, Chinedum O Osuji, Jason D Forster, Eric R Dufresne, and Lynne 
Regan. 2010. “Stimuli-Responsive Smart Gels Realized via Modular Protein 
Design.” Journal of the American Chemical Society 132 (40): 14024–26. 
https://doi.org/10.1021/ja106619w. 
Grove, Tijana Z, Lynne Regan, and Aitziber L Cortajarena. 2013. “Nanostructured 
Functional Films from Engineered Repeat Proteins.” Journal of The Royal Society 
Interface 10 (83): 20130051. https://doi.org/10.1098/rsif.2013.0051. 
Harbury, P B, J J Plecs, B Tidor, T Alber, and P S Kim. 1998. “High-Resolution Protein 
Design with Backbone Freedom.” Science 282 (5393): 1462–67. 
http://www.ncbi.nlm.nih.gov/pubmed/9822371. 
Harvey, Joseph A. 2016. “The Use of Native Chemical Ligation for Controllable 
Assembly of Protein-Based Nanostructures.” 
Harvey, Joseph A., Laura S. Itzhaki, and Ewan R. G. Main. 2018. “Programmed Protein 
Self-Assembly Driven by Genetically Encoded Intein-Mediated Native Chemical 
Ligation.” ACS Synthetic Biology 7 (4): 1067–74. 
https://doi.org/10.1021/acssynbio.7b00447. 
Hengen, Paul N. 1995. “Purification of His-Tag Fusion Proteins from Escherichia Coli.” 
Trends in Biochemical Sciences 20 (7): 285–86. https://doi.org/10.1016/S0968-
0004(00)89045-3. 
Hsia, Yang, Jacob B Bale, Shane Gonen, Dan Shi, William Sheffler, Kimberly K Fong, 
Una Nattermann, et al. 2016. “Design of a Hyperstable 60-Subunit Protein 
Icosahedron.” Nature 535. https://doi.org/10.1038/nature18010. 
Kattula, Sravya, James R Byrnes, and Alisa S Wolberg. 2017. “Fibrinogen and Fibrin in 
Hemostasis and Thrombosis.” Arteriosclerosis, Thrombosis, and Vascular Biology 
37 (3). https://doi.org/10.1161/atvbaha.117.308564. 
Kerfeld, Cheryl A, and Onur Erbilgin. 2015. “Bacterial Microcompartments and the 
Modular Construction of Microbial Metabolism.” Trends in Microbiology 23 (1): 
22–34. https://doi.org/10.1016/j.tim.2014.10.003. 
Chapter 7 References 
163 
 
Kim, Y E, Y N Kim, J A Kim, H M Kim, and Y Jung. 2015. “Green Fluorescent Protein 
Nanopolygons as Monodisperse Supramolecular Assemblies of Functional 
Proteins with Defined Valency.” Nat Commun 6: 7134. 
https://doi.org/10.1038/ncomms8134. 
King, N P, J B Bale, W Sheffler, D E McNamara, S Gonen, T Gonen, T O Yeates, and 
D Baker. 2014. “Accurate Design of Co-Assembling Multi-Component Protein 
Nanomaterials.” Nature 510 (7503): 103–8. https://doi.org/10.1038/nature13404. 
King, N P, W Sheffler, M R Sawaya, B S Vollmar, J P Sumida, I André, T Gonen, T O 
Yeates, and D Baker. 2012. “Computational Design of Self-Assembling Protein 
Nanomaterials with Atomic Level Accuracy.” Science 336 (6085): 1171–74. 
https://doi.org/10.1126/science.1219364. 
Kohl, A, H K Binz, P Forrer, M T Stumpp, A Plückthun, and M G Grütter. 2003. 
“Designed to Be Stable: Crystal Structure of a Consensus Ankyrin Repeat Protein.” 
Proc Natl Acad Sci U S A 100 (4): 1700–1705. 
https://doi.org/10.1073/pnas.0337680100. 
Kreplak, L, J Doucet, P Dumas, and F Briki. 2004. “New Aspects of the Alpha-Helix to 
Beta-Sheet Transition in Stretched Hard Alpha-Keratin Fibers.” Biophysical 
Journal 87 (1): 640–47. https://doi.org/10.1529/biophysj.103.036749. 
Kudryashov, Dmitri S, and Emil Reisler. 2013. “ATP and ADP Actin States.” 
Biopolymers 99 (4): 245–56. https://doi.org/10.1002/bip.22155. 
Lai, Y T, D Cascio, and T O Yeates. 2012. “Structure of a 16-Nm Cage Designed by 
Using Protein Oligomers.” Science 336 (6085): 1129. 
https://doi.org/10.1126/science.1219351. 
Lawson, David M., Peter J. Artymiuk, Stephen J. Yewdall, John M. A. Smith, J. Craig 
Livingstone, Amyra Treffry, Alessandra Luzzago, et al. 1991. “Solving the 
Structure of Human H Ferritin by Genetically Engineering Intermolecular Crystal 
Contacts.” Nature 349 (6309): 541–44. https://doi.org/10.1038/349541a0. 
Lee, J, S I Blaber, V K Dubey, and M Blaber. 2011. “A Polypeptide ‘Building Block’ 
for the β-Trefoil Fold Identified by ‘Top-down Symmetric Deconstruction.’” J Mol 
Biol 407 (5): 744–63. https://doi.org/10.1016/j.jmb.2011.02.002. 
  
Chapter 7 References 
164 
 
Lee, Jung-Lim, Cheon-Seok Park, and Hae-Yeong Kim. 2007. “Functional Assembly of 
Recombinant Human Ferritin Subunits in Pichia Pastoris.” Journal of 
Microbiology and Biotechnology 17 (10): 1695–99. 
http://www.ncbi.nlm.nih.gov/pubmed/18156787. 
Ljubetič, A., I. Drobnak, H. Gradišar, and R. Jerala. 2016. “Designing the Structure and 
Folding Pathway of Modular Topological Bionanostructures.” Chemical 
Communications 52 (30): 5220–29. https://doi.org/10.1039/c6cc00421k. 
Ljubetič, Ajasja, Fabio Lapenta, Helena Gradišar, Igor Drobnak, Jana Aupič, Žiga 
Strmšek, Duško Lainšček, et al. 2017. “Design of Coiled-Coil Protein-Origami 
Cages That Self-Assemble in Vitro and in Vivo.” Nature Biotechnology 35 (11): 
1094. https://doi.org/10.1038/nbt.3994. 
Main, E R, A R Lowe, S G Mochrie, S E Jackson, and L Regan. 2005. “A Recurring 
Theme in Protein Engineering: The Design, Stability and Folding of Repeat 
Proteins.” Curr Opin Struct Biol 15 (4): 464–71. 
https://doi.org/10.1016/j.sbi.2005.07.003. 
Main, E R, K Stott, S E Jackson, and L Regan. 2005. “Local and Long-Range Stability 
in Tandemly Arrayed Tetratricopeptide Repeats.” Proc Natl Acad Sci U S A 102 
(16): 5721–26. https://doi.org/10.1073/pnas.0404530102. 
Main, E R, Y Xiong, M J Cocco, L D’Andrea, and L Regan. 2003. “Design of Stable 
Alpha-Helical Arrays from an Idealized TPR Motif.” Structure 11 (5): 497–508. 
http://www.ncbi.nlm.nih.gov/pubmed/12737816. 
Markham, Nicholas R., and Michael Zuker. 2008. “UNAFold.” In , 3–31. Humana 
Press. https://doi.org/10.1007/978-1-60327-429-6_1. 
Martin, D D, M Q Xu, and T C Evans. 2001. “Characterization of a Naturally Occurring 
Trans-Splicing Intein from Synechocystis Sp. PCC6803.” Biochemistry 40 (5): 
1393–1402. http://www.ncbi.nlm.nih.gov/pubmed/11170467. 
Mateu, Mauricio G. 2013. “Assembly, Stability and Dynamics of Virus Capsids.” 
Archives of Biochemistry and Biophysics 531: 65–79. 
https://doi.org/10.1016/j.abb.2012.10.015. 
  
Chapter 7 References 
165 
 
McKittrick, J., P. Y. Chen, S G Bodde, W Yang, E E Novitskaya, and M A Meyers. 
2012. “The Structure, Functions, and Mechanical Properties of Keratin.” JOM 64 
(4): 449–68. https://doi.org/10.1007/s11837-012-0302-8. 
Mosavi, L K, D L Minor, and Z Y Peng. 2002. “Consensus-Derived Structural 
Determinants of the Ankyrin Repeat Motif.” Proc Natl Acad Sci U S A 99 (25): 
16029–34. https://doi.org/10.1073/pnas.252537899. 
Motojima, Fumihiro. 2015. “How Do Chaperonins Fold Protein?” BIOPHYSICS 11: 
93–102. https://doi.org/10.2142/biophysics.11.93. 
Pang, A, S Frank, I Brown, M J Warren, and R W Pickersgill. 2014. “Structural Insights 
into Higher Order Assembly and Function of the Bacterial Microcompartment 
Protein PduA.” J Biol Chem 289 (32): 22377–84. 
https://doi.org/10.1074/jbc.M114.569285. 
Parsons, J B, S Frank, D Bhella, M Liang, M B Prentice, D P Mulvihill, and M J 
Warren. 2010. “Synthesis of Empty Bacterial Microcompartments, Directed 
Organelle Protein Incorporation, and Evidence of Filament-Associated Organelle 
Movement.” Mol Cell 38 (2): 305–15. 
https://doi.org/10.1016/j.molcel.2010.04.008. 
Perlmutter, Jason D, and Michael F Hagan. 2015. “Mechanisms of Virus Assembly.” 
Annual Review of Physical Chemistry 66 (April): 217–39. 
https://doi.org/10.1146/annurev-physchem-040214-121637. 
Petoukhov, Maxim V., Peter V. Konarev, Alexey G. Kikhney, and Dmitri I. Svergun. 
2007. “ATSAS 2.1 – towards Automated and Web-Supported Small-Angle 
Scattering Data Analysis.” Journal of Applied Crystallography 40 (s1): s223–28. 
https://doi.org/10.1107/S0021889807002853. 
Phillips, J J, Y Javadi, C Millership, and E R Main. 2012. “Modulation of the Multistate 
Folding of Designed TPR Proteins through Intrinsic and Extrinsic Factors.” 
Protein Sci 21 (3): 327–38. https://doi.org/10.1002/pro.2018. 
Phillips, Jonathan J., Charlotte Millership, and Ewan R. G. Main. 2012. “Fibrous 
Nanostructures from the Self-Assembly of Designed Repeat Protein Modules.” 
Angew Chem Int Ed Engl 51 (52): 13132–35. 
https://doi.org/10.1002/anie.201203795.  
Chapter 7 References 
166 
 
Pollard, Thomas D, Laurent Blanchoin, and R. Dyche Mullins. 2002. “Molecular 
Mechanisms Controlling Actin Filament Dynamics in Nonmuscle Cells.” Annual 
Review of Biophysics and Biomolecular Structure 29 (1): 545–76. 
https://doi.org/10.1146/annurev.biophys.29.1.545. 
Rath, Arianna, Mira Glibowicka, Vincent G. Nadeau, Gong Chen, and Charles M. 
Deber. 2009. “Detergent Binding Explains Anomalous SDS-PAGE Migration of 
Membrane Proteins.” Proceedings of the National Academy of Sciences 106 (6): 
1760–65. https://doi.org/10.1073/pnas.0813167106. 
Rauscher, Sarah. 2017. “The Liquid Structure of Elastin Aggregates.” Biophysics and 
Structural Biology, 1–21. https://doi.org/10.7554/eLife.26526.001. 
Roos, W H, I L Ivanovska, A Evilevitch, and G J L Wuite. 2007. “Viral Capsids: 
Mechanical Characteristics, Genome Packaging and Delivery Mechanisms.” 
Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-007-6451-1. 
Ross, James F, Angela Bridges, Jordan M Fletcher, Deborah Shoemark, Dominic 
Alibhai, Harriet E V Bray, Joseph L Beesley, et al. 2017. “Decorating Self-
Assembled Peptide Cages with Proteins.” https://doi.org/10.1021/acsnano.7b02368. 
Ross, James F, Gemma C Wildsmith, Michael Johnson, Daniel L Hurdiss, Kristian 
Hollingsworth, Rebecca F Thompson, Majid Mosayebi, et al. 2019. “Directed 
Assembly of Homopentameric Cholera Toxin B-Subunit Proteins into Higher-
Order Structures Using Coiled-Coil Appendages.” 
https://doi.org/10.1021/jacs.8b11480. 
SantaLucia, John, and Donald Hicks. 2004. “The Thermodynamics of DNA Structural 
Motifs.” Annual Review of Biophysics and Biomolecular Structure 33 (1): 415–40. 
https://doi.org/10.1146/annurev.biophys.32.110601.141800. 
Schlinkmann, K M, and A Plückthun. 2013. “Directed Evolution of G-Protein-Coupled 
Receptors for High Functional Expression and Detergent Stability.” Methods 
Enzymol 520: 67–97. https://doi.org/10.1016/B978-0-12-391861-1.00004-6. 
  
Chapter 7 References 
167 
 
Sciore, Aaron, Min Su, Philipp Koldewey, Joseph D Eschweiler, Kelsey A Diffley, 
Brian M Linhares, Brandon T Ruotolo, James C A Bardwell, Georgios Skiniotis, 
and E Neil G Marsh. 2016. “Flexible, Symmetry-Directed Approach to 
Assembling Protein Cages.” Proceedings of the National Academy of Sciences of 
the United States of America 113 (31): 8681–86. 
https://doi.org/10.1073/pnas.1606013113. 
Scotter, A J, M Guo, M M Tomczak, M E Daley, R L Campbell, R J Oko, D A Bateman, 
A Chakrabartty, B D Sykes, and P L Davies. 2007. “Metal Ion-Dependent, 
Reversible, Protein Filament Formation by Designed Beta-Roll Polypeptides.” 
BMC Struct Biol 7: 63. https://doi.org/10.1186/1472-6807-7-63. 
Shah, Neel H, and Tom W Muir. 2014. “Inteins: Nature’s Gift to Protein Chemists.” 
Chemical Science 5 (1): 446–61. https://doi.org/10.1039/C3SC52951G. 
Speltz, E B, A Nathan, and L Regan. 2015. “Design of Protein-Peptide Interaction 
Modules for Assembling Supramolecular Structures in Vivo and in Vitro.” ACS 
Chem Biol 10 (9): 2108–15. https://doi.org/10.1021/acschembio.5b00415. 
Spiess, Christoph, Anne S Meyer, Stefanie Reissmann, and Judith Frydman. 2004. 
“Mechanism of the Eukaryotic Chaperonin: Protein Folding in the Chamber of 
Secrets.” Trends Cell Biol 14 (11): 598–604. 
https://doi.org/10.1016/j.tcb.2004.09.015. 
Stranges, P B, and B Kuhlman. 2013. “A Comparison of Successful and Failed Protein 
Interface Designs Highlights the Challenges of Designing Buried Hydrogen Bonds.” 
Protein Sci 22 (1): 74–82. https://doi.org/10.1002/pro.2187. 
Svergun, D., C. Barberato, and M. H. J. Koch. 1995. “CRYSOL – a Program to Evaluate 
X-Ray Solution Scattering of Biological Macromolecules from Atomic 
Coordinates.” Journal of Applied Crystallography 28 (6): 768–73. 
https://doi.org/10.1107/S0021889895007047. 
Svergun, D. I. 1992. “Determination of the Regularization Parameter in Indirect-
Transform Methods Using Perceptual Criteria.” Journal of Applied 
Crystallography 25 (pt 4): 495–503. https://doi.org/10.1107/S0021889892001663. 
  
Chapter 7 References 
168 
 
Svergun, D I. 1999. “Restoring Low Resolution Structure of Biological 
Macromolecules from Solution Scattering Using Simulated Annealing.” 
Biophysical Journal 76 (6): 2879–86. https://doi.org/10.1016/S0006-
3495(99)77443-6. 
Svergun, D I, M V Petoukhov, and M H Koch. 2001. “Determination of Domain 
Structure of Proteins from X-Ray Solution Scattering.” Biophysical Journal 80 (6): 
2946–53. https://doi.org/10.1016/S0006-3495(01)76260-1. 
Uddin, Ismail, Stefanie Frank, Martin J. Warren, and Richard W. Pickersgill. 2018. “A 
Generic Self-Assembly Process in Microcompartments and Synthetic Protein 
Nanotubes.” Small 14 (19): 1704020. https://doi.org/10.1002/smll.201704020. 
Undas, Anetta, and Robert A S Ariëns. 2011. “Brief Review Fibrin Clot Structure and 
Function A Role in the Pathophysiology of Arterial and Venous Thromboembolic 
Diseases.” https://doi.org/10.1161/ATVBAHA.111.230631. 
Vagin, Alexei A., Roberto A. Steiner, Andrey A. Lebedev, Liz Potterton, Stuart 
McNicholas, Fei Long, and Garib N. Murshudov. 2004. “REFMAC 5 Dictionary: 
Organization of Prior Chemical Knowledge and Guidelines for Its Use.” Acta 
Crystallographica Section D Biological Crystallography 60 (12): 2184–95. 
https://doi.org/10.1107/S0907444904023510. 
Voet, A R, H Noguchi, C Addy, D Simoncini, D Terada, S Unzai, S Y Park, K Y Zhang, 
and J R Tame. 2014. “Computational Design of a Self-Assembling Symmetrical β-
Propeller Protein.” Proc Natl Acad Sci U S A 111 (42): 15102–7. 
https://doi.org/10.1073/pnas.1412768111. 
Volkov, Vladimir V., and Dmitri I. Svergun. 2003. “Uniqueness of Ab Initio Shape 
Determination in Small-Angle Scattering.” Journal of Applied Crystallography 36 
(3): 860–64. https://doi.org/10.1107/S0021889803000268. 
Votteler, Jörg, Cassandra Ogohara, Sue Yi, Yang Hsia, Una Nattermann, David M 
Belnap, Neil P King, and Wesley I Sundquist. 2016. “Designed Proteins Induce the 
Formation of Nanocage-Containing Extracellular Vesicles.” Nature 540 (7632): 
292–95. https://doi.org/10.1038/nature20607. 
  
Chapter 7 References 
169 
 
Wang, Bin, Wen Yang, Joanna McKittrick, and Marc André Meyers. 2016. “Keratin: 
Structure, Mechanical Properties, Occurrence in Biological Organisms, and Efforts 
at Bioinspiration.” Progress in Materials Science 76 (March): 229–318. 
https://doi.org/10.1016/j.pmatsci.2015.06.001. 
Watanabe, T, Y Ito, T Yamada, M Hashimoto, S Sekine, and H Tanaka. 1994. “The 
Roles of the C-Terminal Domain and Type III Domains of Chitinase A1 from 
Bacillus Circulans WL-12 in Chitin Degradation.” Journal of Bacteriology 176 
(15): 4465. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC196264/. 
Weisel, John W, and Rustem I Litvinov. 2017. “Fibrin Formation, Structure and 
Properties.” Sub-Cellular Biochemistry 82: 405–56. https://doi.org/10.1007/978-3-
319-49674-0_13. 
“What Is Synthetic Biology?” 2015. Synthetic Biology Project. 
http://www.synbioproject.org/topics/synbio101/definition/. 
Wolberg, Alisa S, Robert A Campbell, and Alisa S Wolberg. 2008. “Thrombin 
Generation, Fibrin Clot Formation and Hemostasis.” Transfus Apher Sci 38 (1): 
15–23. https://doi.org/10.1016/j.transci.2007.12.005. 
Woolfson, Derek N. 2014. “Assessing Cellular Response to Functionalized α-Helical 
Peptide Hydrogels.” Advanced Healthcare Materials 3 (9): 1387–91. 
https://doi.org/10.1002/adhm.201400065. 
Wright, James N. 2018. “Studies on the Self-Assembly of Geometrically Designed 
Protein Fusions Using Genetically Programmed Chemistry.” 
Wu, H, Z Hu, and X Q Liu. 1998. “Protein Trans-Splicing by a Split Intein Encoded in 
a Split DnaE Gene of Synechocystis Sp. PCC6803.” Proceedings of the National 
Academy of Sciences of the United States of America 95 (16): 9226–31. 
http://www.ncbi.nlm.nih.gov/pubmed/9689062. 
Yamagami, Motoya, Tomohisa Sawada, and Makoto Fujita. 2018. “Synthetic β-Barrel 
by Metal-Induced Folding and Assembly.” J. Am. Chem. Soc 140: 15. 
https://doi.org/10.1021/jacs.8b04284. 
Yin, Liang, Xiang Guo, Lu Liu, Yong Zhang, and Yan Feng. 2019. “Self-Assembled 
Multimeric-Enzyme Nanoreactor for Robust and Efficient Biocatalysis” 8: 5. 
https://doi.org/10.1021/acsbiomaterials.8b00279. 
Chapter 7 References 
170 
 
Zettler, J, V Schütz, and H D Mootz. 2009. “The Naturally Split Npu DnaE Intein 
Exhibits an Extraordinarily High Rate in the Protein Trans-Splicing Reaction.” 
FEBS Lett 583 (5): 909–14. https://doi.org/10.1016/j.febslet.2009.02.003. 
Zhang, Yu, and Brendan P Orner. 2011. “Self-Assembly in the Ferritin Nano-Cage 
Protein Superfamily.” International Journal of Molecular Sciences 12 (8): 5406–
21. https://doi.org/10.3390/ijms12085406. 
 
